Associate Professor Aaron Hansen

Hansen, Aaron and Le Tourneau, Christophe (2016). Phase I study methodology in head and neck oncology. Head and Neck Cancer: Multimodality Management, Second Edition. (pp. 731-742) Springer International Publishing. doi: 10.1007/978-3-319-27601-4_43

Tam, Laura and Hansen, Aaron R. (2025). ARTSCAN: Time to Rethink De-escalation in LA-HNSCC. International Journal of Radiation Oncology Biology Physics, 123 (3), 691-693. doi: 10.1016/j.ijrobp.2025.05.081

Soleimani, Shirin, Li, Xuan, Wang, Ben X., Pedersen, Stephanie, Bruce, Jeffrey P., Eagles, Jenna, Liu, Zhihui Amy, Bratman, Scott V., Butler, Marcus O., Hansen, Aaron R., Bedard, Philippe L., Lheureux, Stephanie, Spreafico, Anna, Razak, Albiruni, Siu, Lillian L., Ohashi, Pamela S. and Pugh, Trevor J. (2025). T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab. Cell Reports, 44 (9) 116190, 1-23. doi: 10.1016/j.celrep.2025.116190

Maio, Michele, Moreno, Victor, Martin-Liberal, Juan, Opdam, Frans, Hansen, Aaron, Bauer, Todd M, Le Tourneau, Christophe, Italiano, Antoine, Rischin, Danny, Ellis, Catherine, Turner, David, Yadavilli, Sapna, Zhou, Helen, Hirschfeld, Steven, Ballas, Marc, Diaz-Padilla, Ivan and Angevin, Eric (2025). First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer, 13 (8) e011475, e011475-8. doi: 10.1136/jitc-2025-011475

Ng, Stephanie, Ward, Elizabeth C., Garvey, Gail, Butler, Tamara, Tesiram, Joanne, Brown, Bena, Foley, Jasmine, Packer, Rebecca and Hansen, Aaron (2025). First Nations Australians and head and neck cancer: health professionals’ priorities for improving the pathway of care. Supportive Care in Cancer, 33 (7) 624, 1-12. doi: 10.1007/s00520-025-09651-y

Noel, Christopher W., Keshavarzi, Sareh, Forner, David, Stephens, Robert F., Watson, Erin, Monteiro, Eric, Hosni, Ali, Hansen, Aaron, Goldstein, David P. and de Almeida, John R. (2025). Construct validity of the EuroQoL-5 Dimension and the Health Utilities Index in head and neck cancer. Otolaryngology-Head and Neck Surgery, 166 (5), 877-885. doi: 10.1177/01945998211030173

de Almeida, John R., Su, Jie, Alshenaiber, Abdullah, Noroozi, Hesameddin, Buttner, Matthias, Goldstein, David P., Hansen, Aaron, Kowalski, Luiz P., Licitra, Lisa, Mehanna, Hisham, Noel, Christopher W., Parmar, Ambica, Porceddu, Sandro, Ringash, Jolie, Rogers, Simon, Dos Santos, Marcos Antonio, Simon, Christian, Truong, Minh-Tam and Xu, Wei (2025). Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D) A Head and Neck Cancer International Group Collaborative Study. Jama Otolaryngology-Head & Neck Surgery, 151 (6), 549-557. doi: 10.1001/jamaoto.2025.0160

Carneiro, Benedito A., Jotte, Robert M., Gabrail, Nashat Y., Wentzel, Kristopher, Huang, Funan, Chaturvedi, Shalini, Weispfenning, Anke, Hiemeyer, Florian, Morcos, Peter N., Soler, Lidia Mongay, Childs, Barrett H. and Hansen, Aaron R. (2025). Safety and efficacy of Copanlisib in combination with Nivolumab: a phase Ib study in patients with advanced solid tumors. Cancer Research Communications, 5 (3), 444-457. doi: 10.1158/2767-9764.CRC-24-0407

O'Malley, David M., Bariani, Giovani M., Cassier, Philippe A., Marabelle, Aurelien, Hansen, Aaron R., Acosta, Ana De Jesus, Miller Jr, Wilson H., Safra, Tamar, Italiano, Antoine, Mileshkin, Linda, Yao, Lili, Gozma, Alexander, Jin, Fan and Maio, Michele (2025). Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results. Gynecologic Oncology, 193, 130-135. doi: 10.1016/j.ygyno.2024.12.020

Calvo, Emiliano, Doger, Bernard, Carles, Joan, Peer, Avivit, Sarid, David, Eigl, Bernhard J., Avadhani, Anjali, Yao, David, Lin, Vincent, Wu, Shujian, Jaiprasart, Pharavee, Loffredo, John, Tamegnon, Monelle, Xu, Weichun, Xie, Hong and Hansen, Aaron R. (2025). A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer. Oncologist, 30 (1) oyae313, 1-9. doi: 10.1093/oncolo/oyae313

Winquist, Eric, Hotte, Sebastien J., Chi, Kim, Sridhar, Srikala, Ellard, Susan, Ong, Michael, Iqbal, Nayyer, Salim, Muhammad, Emmenegger, Urban, Gingerich, Joel R., Lalani, Aly-Khan, Major, Pierre, Kollmannsberger, Christian, Yip, Steven, Hansen, Aaron, Finch, Daygen, Canil, Christina, Hutchenreuther, James, Vera-Badillo, Francisco, Smoragiewicz, Martin, Cabanero, Michael, Tsao, Ming-Sound, Ritch, Elie, Wyatt, Alexander W. and Seymour, Lesley (2025). Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research, 31 (1), 45-55. doi: 10.1158/1078-0432.CCR-24-1612

Manojlovic-Kolarski, Mirko, Su, Susie, Weinreb, Ilian, Calvisi, Robert, Perez-Ordonez, Bayardo, Smith, Stephen, Patel, Snehal, Valero, Cristina, Xu, Bin, Ghossein, Ronald, Katabi, Nora, Clark, Jonathan, Low, Tsu-Hui (Hubert), Gupta, Ruta, Graboyes, Evan, Davies, Joel, Richardson, Mary, Goldstein, David, Huang, Shao Hui, O'sullivan, Brian, Xu, Weu, Hansen, Aaron and De Almeida, John R. (2025). Adjuvant Chemoradiotherapy for Oral Cavity SCC With Minor and Major Extranodal Extension. JAMA Otolaryngology - Head and Neck Surgery, 785-8. doi: 10.1001/jamaoto.2025.1721

Hansen, Aaron R., Gomez-Roca, Carlos A., Robbrecht, Debbie G.J., Verlingue, Loic, Italiano, Antoine, Bauman, Julie E., Steeghs, Neeltje, Prenen, Hans, Fayette, Jérôme, Spicer, James, Niu, Jiaxin, Habigt, Christin, Schneider, Meike, Evers, Stefan, Sleiman, Nassim, Dejardin, David, Ardeshir, Caroline, Schmid, Daniela, Boetsch, Christophe, Charo, Jehad, Kraxner, Anton, Teichgräber, Volker, Keshelava, Nino and Bonomi, Marcelo R. (2024). Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research, 30 (24), 5540-5547. doi: 10.1158/1078-0432.CCR-24-1562

Ayre, Susannah K., Johnston, Elizabeth A., Bourdaniotis, Xanthia E., Zajdlewicz, Leah, Beesley, Vanessa L., Pole, Jason D., Hansen, Aaron, Gasper, Harry, Cossio, Danica, Lock, Gemma and Goodwin, Belinda C. (2024). From many voices, one question: community co-design of a population-based qualitative cancer research study. PLoS One, 19 (8) e0309361, 1-22. doi: 10.1371/journal.pone.0309361

Algazi, A., Papadopoulos, K. P., Tsai, F., Hansen, A. R., Angra, N., Das, M., Sheth, S. and Siu, L. L. (2024). Safety and clinical activity of durvalumab combined with tremelimumab in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase I study. Esmo Open, 9 (8) 103646, 103646. doi: 10.1016/j.esmoop.2024.103646

de Almeida, John R., Martino, Rosemary, Hosni, Ali, Goldstein, David P., Bratman, Scott V., Chepeha, Douglas B., Waldron, John N., Weinreb, Ilan, Perez-Ordonez, Bayardo, Yu, Eugene, Metser, Ur, Hansen, Aaron R., Xu, Wei, Su, Susie Jie and Kim, John (2024). Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck. Jama Otolaryngology-Head & Neck Surgery, 150 (6), 463-471. doi: 10.1001/jamaoto.2024.0423

Chénard-Poirier, Maxime, Hansen, Aaron R., Gutierrez, Martin E., Rasco, Drew, Xing, Yan, Chen, Lin-Chi, Zhou, Heng, Webber, Andrea L., Freshwater, Tomoko and Sharma, Manish R. (2024). A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors. Investigational New Drugs, 42 (3), 241-251. doi: 10.1007/s10637-024-01428-0

Stutheit-Zhao, Eric Y., Sanz-Garcia, Enrique, Liu, Zhihui, Wong, Derek, Marsh, Kayla, Abdul Razak, Albiruni R., Spreafico, Anna, Bedard, Philippe L., Hansen, Aaron R., Lheureux, Stephanie, Torti, Dax, Lam, Bernard, Yang, Shih Yu Cindy, Burgener, Justin, Luo, Ping, Zeng, Yong, Cheng, Nicholas, Awadalla, Philip, Bratman, Scott V., Ohashi, Pamela S., Pugh, Trevor J. and Siu, Lillian L. (2024). Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors. Cancer Discovery, 14 (6), 1048-1063. doi: 10.1158/2159-8290.CD-23-1060

Armstrong, Andrew J., Geva, Ravit, Chung, Hyun Cheol, Lemech, Charlotte, Miller Jr, Wilson H., Hansen, Aaron R., Lee, Jong-Seok, Tsai, Frank, Solomon, Benjamin J., Kim, Tae Min, Rolfo, Christian, Giranda, Vincent, Ren, Yixin, Liu, Fang, Kandala, Bhargava, Freshwater, Tomoko and Wang, Judy S. (2024). CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial (vol 42, pg 145, 2024). Investigational New Drugs, 42 (3), 340-341. doi: 10.1007/s10637-024-01444-0

Oliva, Marc, Heirali, Alya, Watson, Geoffrey, Rooney, Ashley M., Cochrane, Kyla, Jennings, Sarah, Taylor, Rachel, Xu, Minge, Hosni, Ali, Hope, Andrew, Bratman, Scott V., Chepeha, Douglas, Weinreb, Ilan, Perez-Ordonez, Bayardo, Nin, Ricard Mesia, Waldron, John, Xu, Wei, Hansen, Aaron R., Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2024). Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. British Journal of Cancer, 130 (12), 1936-1942. doi: 10.1038/s41416-024-02701-y

Lampe, Harriet, Tam, Laura and Hansen, Aaron R. (2024). Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future. Frontiers in Pharmacology, 15 1399802, 1-13. doi: 10.3389/fphar.2024.1399802

Griffiths, Matthew R., Pattison, David A., Latter, Melissa, Kuan, Kevin, Taylor, Stephen, Tieu, William, Kryza, Thomas, Meyrick, Danielle, Lee, Boon Quan, Hansen, Aaron, Rose, Stephen E. and Puttick, Simon G. (2024). First-in-human212Pb-PSMA–targeted α-therapy SPECT/CT imaging in a patient with metastatic castration-resistant prostate cancer. Journal of Nuclear Medicine, 65 (4), 664-664. doi: 10.2967/jnumed.123.267189

Hilton, John F., Ott, Patrick A., Hansen, Aaron R., Li, Zujun, Mathew, Matthen, Messina, Cristina H., Dave, Vimal, Ji, Xiao, Karpinich, Natalie O., Hirschfeld, Steven, Ballas, Marc and Zandberg, Dan P. (2024). INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer Immunology, Immunotherapy, 73 (3) 44, 1-12. doi: 10.1007/s00262-023-03623-z

Sanz-Garcia, Enrique, Zou, Jinfeng, Avery, Lisa, Spreafico, Anna, Waldron, John, Goldstein, David, Hansen, Aaron, Cho, B. C. John, de Almeida, John, Hope, Andrew, Hosni, Ali, Hahn, Ezra, Perez-Ordonez, Bayardo, Zhao, Zhen, Smith, Christopher, Zheng, Yangqiao, Singaravelan, Nitthusha, Bratman, Scott V. and Siu, Lillian L. (2024). Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck. Cell Death and Differentiation, 31 (4), 460-468. doi: 10.1038/s41418-024-01272-y

Parthipan, Milothy, Feng, Gregory, Breunis, Henriette, Timilshina, Narhari, Emmenegger, Urban, Hansen, Aaron, Tomlinson, George, Matthew, Andrew, Clarke, Hance, Santa Mina, Daniel, Soto-Perez-de-Celis, Enrique, Puts, Martine and Alibhai, Shabbir M. H. (2024). Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. Journal of Geriatric Oncology, 15 (3) 101720. doi: 10.1016/j.jgo.2024.101720

Armstrong, Andrew J., Geva, Ravit, Chung, Hyun Cheol, Lemech, Charlotte, Miller Jr., Wilson H., Hansen, Aaron R., Lee, Jong-Seok, Tsai, Frank, Solomon, Benjamin J., Kim, Tae Min, Rolfo, Christian, Giranda, Vincent, Ren, Yixin, Liu, Fang, Kandala, Bhargava, Freshwater, Tomoko and Wang, Judy S. (2024). CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational New Drugs, 42 (1), 145-159. doi: 10.1007/s10637-023-01410-2

Al-Ezzi, Esmail, Mittal, Abhenil, Veitch, Zachary W., Zahralliyali, Amer, Mejia, Nely Mercy Diaz, Abdeljalil, Osama, Alqaisi, Husam, Kumar, Vikaash, Hansen, Aaron R., Fallah-Rad, Nazanin and Sridhar, Srikala S. (2024). The survival outcomes of the metastatic nonclear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre experience. Journal of Kidney Cancer and VHL, 11 (1), 41-48. doi: 10.15586/jkcvhl.v11i1.307

Lee, Cha Len, O'Kane, Grainne M., Mason, Warren P., Zhang, Wen-Jiang, Spiliopoulou, Pavlina, Hansen, Aaron R., Grant, Robert C., Knox, Jennifer J., Stockley, Tracy L., Zadeh, Gelareh and Chen, Eric X. (2024). Circulating oncometabolite 2-hydroxyglutarate as a potential biomarker for isocitrate dehydrogenase (IDH1/2) mutant cholangiocarcinoma. Molecular Cancer Therapeutics, 23 (3), 394-399. doi: 10.1158/1535-7163.mct-23-0460

Genta, Sofia, Lajkosz, Katherine, Yee, Noelle R., Spiliopoulou, Pavlina, Heirali, Alya, Hansen, Aaron R., Siu, Lillian L., Saibil, Sam, Stayner, Lee-Anne, Yanekina, Maryia, Sauder, Maxwell B., Keshavarzi, Sareh, Salawu, Abdulazeez, Vornicova, Olga, Butler, Marcus O., Bedard, Philippe L., Razak, Albiruni R. Abdul, Rottapel, Robert, Chruscinski, Andrzej, Coburn, Bryan and Spreafico, Anna (2023). Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT). Journal of Experimental and Clinical Cancer Research, 42 (1) 276. doi: 10.1186/s13046-023-02851-6

Salawu, Abdulazeez, Wang, Ben X., Han, Ming, Geady, Caryn, Heirali, Alya, Berman, Hal K., Pfister, Thomas D., Hernando-Calvo, Alberto, Al-Ezzi, Esmail Mutahar, Stayner, Lee-Anne, Gupta, Abha A., Ayodele, Olubukola, Lam, Bernard, Hansen, Aaron R., Spreafico, Anna, Bedard, Philippe L., Butler, Marcus O., Avery, Lisa, Coburn, Bryan, Haibe-Kains, Benjamin, Siu, Lillian L. and Abdul Razak, Albiruni R. (2023). Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial. Clinical Cancer Research, 29 (20), 4128-4138. doi: 10.1158/1078-0432.CCR-23-1137

Hernando-Calvo, Alberto, Malone, Eoghan, Day, Daphne, Prawira, Amy, Weinreb, Ilan, Yang, S. Y. Cindy, Wong, Horace, Rodriguez, Angela, Jennings, Sarah, Eliason, Anneli, Wang, Lisa, Spreafico, Anna, Siu, Lillian L. and Hansen, Aaron R. (2023). Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial. Cancer Medicine, 12 (20), 20299-20310. doi: 10.1002/cam4.6589

Geissel, Matthias, Harvey-Thompson, Adam J., Weis, Matthew R., Fein, Jeffrey R., Ampleford, David, Bliss, David E., Hansen, Aaron M., Jennings, Christopher, Kimmel, Mark W., Rambo, Patrick, Shores, Jonathon E., Smith, Ian C., Speas, C. Shane and Porter, John L. (2023). Helium as a Surrogate for Deuterium in LPI Studies. Laser and Particle Beams, 2023 2083295. doi: 10.1155/2023/2083295

Fleshner, Neil E., Sayyid, Rashid K., Hansen, Aaron R., Chin, Joseph L.K., Fernandes, Ricardo, Winquist, Eric, van der Kwast, Theodorus, Sweet, Joan, Lajkosz, Katherine, Kenk, Miran, Hersey, Karen, Veloso, Rosette, Berlin, Doron, Herrera-Caceres, Jaime O., Sridhar, Srikala, Moussa, Madeleine, Finelli, Antonio, Hamilton, Robert J., Kulkarni, Girish S., Zlotta, Alexandre R. and Joshua, Anthony M. (2023). Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial. Clinical Cancer Research, 29 (19), 3867-3874. doi: 10.1158/1078-0432.ccr-23-0731

Al-Ezzi, Esmail M., Zahralliyali, Amer, Hansen, Aaron R., Hamilton, Robert J., Crump, Michael, Kuruvilla, John, Wood, Lori, Nappi, Lucia, Kollmannsberger, Christian K., North, Scott A., Winquist, Eric, Soulieres, Denis, Hotte, Sebastien J. and Jiang, Di Maria (2023). The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. Current Oncology, 30 (7), 6166-6176. doi: 10.3390/curroncol30070458

Spreafico, A., Heirali, A. A., Araujo, D. V., Tan, T. J., Oliva, M., Schneeberger, P. H. H., Chen, B., Wong, M. K., Stayner, L-A., Hansen, A. R., Saibil, S. D., Wang, B. X., Cochrane, K., Sherriff, K., Allen-Vercoe, E., Xu, W., Siu, L. L. and Coburn, B. (2023). First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial). Annals of Oncology, 34 (6), 520-530. doi: 10.1016/j.annonc.2023.02.011

Lim, Emerson A., Schweizer, Michael T., Chi, Kim N., Aggarwal, Rahul, Agarwal, Neeraj, Gulley, James, Attiyeh, Edward, Greger, James, Wu, Shujian, Jaiprasart, Pharavee, Loffredo, John, Bandyopadhyay, Nibedita, Xie, Hong and Hansen, Aaron R. (2023). Phase 1 study of safety and preliminary clinical activity of JNJ-63898081, a PSMA and CD3 bispecific antibody, for metastatic castration-resistant prostate cancer. Clinical Genitourinary Cancer, 21 (3), 366-375. doi: 10.1016/j.clgc.2023.02.010

Taylor, Kirsty, Zou, Jinfeng, Magalhaes, Marcos, Oliva, Marc, Spreafico, Anna, Hansen, Aaron R., McDade, Simon S., Coyle, Vicky M., Lawler, Mark, Elimova, Elena, V. Bratman, Scott and Siu, Lillian L. (2023). Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. European Journal of Cancer, 188, 29-38. doi: 10.1016/j.ejca.2023.04.014

Postel-Vinay, Sophie, Lam, Vincent K., Ros, Willeke, Bauer, Todd M., Hansen, Aaron R., Cho, Daniel C., Stephen Hodi, F., Schellens, Jan H. M., Litton, Jennifer K., Aspeslagh, Sandrine, Autio, Karen A., Opdam, Frans L., McKean, Meredith, Somaiah, Neeta, Champiat, Stephane, Altan, Mehmet, Spreafico, Anna, Rahma, Osama, Paul, Elaine M., Ahlers, Christoph M., Zhou, Helen, Struemper, Herbert, Gorman, Shelby A., Watmuff, Maura, Yablonski, Kaitlin M., Yanamandra, Niranjan, Chisamore, Michael J., Schmidt, Emmett, Hoos, Axel ... Heymach, John (2023). First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Journal for Immunotherapy of Cancer, 11 (3) e005301, e005301. doi: 10.1136/jitc-2022-005301

Yang, Helen, Kim, Valerie S., Timilshina, Narhari, Breunis, Henriette, Emmenegger, Urban, Gregg, Richard, Hansen, Aaron, Tomlinson, George and Alibhai, Shabbir M. H. (2023). Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancer. Journal of Geriatric Oncology, 14 (1) 101395. doi: 10.1016/j.jgo.2022.10.010

Spiliopoulou, Pavlina, van Rensburg, Helena J. Janse J., Avery, Lisa, Kulasingam, Vathany, Razak, Albiruni, Bedard, Philippe, Hansen, Aaron, Chruscinski, Andrzej, Wang, Ben, Kulikova, Maria, Chen, Rachel, Speers, Vanessa, Nguyen, Alisa, Lee, Jasmine, Coburn, Bryan, Spreafico, Anna and Siu, Lillian L. (2023). Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy. Cell Death & Disease, 14 (1) 49. doi: 10.1038/s41419-022-05548-4

Kim, Valerie S., Yang, Helen, Timilshina, Narhari, Breunis, Henriette, Emmenegger, Urban, Gregg, Richard, Hansen, Aaron R., Tomlinson, George and Alibhai, Shabbir M. H. (2023). The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer. Journal of Geriatric Oncology, 14 (2) 101417. doi: 10.1016/j.jgo.2022.12.005

Mittal, Abhenil, Al-Ezzi, Esmail, Li, Xuan, Moloney, Brian, Wilson, Brooke, Spiliopoulou, Pavlina, Sridhar, Srikala, Fallah-Rad, Nazanin, Chung, Peter, Hamilton, Robert James, O’malley, Martin and Hansen, Aaron R. (2023). The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma. British Journal of Cancer, 128 (10), 1888-1896. doi: 10.1038/s41416-023-02166-5

Janse van Rensburg, Helena J., Liu, Zhihui, Watson, Geoffrey A., Veitch, Zachary W., Shepshelovich, Daniel, Spreafico, Anna, Abdul Razak, Albiruni R., Bedard, Philippe L., Siu, Lillian L., Minasian, Lori and Hansen, Aaron R. (2023). A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events. British Journal of Cancer, 129 (4), 612-619. doi: 10.1038/s41416-023-02307-w

Parmar, Ambica, Ghosh, Sunita, Sahgal, Arjun, Lalani, Aly-Khan A., Hansen, Aaron R., Reaume, M. Neil, Wood, Lori, Basappa, Naveen S., Heng, Daniel Y. C., Graham, Jeffrey, Kollmannsberger, Christian, Soulieres, Denis, Breau, Rodney H., Tanguay, Simon, Kapoor, Anil, Pouliot, Frederic and Bjarnason, Georg A. (2022). Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer Reports, 6 (3) e1763. doi: 10.1002/cnr2.1763

Hilton, John, Gelmon, Karen, Bedard, Philippe L., Tu, Dongsheng, Xu, Hong, Tinker, Anna V., Goodwin, Rachel, Laurie, Scott A., Jonker, Derek, Hansen, Aaron R., Veitch, Zachary W., Renouf, Daniel J., Hagerman, Linda, Lui, Hongbo, Chen, Bingshu, Kellar, Deb, Li, Irene, Lee, Sung-Eun, Kono, Takako, Cheng, Brian Y. C., Yap, Damian, Lai, Daniel, Beatty, Sean, Soong, John, Pritchard, Kathleen I., Soria-Bretones, Isabel, Chen, Eric, Feilotter, Harriet, Rushton, Moira ... Cescon, David W. (2022). Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies. Nature Communications, 13 (1) 3607, 1-12. doi: 10.1038/s41467-022-31199-2

Mahler, Mary, Al-Ezzi, Esmail, Shrem, Noa Shani, Zhang, Liying, Winquist, Eric, Canil, Christina, Ong, Michael, Hansen, Aaron R. and Emmenegger, Urban (2022). UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive cancer. Urologic Oncology-Seminars and Original Investigations, 40 (12), 539.e17-539.e22. doi: 10.1016/j.urolonc.2022.09.010

Dragomir, Alice, Nazha, Sara, Tanguay, Simon, Breau, Rodney H., Bhindi, Bimal, Rendon, Ricardo A., Kapoor, Anil, Hotte, Sebastien J., Basappa, Naveen, Fairey, Adrian, So, Alan I., Kollmannsberger, Christian, Finelli, Antonio, Hansen, Aaron, Canil, Christina, Heng, Daniel, Lattouf, Jean-Baptiste, Bjarnason, Georg, Power, Nicholas, Pouliot, Frederic and Wood, Lori A. (2022). Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers. European Urology Focus, 8 (6), 1703-1710. doi: 10.1016/j.euf.2021.10.004

Steeghs, Neeltje, Hansen, Aaron R., Hanna, Glenn J., Garralda, Elena, Park, Haeseong, Strauss, James, Adam, Michael, Campbell, Gossett, Carver, Jennifer, Easton, Rachael, Mays, Katherine, Skrdla, Peter, Struemper, Herbert, Washburn, Michael L., Matheny, Christopher and Piha-Paul, Sarina A. (2022). Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development. Cts-Clinical and Translational Science, 15 (11), 2625-2639. doi: 10.1111/cts.13387

McAlpine, Kristen, Clark, Roderick, Jiang, Maria, Hansen, Aaron, Hemminki, Otto and Hamilton, Robert J. (2022). Case - Intra-abdominal metastases following ventriculoperitoneal shunt insertion for primary intracranial germ cell tumor. Cuaj-Canadian Urological Association Journal, 16 (9), E496-E498. doi: 10.5489/cuaj.7895

Even, Caroline, Delord, Jean-Pierre, Price, Katharine A., Nakagawa, Kazuhiko, Oh, Do-Youn, Burge, Matthew, Chung, Hyun C., Doi, Toshihiko, Fakih, Marwan, Takahashi, Shunji, Yao, Lili, Jin, Fan, Norwood, Kevin and Hansen, Aaron R. (2022). Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. European Journal of Cancer, 171, 259-268. doi: 10.1016/j.ejca.2022.05.007

Graham, Jeffrey, Wells, John Connor, Dudani, Shaan, Gan, Chun L., Donskov, Frede, Lee, Jae-Lyun, Kollmannsberger, Christian K., Meza, Luis, Beuselinck, Benoit, Hansen, Aaron, North, Scott A., Bjarnason, Georg A., Sayegh, Nicolas, Kanesvaran, Ravindran, Wood, Lori A., Hotte, Sebastien J., McKay, Rana R., Choueiri, Toni K. and Heng, Daniel Y. C. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer, 171, 124-132. doi: 10.1016/j.ejca.2022.05.002

O'Malley, D. M., Bariani, G. M., Cassier, P. A., Marabelle, A., Hansen, A. R., Acosta, A. De Jesus, Miller, W. H., Safra, T., Italiano, A., Mileshkin, L., Amonkar, M., Jin, F., Yao, L., Norwood, K. and Maio, M. (2022). Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study. Gynecologic Oncology, 166 (2), 245-253. doi: 10.1016/j.ygyno.2022.06.005

Boukhaled, Giselle M., Gadalla, Ramy, Elsaesser, Heidi J., Abd-Rabbo, Diala, Quevedo, Rene, Yang, S. Y. Cindy, Guo, Mengdi, Wang, Ben X., Noamani, Babak, Gray, Diana, Lau, Sally C. M., Taylor, Kirsty, Aung, Kyaw, Spreafico, Anna, Hansen, Aaron R., Saibil, Samuel D., Hirano, Naoto, Guidos, Cynthia, Pugh, Trevor J., McGaha, Tracy L., Ohashi, Pamela S., Sacher, Adrian G., Butler, Marcus O. and Brooks, David G. (2022). Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy. Nature Immunology, 23 (8), 1273-+. doi: 10.1038/s41590-022-01262-7

Peter, Madonna R., Bilenky, Misha, Shi, Yuliang, Pu, Jiajie, Kamdar, Shivani, Hansen, Aaron R., Fleshner, Neil E., Sridhar, Srikala S., Joshua, Anthony M., Hirst, Martin, Xu, Wei and Bapat, Bharati (2022). A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer. Epigenomics, 14 (13), 811-822. doi: 10.2217/epi-2022-0103

Haddad, Ghazal, Hueniken, Katrina, Xu, Maria Christine, Bratman, Scott, de Almeida, John, Goldstein, David, Huang, Shao Hui, Hansen, Aaron, Hope, Andrew, Spreafico, Anna, Xu, Wei and Liu, Geoffrey (2022). Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 44 (10), 2181-2196. doi: 10.1002/hed.27139

Khan, Mohemmed N., Hueniken, Katrina, Manojlovic-Kolarski, Mirko, Eng, Lawson, Mirshams, Maryam, Khan, Khaleeq, Simpson, Colleen, Au, Michael, Liu, Geoffrey, Xu, Wei, Longo, Christopher J., Goldstein, David P., Ringash, Jolie, Martino, Rosemary, Hansen, Aaron R. and de Almeida, John R. (2022). Out-of-pocket costs associated with head and neck cancer treatment. Cancer Reports, 5 (7) e1528. doi: 10.1002/cnr2.1528

Watson, Geoffrey Alan, Sanz-Garcia, Enrique, Zhang, Wen-Jiang, Liu, Zhihui Amy, Yang, S. Y. Cindy, Wang, Ben, Liu, Shaofeng, Kubli, Shawn, Berman, Hal, Pfister, Thomas, Genta, Sofia, Spreafico, Anna, Hansen, Aaron R., Bedard, Philippe L., Lheureux, Stephanie, Razak, Albiruni Abdul, Cescon, Dave, Butler, Marcus O., Xu, Wei, Mak, Tak W., Siu, Lillian L. and Chen, Eric (2022). Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab. Journal for Immunotherapy of Cancer, 10 (6) e004378, e004378. doi: 10.1136/jitc-2021-004378

Choudhury, Atish D., Higano, Celestia S., de Bono, Johann S., Cook, Natalie, Rathkopf, Dana E., Wisinski, Kari B., Martin-Liberal, Juan, Linch, Mark, Heath, Elisabeth I., Baird, Richard D., García-Carbacho, Javier, Quintela-Fandino, Miguel, Barry, Simon T., de Bruin, Elza C., Colebrook, Steve, Hawkins, George, Klinowska, Teresa, Maroj, Brijesh, Moorthy, Ganesh, Mortimer, Peter G., Moschetta, Michele, Nikolaou, Myria, Sainsbury, Liz, Shapiro, Geoffrey I., Siu, Lillian L. and Hansen, Aaron R. (2022). A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors. Clinical Cancer Research, 28 (11), 2257-2269. doi: 10.1158/1078-0432.CCR-21-3087

Salawu, Abdulazeez, Hansen, Aaron R., Spreafico, Anna, Al-Ezzi, Esmail, Webster, Sheila, Bedard, Philippe L., Doi, Jeffrey, Wang, Lisa, Siu, Lillian L. and Razak, Albiruni R. Abdul (2022). A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study. Targeted Oncology, 17 (3), 271-281. doi: 10.1007/s11523-022-00884-z

Kappel, Coralea, Jiang, Di Maria, Wong, Bryan, Zhang, Tong, Selvarajah, Shamini, Warner, Evan, Hansen, Aaron R., Fallah-Rad, Nazanin, Sacher, Adrian G., Stockley, Tracy L., Bedard, Philippe L. and Sridhar, Srikala S. (2022). Comprehensive genomic profiling of treatment. Clinical Genitourinary Cancer, 20 (3), 278-284. doi: 10.1016/j.clgc.2022.02.004

Thana, Myuran, Basappa, Naveen S., Ghosh, Sunita, Kollmannsberger, Christian K., Heng, Daniel Y. C., Hansen, Aaron R., Graham, Jeffery, Soulieres, Denis, Reaume, Martin Neil, Lalani, Aly-Khan A., Castonguay, Vincent, Bjarnason, Georg A., Patenaude, Francois, Breau, Rodney H., Pouliot, Frederic, Kapoor, Anil and Wood, Lori A. (2022). Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients. Clinical Genitourinary Cancer, 20 (3), 210-218. doi: 10.1016/j.clgc.2021.12.003

Zimmermann, Camilla, Pope, Ashley, Hannon, Breffni, Krzyzanowska, Monika K., Rodin, Gary, Li, Madeline, Howell, Doris, Knox, Jennifer J., Leighl, Natasha B., Sridhar, Srikala, Oza, Amit M., Prince, Rebecca, Lheureux, Stephanie, Hansen, Aaron R., Rydall, Anne, Chow, Brittany, Herx, Leonie, Booth, Christopher M., Dudgeon, Deborah, Dhani, Neesha, Liu, Geoffrey, Bedard, Philippe L., Mathews, Jean, Swami, Nadia and Le, Lisa W. (2022). Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer. Journal of the National Comprehensive Cancer Network, 20 (4), 361-+. doi: 10.6004/jnccn.2020.7803

O'Malley, David M., Bariani, Giovanni Mendonca, Cassier, Philippe A., Marabelle, Aurelien, Hansen, Aaron R., De Jesus Acosta, Ana, Miller, Wilson H., Safra, Tamar, Italiano, Antoine, Mileshkin, Linda, Xu, Lei, Jin, Fan, Norwood, Kevin and Maio, Michele (2022). Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Journal of Clinical Oncology, 40 (7), 752-761. doi: 10.1200/jco.21.01874

Parmar, Ambica, Qazi, Abdul Aziz, Stundzia, Audrius, Sim, Hao-Wen, Lewin, Jeremy, Metser, Ur, O'Malley, Martin and Hansen, Aaron R. (2022). Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Cuaj-Canadian Urological Association Journal, 16 (3), E113-E119. doi: 10.5489/cuaj.7294

Voon, Pei Jye, Chen, Eric X., Chen, Helen X., Lockhart, Albert C., Sahebjam, Solmaz, Kelly, Karen, Vaishampayan, Ulka N., Subbiah, Vivek, Razak, Albiruni R., Renouf, Daniel J., Hotte, Sebastien J., Singh, Arti, Bedard, Philippe L., Hansen, Aaron R., Ivy, S. Percy, Wang, Lisa, Stayner, Lee-Anne, Siu, Lillian L. and Spreafico, Anna (2022). Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. Journal of Experimental & Clinical Cancer Research, 41 (1) 51. doi: 10.1186/s13046-021-02236-7

Malone, Eoghan R., Lewin, Jeremy, Li, Xuan, Zhang, Wen‐Jiang, Lau, Susan, Jarvi, Keith, Hamilton, Robert J., Hansen, Aaron R., Chen, Eric X. and Bedard, Philippe L. (2022). Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer. Cancer Medicine, 11 (3), 728-734. doi: 10.1002/cam4.4480

Malone, Eoghan R., Sim, Hao-Wen, Stundzia, Audrius, Pierre, Sacha, Metser, Ur, O'Malley, Martin, Sacher, Adrian G., Sridhar, Srikala S. and Hansen, Aaron R. (2022). Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. Cuaj-Canadian Urological Association Journal, 16 (2), E94-E101. doi: 10.5489/cuaj.7467

Chin, Olivia, Alshafai, Laila, O'Sullivan, Brian, Su, Jie, Hope, Andrew, Bartlett, Eric, Hansen, Aaron R., Waldron, John, Chepeha, Douglas, Xu, Wei, Huang, Shao Hui and Yu, Eugene (2022). Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma. Oral Oncology, 125 105716, 105716. doi: 10.1016/j.oraloncology.2022.105716

Alshammari, Kanan, Aung, Kyaw L., Zhang, Tong, Razak, Albiruni R. A., Serra, Stefano, Stockley, Tracy, Wang, Lisa, Nguyen, Jessica, Spreafico, Anna, Hansen, Aaron R., Zwir, Dave, Siu, Lillian L. and Bedard, Philippe L. (2021). Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 20 (4), 334-341. doi: 10.1016/j.clcc.2021.07.004

Kushnir, Igal, Basappa, Naveen S., Ghosh, Sunita, Lalani, Aly-Khan A., Hansen, Aaron R., Wood, Lori, Kollmannsberger, Christian K., Heng, Daniel Y. C., Bjarnason, Georg A., Soulieres, Denis, Dawe, David E., Tanguay, Simon, Breau, Rodney H., Pouliot, Frederic, Kapoor, Anil, Graham, Jeffrey and Reaume, M. Neil (2021). Active surveillance in metastatic renal cell carcinoma: results from the Canadian kidney cancer information system. Clinical Genitourinary Cancer, 19 (6), 521-530. doi: 10.1016/j.clgc.2021.05.004

Aghel, Nazanin, Gustafson, Dakota, Di Meo, Ashley, Music, Milena, Prassas, Ioannis, Seidman, Michael A., Hansen, Aaron R., Thavendiranathan, Paaladinesh, Diamandis, Eleftherios P., Delgado, Diego and Fish, Jason E. (2021). Recurrent myocarditis induced by immune-checkpoint inhibitor treatment is accompanied by persistent inflammatory markers despite immunosuppressive treatment. JCO Precision Oncology, 5, 485-491. doi: 10.1200/po.20.00370

Al-Ezzi, Esmail M., Veitch, Zachary W., Salah, Samer H., Van der Kwast, Theodorus H., Stockley, Tracy L., Selvarajah, Shamini, Zhang, Tong, Sridhar, Srikala S., Sacher, Adrian G., Fallah-Rad, Nazanin, Kulkarni, Girish S., Zlotta, Alexandre R., Finelli, Antonio and Hansen, Aaron R. (2021). Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: a retrospective exploratory study. PLoS One, 16 (12) e0259272, 1-13. doi: 10.1371/journal.pone.0259272

Chin, Olivia, Yu, Eugene, O'Sullivan, Brian, Su, Jie, Tellier, Anais, Siu, Lillian, Waldron, John, Kim, John, Hansen, Aaron, Hope, Andrew, Cho, John, Giuliani, Meredith, Ringash, Jolie, Spreafico, Anna, Bratman, Scott, Hosni, Ali, Hahn, Ezra, Tong, Li, Xu, Wei and Huang, Shao Hui (2021). Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort. Radiotherapy and Oncology, 165, 94-102. doi: 10.1016/j.radonc.2021.10.018

Oliva, Marc, Chepeha, Douglas, Araujo, Daniel V., Diaz-Mejia, J. Javier, Olson, Peter, Prawira, Amy, Spreafico, Anna, Bratman, Scott V., Shek, Tina, De Almeida, John, Hansen, Aaron R., Hope, Andrew, Goldstein, David, Weinreb, Ilan, Smith, Stephen, Perez-Ordoñez, Bayardo, Irish, Jonathan, Torti, Dax, Bruce, Jeffrey P., Wang, Ben X., Fortuna, Anthony, Pugh, Trevor J., Der-Torossian, Hirak, Shazer, Ronald, Attanasio, Nickolas, Au, Qingyan, Tin, Antony, Feeney, Jordan, Sethi, Himanshu ... Siu, Lillian (2021). Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. Journal for ImmunoTherapy of Cancer, 9 (10) e003476, 1-13. doi: 10.1136/jitc-2021-003476

Nason, Gregory J., Rendon, Ricardo A., Wood, Lori, Huddart, Robert A., Albers, Peter, Einhorn, Lawrence H., Nichols, Craig R., Kollmannsberger, Christian, Anson-Cartwright, Lynn, Warde, Padraig, Jewett, Michael A. S., Chung, Peter, Bedard, Philippe L., Hansen, Aaron R. and Hamilton, Robert J. (2021). Clinical dilemmas in local and regional testis cancer. CUAJ-Canadian Urological Association Journal, 15 (1), E58-E64. doi: 10.5489/cuaj.6913

Al-Ezzi, Esmail M., Alqaisi, Husam A., Iafolla, Marco A. J., Wang, Lisa, Sridhar, Srikala S., Sacher, Adrian G., Fallah-Rad, Nazanin, Jiang, Di M., Watson, Geoffrey A., Catton, Charles N., Warde, Padraig R., Hamilton, Rob J., Fleshner, Neil E., Zlotta, Alexandre R. and Hansen, Aaron R. (2021). Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223. Cancer Medicine, 10 (17), 5775-5782. doi: 10.1002/cam4.4125

Gudi, Shivakumar, O'Sullivan, Brian, Hosni, Ali, Su, Jie, Hope, Andrew, Ringash, Jolie, Hueniken, Katrina, Liu, Geoffrey, Tong, Li, Goldstein, David, de Almeida, John, Hansen, Aaron R., Bratman, Scott, Cho, John, Giuliani, Meredith, Hahn, Ezra, Kim, John, Xu, Wei, Waldron, John and Huang, Shao Hui (2021). Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-) radiotherapy delivered under similar multidisciplinary care: a propensity-matched cohort study. Oral Oncology, 120 105419, 1-8. doi: 10.1016/j.oraloncology.2021.105419

Wells, J. Connor, Dudani, Shaan, Gan, Chun Loo, Stukalin, Igor, Azad, Arun A., Liow, Elizabeth, Donskov, Frede, Yuasa, Takeshi, Pal, Sumanta K., De Velasco, Guillermo, Hansen, Aaron R., Beuselinck, Benoit, Kollmannsberger, Christian K., Powles, Thomas, McGregor, Bradley A., Duh, Mei S., Huynh, Lynn and Heng, Daniel Y. C. (2021). Clinical effectiveness of second-line sunitinib following immuno-oncology therapy in patients with metastatic renal cell carcinoma: a real-world study. Clinical Genitourinary Cancer, 19 (4), 354-361. doi: 10.1016/j.clgc.2021.03.006

Malone, Eoghan, Barua, Reeta, Meti, Nicholas, Li, Xuan, Fazelzad, Rouhi and Hansen, Aaron R. (2021). Quality of patient‐reported outcomes in oncology clinical trials using immune checkpoint inhibitors: a systematic review. Cancer Medicine, 10 (15), 5031-5040. doi: 10.1002/cam4.4086

Ezeife, Doreen A., Morganstein, Brendon Josh, Yip, Steven, Ryan, Malcolm, Law, Jennifer H., Guan, Amy Yimin, Le, Lisa W., Hansen, Aaron R., Sacher, Adrian, Bjarnason, Georg A., Doherty, Mark K. and Leighl, Natasha B. (2021). The financial impact of cancer care on renal cancer patients. Canadian Journal of Urology, 28 (4), 10762-10767.

Alibhai, Shabbir M. H., Breunis, Henriette, Hansen, Aaron R., Gregg, Richard, Warde, Padraig, Timilshina, Narhari, Tomlinson, George, Joshua, Anthony M., Hotte, Sebastien, Fleshner, Neil and Emmenegger, Urban (2021). Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer. Cancer, 127 (14), 2587-2594. doi: 10.1002/cncr.33523

Alibhai, Shabbir M. H., Breunis, Henriette, Feng, Gregory, Timilshina, Narhari, Hansen, Aaron, Warde, Padraig, Gregg, Richard, Joshua, Anthony, Fleshner, Neil, Tomlinson, George and Emmenegger, Urban (2021). Association of chemotherapy, enzalutamide, abiraterone, and radium 223 with cognitive function in older men with metastatic castration-resistant prostate cancer. JAMA Network Open, 4 (7) e2114694, 1-13. doi: 10.1001/jamanetworkopen.2021.14694

de Almeida, John R., Bratman, Scott and Hansen, Aaron R. (2021). Screening for Nasopharyngeal Cancer in High-Risk Populations: A Small Price to Pay for Early Disease Identification?. Jnci-Journal of the National Cancer Institute, 113 (7) djaa199, 803-804. doi: 10.1093/jnci/djaa199

Nguyen, Eric K., Lalani, Aly Khan A., Ghosh, Sunita, Basappa, Naveen S., Kapoor, Anil, Hansen, Aaron R., Kollmannsberger, Christian, Heng, Daniel, Wood, Lori A., Castonguay, Vincent, Soulieres, Denis, Winquist, Eric, Canil, Christina, Graham, Jeffrey, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frederic and Swaminath, Anand (2021). Outcomes of radiation therapy plus immunotherapy in metastatic renal cell carcinoma: results from the Canadian Kidney Cancer Information System. Advances in Radiation Oncology, 7 (4) 100899, 100899. doi: 10.1016/j.adro.2022.100899

Araujo, Daniel, Wells, J. Connor, Hansen, Aaron R., Dizman, Nazli, Pal, Sumanta K., Beuselinck, Benoit, Donskov, Frede, Gan, Chun L., Yan, Flora, Tran, Ben, Kollmannsberger, Christian K., de Velasco, Guillermo, Yuasa, Takeshi, Reaume, M. Neil, Ernst, D. Scott, Powles, Thomas, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Y. C. and Dudani, Shaan (2021). Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis. Journal of Geriatric Oncology, 12 (5), 820-826. doi: 10.1016/j.jgo.2021.02.022

Araujo, Daniel, Wang, Ao, Torti, Dax, Leon, Alberto, Marsh, Kayla, McCarthy, Aoife, Berman, Hal, Spreafico, Anna, Hansen, Aaron R., Razak, Albiruni-Abdul, Bedard, Philippe L., Wang, Lisa, Plackmann, Eric, Chow, Helen, Bao, Hua, Wu, Xue, Pugh, Trevor J. and Siu, Lillian L. (2021). Applications of circulating tumor DNA in a cohort of phase I solid tumor patients treated with immunotherapy. JNCI Cancer Spectrum, 5 (3) pkaa122. doi: 10.1093/jncics/pkaa122

Lobo, Joao, Leao, Ricardo, Gillis, Ad J. M., van den Berg, Annette, Anson-Cartwright, Lynn, Atenafu, Eshetu G., Kuhathaas, Kopika, Chung, Peter, Hansen, Aaron, Bedard, Philippe L., Jewett, Michael A. S., Warde, Padraig, O'Malley, Martin, Sweet, Joan, Looijenga, Leendert H. J. and Hamilton, Robert J. (2021). Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer. European Urology Oncology, 4 (3), 483-491. doi: 10.1016/j.euo.2020.11.004

Spira, Alexander, Hansen, Aaron R., Harb, Wael A., Curtis, Kelly K., Koga-Yamakawa, Erina, Origuchi, Makoto, Li, Zhonggai, Ertik, Bella and Shaib, Walid L. (2021). Multicenter, open-label, phase I study of DSP-7888 dosing emulsion in patients with advanced malignancies. Targeted Oncology, 16 (4), 461-469. doi: 10.1007/s11523-021-00813-6

Voon, Pei Jye, Cella, David and Hansen, Aaron R. (2021). Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies. Cancer, 127 (9), 1360-1368. doi: 10.1002/cncr.33457

Nason, Gregory J., Jewett, Michael A. S., Bostrom, Peter J., Goldberg, Hanan, Hansen, Aaron R., Bedard, Philippe L., Sturgeon, Jeremy, Warde, Padraig, Chung, Peter, Anson-Cartwright, Lynn, Sweet, Joan, Atenafu, Eshetu G., O'Malley, Martin and Hamilton, Robert J. (2021). Long-term surveillance of patients with complete response following chemotherapy for metastatic nonseminomatous germ cell tumor. European Urology Oncology, 4 (2), 289-296. doi: 10.1016/j.euo.2020.08.007

Spreafico, Anna, Hansen, Aaron R., Razak, Albiruni R. Abdul, Bedard, Philippe L. and Siu, Lillian L. (2021). The Future of Clinical Trial Design in Oncology. Cancer Discovery, 11 (4), 822-837. doi: 10.1158/2159-8290.CD-20-1301

Sananmuang, Thiparom, Yu, Eugene, Su, Jie, O'Sullivan, Brian, Rathod, Shrinivas, Chan, Biu, Bartlett, Eric, Waldron, John, Ringash, Jolie, Kim, John, Bratman, Scott V., Hope, Andrew, Spreafico, Anna, Hansen, Aaron R., de Almeida, John, Goldstein, David P., Witterick, Ian, Tong, Li, Xu, Wei and Huang, Shao H. (2021). Pre- and post-radiotherapy radiologic nodal features and oropharyngeal cancer outcomes. Laryngoscope, 131 (4), E1162-E1171. doi: 10.1002/lary.29045

Wong, Erin T., Huang, Shao Hui, O'Sullivan, Brian, Persaud, Vincent, Su, Jie, Waldron, John, Goldstein, David P., de Almeida, John, Ringash, Jolie, Kim, John, Hope, Andrew, Bratman, Scott, Cho, John, Giuliani, Meredith, Hosni, Ali, Spreafico, Anna, Hansen, Aaron, Tong, Li, Xu, Wei and Yu, Eugene (2021). Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy. Radiotherapy and Oncology, 157, 255-262. doi: 10.1016/j.radonc.2021.02.005

Beyer, Jörg, Collette, Laurence, Sauvé, Nicolas, Daugaard, Gedske, Feldman, Darren R., Tandstad, Torgrim, Tryakin, Alexey, Stahl, Olof, Gonzalez-Billalabeitia, Enrique, de Giorgi, Ugo, Culine, Stéphane, de Wit, Ronald, Hansen, Aaron R., Bebek, Marko, Terbuch, Angelika, Albany, Costantine, Hentrich, Marcus, Gietema, Jourik A., Negaard, Helene, Huddart, Robert A., Lorch, Anja, Cafferty, Fay H., Heng, Daniel Y.C., Sweeney, Christopher J., Winquist, Eric, Chovanec, Michal, Fankhauser, Christian, Stark, Daniel, Grimison, Peter ... Gillessen, Silke (2021). Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium. Journal of Clinical Oncology, 39 (14), 1553-1562. doi: 10.1200/JCO.20.03292

Oliva, Marc, Schneeberger, Pierre H. H., Rey, Victor, Cho, Matthew, Taylor, Rachel, Hansen, Aaron R., Taylor, Kirsty, Hosni, Ali, Bayley, Andrew, Hope, Andrew J., Bratman, Scott, Ringash, Jolie, Singh, Simron, Weinreb, Ilan, Perez-Ordonez, Bayardo, Chepeha, Douglas, Waldron, John, Xu, Wei, Guttman, David, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2021). Transitions in oral and gut microbiome of HPV plus oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). British Journal of Cancer, 124 (9), 1543-1551. doi: 10.1038/s41416-020-01253-1

Canil, Christina, Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg, Bosse, Dominick, Dudani, Shaan, Graham, Jeffrey, Gray, Samantha, Hansen, Aaron R., Heng, Daniel Y. C., Karakiewicz, Pierre, Kollmannsberger, Christian, Lalani, Aly-Khan A., North, Scott A., Patenaude, Francois, Soulieres, Denis, Thana, Myuran, Winquist, Eric, Wood, Lori A., Reaume, M. Neil, Maloni, Ranjena and Hotte, Sebastien J. (2021). Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021. CUAJ-Canadian Urological Association Journal, 15 (4), 84-97. doi: 10.5489/cuaj.7245

Iafolla, Marco A. J, Yang, Cindy, Chandran, Vinod, Pintilie, Melania, Li, Quan, Bedard, Philippe L., Hansen, Aaron, Lheureux, Stephanie, Spreafico, Anna, Razak, Albiruni A., Hakgor, Sevan, Giesler, Amanda, Pugh, Trevor J. and Siu, Lillian L. (2021). Predicting toxicity and response to pembrolizumab through germline genomic HLA class 1 analysis. JNCI Cancer Spectrum, 5 (1) pkaa115, 1-9. doi: 10.1093/jncics/pkaa115

Graham, Jeffrey, Shah, Amishi Y., Wells, J. Connor, McKay, Rana R., Vaishampayan, Ulka, Hansen, Aaron, Donskov, Frede, Bjarnason, Georg A., Beuselinck, Benoit, De Velasco, Guillermo, Iafolla, Marco, Duh, Mei S., Huynh, Lynn, Chang, Rose, Zanotti, Giovanni, Ramaswamy, Krishnan, Choueiri, Toni K., Tannir, Nizar M. and Heng, Daniel Y. C. (2021). Outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy after immuno-oncology checkpoint inhibitors. European Urology Oncology, 4 (1), 102-111. doi: 10.1016/j.euo.2019.11.001

Ribnikar, Domen, Stukalin, Igor, Bedard, Philippe L., Hamilton, Robert J., Jewett, Michael, Warde, Padraig, Chung, Peter, Anson-Cartwright, Lynn, Templeton, Arnoud J., Amir, Eitan, Hansen, Aaron R., Heng, Daniel Y. C. and Lewin, Jeremy (2021). The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Current Oncology, 28 (1), 107-114. doi: 10.3390/curroncol28010014

Jiang, Di Maria, Fallah-Rad, Nazanin, Lee, Roy, Ng, Pamela, Smith, Alan D., Hansen, Aaron R., Joshua, Anthony M., Beca, Jaclyn and Sridhar, Srikala S. (2021). Significantly minimizing drug wastage and the cost of cabazitaxel used to treat metastatic castration-resistant prostate cancer. European Urology, 79 (2), 177-179. doi: 10.1016/j.eururo.2020.09.048

Pilar, Avinash, Yu, Eugene, Su, Jie, O'Sullivan, Brian, Bartlett, Eric, Waldron, John N., Ringash, Jolie, Spreafico, Anna, Hansen, Aaron R., de Almeida, John, Bayley, Andrew, Bratman, Scott, Cho, John, Giuliani, Meredith, Hope, Andrew, Hosni, Ali, Kim, John, Tong, Li, Xu, Wei and Huang, Shao Hui (2021). Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma. Oral Oncology, 114 105167, 105167. doi: 10.1016/j.oraloncology.2020.105167

Dudani, Shaan, de Velasco, Guillermo, Wells, J. Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Hansen, Aaron, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina, Choueiri, Toni K. and Heng, Daniel Y. C. (2021). Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival. JAMA Network Open, 4 (1) e2021869, 1-11. doi: 10.1001/jamanetworkopen.2020.21869

Bebb, D. Gwyn, Banerji, Shantanu, Blais, Normand, Desmeules, Patrice, Gill, Sharlene, Grin, Andrea, Feilotter, Harriet, Hansen, Aaron R., Hyrcza, Martin, Krzyzanowska, Monika, Melosky, Barbara, Noujaim, Jonathan, Purgina, Bibiana, Ruether, Dean, Simmons, Christine E., Soulieres, Denis, Torlakovic, Emina Emilia and Tsao, Ming-Sound (2021). Canadian consensus for biomarker testing and treatment of TRK fusion cancer in adults. Current Oncology, 28 (1), 523-548. doi: 10.3390/curroncol28010053

Zhang, Hanbo, Basappa, Naveen S., Ghosh, Sunita, Joy, Isaiah, Lalani, Aly-Khan A., Hansen, Aaron R., Heng, Daniel Y. C., Castonguay, Vincent, Kollmannsberger, Christian K., Winquist, Eric, Wood, Lori, Bjarnason, Georg A., Breau, Rodney H., Kapoor, Anil and Graham, Jeffrey (2021). Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). Kidney Cancer, 5 (1), 21-29. doi: 10.3233/KCA-210110

Schumacher, Garrett J., Sawaya, Sterling, Nelson, Demetrius and Hansen, Aaron J. (2020). Genetic Information Insecurity as State of the Art. Frontiers in Bioengineering and Biotechnology, 8 591980. doi: 10.3389/fbioe.2020.591980

de Almeida, John R., Truong, Tra, Khan, Nazir Mohemmed, Su, Jie Susie, Irish, Jonathan, Gilbert, Ralph, Goldstein, David, Huang, Shao Hui, O'Sullivan, Brian, Hosni, Ali, Hope, Andrew, Waldron, John, Hansen, Aaron R., Spreafico, Anna, Siu, Lillian L., Perez-Ordonez, Bayardo, Xu, Wei and Weinreb, Ilan (2020). Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension. Oral Oncology, 110 104845, 1-9. doi: 10.1016/j.oraloncology.2020.104845

Sanmamed, Noelia, Glicksman, Rachel M., Herrera-Caceres, Jaime, Lehrer, Eric J., Heaton, Jaqueline, Hansen, Aaron R., Chung, Peter, Fleshner, Neil E., Den, Robert B., Zaorsky, Nicholas G. and Berlin, Alejandro (2020). Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice. Urologic Oncology-Seminars and Original Investigations, 38 (11) 848.e1, 848.e1-848.e7. doi: 10.1016/j.urolonc.2020.04.019

Wilson, Brooke E. and Hansen, Aaron R. (2020). Dual Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancer: Just a Gambit or Real CheckMate?. Cancer Cell, 38 (4), 438-440. doi: 10.1016/j.ccell.2020.09.009

Dragomir, Alice, Nazha, Sara, Wood, Lori A., Rendon, Ricardo A., Finelli, Antonio, Hansen, Aaron, So, Alan I., Kollmannsberger, Christian, Basappa, Naveen S., Pouliot, Frédéric, Soulières, Denis, Heng, Daniel Y.C., Kapoor, Anil and Tanguay, Simon (2020). Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: the Canadian Kidney Cancer information system experience. Urologic Oncology: Seminars and Original Investigations, 38 (10), 799.e1-799.e10. doi: 10.1016/j.urolonc.2020.07.021

Bhindi, Bimal, Graham, Jeffrey, Wells, J. Connor, Bakouny, Ziad, Donskov, Frede, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Basappa, Naveen S., Hansen, Aaron, Kollmannsberger, Christian K., Kanesvaran, Ravindran, Yuasa, Takeshi, Ernst, D. Scott, Srinivas, Sandy, Rini, Brian, Bowman, Isaac, Pal, Sumanta K., Choueiri, Toni K. and Heng, Daniel Y. C. (2020). Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. European Urology, 78 (4), 615-623. doi: 10.1016/j.eururo.2020.04.038

Iafolla, Marco A. J., Picardo, Sarah, Aung, Kyaw and Hansen, Aaron R. (2020). Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts. Jnci Cancer Spectrum, 4 (5) pkaa050. doi: 10.1093/jncics/pkaa050

Peter, Madonna R., Bilenky, Misha, Isserlin, Ruth, Bader, Gary D., Shen, Shu Yi, De Carvalho, Daniel D., Hansen, Aaron R., Hu, Pingzhao, Fleshner, Neil E., Joshua, Anthony M., Hirst, Martin and Bapat, Bharati (2020). Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment. Epigenomics, 12 (15), 1317-1332. doi: 10.2217/epi-2020-0173

Day, D., Prawira, A., Spreafico, A., Waldron, J., Karithanam, R., Giuliani, M., Weinreb, , Kim, J., Cho, J., Hope, A., Bayley, A., Ringash, J., Bratman, S., Jang, R., O'Sullivan, B., Siu, L. L. and Hansen, A. R. (2020). Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Oral Oncology, 108 104753, 104753. doi: 10.1016/j.oraloncology.2020.104753

Watson, Geoffrey Alan, Doi, Jeffrey, Hansen, Aaron Richard and Spreafico, Anna (2020). Novel strategies in immune checkpoint inhibitor drug development: how far are we from the paradigm shift?. British Journal of Clinical Pharmacology, 86 (9), 1753-1768. doi: 10.1111/bcp.14355

Taylor, Kirsty, Loo Yau, Helen, Chakravarthy, Ankur, Wang, Ben, Shen, Shu Yi, Ettayebi, Ilias, Ishak, Charles A., Bedard, Philippe L., Abdul Razak, Albiruni, Hansen, Aaron R., Spreafico, Anna, Cescon, Dave, Butler, Marcus O., Oza, Amit M., Lheureux, Stephanie, Stjepanovic, Neda, Van As, Brendan, Boross-Harmer, Sarah, Wang, Lisa, Pugh, Trevor J., Ohashi, Pamela S., Siu, Lillian L. and De Carvalho, Daniel D. (2020). An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Journal for ImmunoTherapy of Cancer, 8 (2) e000883, 1-11. doi: 10.1136/jitc-2020-000883

Wells, J. Connor, Graham, Jeffrey, Beuselinck, Benoit, Bjarnason, Georg A., Donskov, Frede, Hansen, Aaron R., McKay, Rana R., Vaishampayan, Ulka, De Velasco, Guillermo, Duh, Mei S., Huynh, Lynn, Nguyen, Catherine, Zanotti, Giovanni, Ramaswamy, Krishnan, Choueiri, Toni K. and Heng, Daniel Y.C. (2020). Clinical outcomes of first-line sunitinib followed by immuno-oncology checkpoint inhibitors in patients with metastatic renal cell carcinoma. Clinical Genitourinary Cancer, 18 (4), e350-e359. doi: 10.1016/j.clgc.2019.12.007

Murphy, Adrian G., Zahurak, Marianna, Shah, Mirat, Weekes, Colin D., Hansen, Aaron, Siu, Lillian L., Spreafico, Anna, LoConte, Noelle, Anders, Nicole M., Miles, Tearra, Rudek, Michelle A., Doyle, L. Austin, Nelkin, Barry, Maitra, Anirban and Azad, Nilofer S. (2020). A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Cts-Clinical and Translational Science, 13 (6), 1178-1188. doi: 10.1111/cts.12802

Alqaisi, Husam A., Al-ezzi, Esmail and Hansen, Aaron R. (2020). Biomarkers of response to immune checkpoint inhibitors for metastatic castration resistant prostate cancer: looking for the needle in the haystack. Annals of Translational Medicine, 8 (14) 894. doi: 10.21037/atm.2020.03.78

Nason, Gregory J., Chung, Peter, Warde, Padraig, Huddart, Robert, Albers, Peter, Kollmannsberger, Christian, Booth, Christopher M., Hansen, Aaron R., Bedard, Philippe L., Einhorn, Lawrence, Nichols, Craig, Rendon, Ricardo A., Wood, Lori, Jewett, Michael A.S. and Hamilton, Robert J. (2020). Controversies in the management of clinical stage 1 testis cancer. Canadian Urological Association Journal, 14 (11), E537-E542. doi: 10.5489/cuaj.6722

Oliva, Marc, Huang, Shao Hui, Taylor, Rachel, Su, Jie, Xu, Wei, Hansen, Aaron R., Jang, Raymond, Bayley, Andrew, Hosni, Ali, Giuliani, Meredith, Ringash, Jolie, Bratman, Scott, Cho, John, Irish, Jonathan, Waldron, John, Weinreb, Ilan, Kim, John, O'Sullivan, Brian, Siu, Lillian L. and Spreafico, Anna (2020). Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with de finitive chemoradiotherapy. Oral Oncology, 105 104666, 104666. doi: 10.1016/j.oraloncology.2020.104666

Piha-Paul, Sarina A., Oh, Do-Youn, Ueno, Makoto, Malka, David, Chung, Hyun Cheol, Nagrial, Adnan, Kelley, Robin K., Ros, Willeke, Italiano, Antoine, Nakagawa, Kazuhiko, Rugo, Hope S., de Braud, Filippo, Varga, Andrea Iolanda, Hansen, Aaron, Wang, Hui, Krishnan, Suba, Norwood, Kevin G. and Doi, Toshihiko (2020). Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. International Journal of Cancer, 147 (8), 2190-2198. doi: 10.1002/ijc.33013

Ala-Leppilampi, Kari, Baker, Natalie A., McKillop, Chris, Butler, Marcus O., Siu, Lillian L., Spreafico, Anna, Abdul Razak, Albiruni R., Joshua, Anthony M., Hogg, David, Bedard, Philippe L., Leighl, Natasha, Oza, Amit M., Parsons, Janet A. and Hansen, Aaron R. (2020). Cancer patients’ experiences with immune checkpoint modulators: a qualitative study. Cancer Medicine, 9 (9), 3015-3022. doi: 10.1002/cam4.2940

Savard, Marie-France, Wells, J. Connor, Graham, Jeffrey, Dudani, Shaan, Steinharter, John A., McGregor, Bradley A., Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka N., Hansen, Aaron R., Iafolla, Marco A.J., Zanotti, Giovanni, Huynh, Lynn, Chang, Rose, Duh, Mei S. and Heng, Daniel Y.C. (2020). Real-world assessment of clinical outcomes among first-line sunitinib patients with clear cell metastatic renal cell carcinoma (mRCC) by the International mRCC Database Consortium Risk Group. The Oncologist, 25 (5), 422-430. doi: 10.1634/theoncologist.2019-0605

Noel, Christopher W., Stephens, Robert F., Su, Jie (Susie), Xu, Wei, Krahn, Murray, Monteiro, Eric, Goldstein, David P., Giuliani, Meredith, Hansen, Aaron R. and de Almeida, John R. (2020). Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 42 (9), 2277-2286. doi: 10.1002/hed.26181

Nason, Gregory J., Donahoe, Laura, de Perrot, Marc, Aditya, Ishan, Jewett, Michael A.S., Bedard, Philip L., Hansen, Aaron R., Chung, Peter, Warde, Padraig, Anson-Cartwright, Lynn, Sweet, Joan, O'Malley, Martin, Atenafu, Eshetu G. and Hamilton, Robert J. (2020). Simultaneous vs sequential retroperitoneal, thoracic and cervical resection of post chemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. Urology, 138, 69-76. doi: 10.1016/j.urology.2019.12.032

Huang, Shao Hui, O'Sullivan, Brian, Su, Jie, Bartlett, Eric, Kim, John, Waldron, John N., Ringash, Jolie, de Almeida, John R., Bratman, Scott, Hansen, Aaron, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Hosni, Ali, Spreafico, Anna, Siu, Lillian, Chepeha, Douglas, Tong, Lt, Xu, Wei and Yu, Eugene (2020). Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification. Radiotherapy and Oncology, 144, 13-22. doi: 10.1016/j.radonc.2019.10.011

Stephens, Robert F., Noel, Christopher W., Su, Jie, Xu, Wei, Krahn, Murray, Monteiro, Eric, Goldstein, David P., Giuliani, Meredith, Hansen, Aaron R. and de Almeida, John R. (2020). Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer. Head and Neck, 42 (3), 513-521. doi: 10.1002/hed.26031

Kuehne, Nathan, Chen, Lina, McDonald, Kate, Wang, Lisa, Spreafico, Anna, Hansen, Aaron, Razak, Albiruni Ryan Abdul, Bedard, Philippe Lucien, Siu, Lillian L. and Shepshelovich, Daniel (2020). Characterization and outcomes of patients enrolled to multiple phase I cancer trials. Cancer Chemotherapy and Pharmacology, 85 (2), 469-472. doi: 10.1007/s00280-019-03989-x

Jiang, Di Maria, Hamilton, Robert J. and Hansen, Aaron R. (2020). Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time. Cuaj-Canadian Urological Association Journal, 14 (2), 48-49. doi: 10.5489/cuaj.6407

Turnbull, David, Colaitis, Arnaud, Hansen, Aaron M., Milder, Avram L., Palastro, John P., Katz, Joseph, Dorrer, Christophe, Kruschwitz, Brian E., Strozzi, David J. and Froula, Dustin H. (2020). Impact of the Langdon effect on crossed-beam energy transfer. Nature Physics, 16 (2), 181-+. doi: 10.1038/s41567-019-0725-z

Webster, Kimberly A., O'Connor, Mary L., Hansen, Aaron R., Kircher, Sheetal, Jim, Heather S.L., Dicker, Adam P., Janda, Monika, Ala-Leppilampi, Kari, Bingham III, Clifton O., Feliciano, Josephine, Henry, Norah Lynn, McLouth, Laurie E. Steffen and Cella, David (2020). Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators. Journal of Cancer Metastasis and Treatment, 6 8, 1-14. doi: 10.20517/2394-4722.2019.38

Picardo, Sarah L., Doi, Jeffrey and Hansen, Aaron R. (2020). Structure and optimization of checkpoint inhibitors. Cancers, 12 (1) 38, 1-521. doi: 10.3390/cancers12010038

Mifsud, Matthew, de Almeida, John R., Giuliani, Meredith, Hansen, Aaron R. and Goldstein, David P. (2020). Carcinoma of the Hypopharynx. Head and Neck Cancer: Management and Reconstruction, 2Nd Edition, 180-202.

De Almeida, John R., Noel, Christopher W., Veigas, Maria, Martino, Rosemary, Chepeha, Douglas B., Bratman, Scott V., Goldstein, David P., Hansen, Aaron R., Yu, Eugene, Metser, Ur, Weinreb, Ilan, Perez-Ordonez, Bayardo, Xu, Wei and Kim, John (2019). Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma. BMJ Open, 9 (12) e035431, 1-9. doi: 10.1136/bmjopen-2019-035431

Dudani, Shaan, Graham, Jeffrey, Wells, J. Connor, Bakouny, Ziad, Pal, Sumanta K., Dizman, Nazli, Donskov, Frede, Porta, Camillo, de Velasco, Guillermo, Hansen, Aaron, Iafolla, Marco, Beuselinck, Benoit, Vaishampayan, Ulka N., Wood, Lori A., Liow, Elizabeth, Yan, Flora, Yuasa, Takeshi, Bjarnason, Georg A., Choueiri, Toni K. and Heng, Daniel Y.C. (2019). First-line immuno-oncology combination therapies in metastatic renal-cell carcinoma: results from the International Metastatic Renal-cell Carcinoma Database Consortium. European Urology, 76 (6), 861-867. doi: 10.1016/j.eururo.2019.07.048

Mesia, Ricard, Bossi, Paolo, Hansen, Aaron R., Hsieh, Ching-Yun, Licitra, Lisa F., Tan, Eng-Huat, Chen, Peng, Miller, JulieAnn, Siu, Lilian L. and Haddad, Robert I. (2019). Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma. European Journal of Cancer, 123, 138-145. doi: 10.1016/j.ejca.2019.10.002

Day, Daphne, Guo, Christina, Kanjanapan, Yada, Tran, Ben, Spreafico, Anna, Joshua, Anthony M., Wang, Lisa, Razak, Albiruni R. Abdul, Leighl, Natasha B., Hansen, Aaron R., Butler, Marcus O., Siu, Lillian L., Desai, Jayesh and Bedard, Philippe L. (2019). Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index. Jnci Cancer Spectrum, 3 (4) pkz071. doi: 10.1093/jncics/pkz071

Burtness, Barbara, Harrington, Kevin J., Greil, Richard, Soulières, Denis, Tahara, Makoto, de Castro, Gilberto, Psyrri, Amanda, Basté, Neus, Neupane, Prakash, Bratland, Åse, Fuereder, Thorsten, Hughes, Brett G. M., Mesía, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Hong, Ruey-Long, González Mendoza, René, Roy, Ananya, Zhang, Yayan, Gumuscu, Burak, Cheng, Jonathan D., Jin, Fan, Rischin, Danny, Lerzo, Guillermo, Tatangelo, Marcelo, Varela, Mirta, Zarba, Juan Jose, Boyer, Michael ... on behalf of the KEYNOTE-048 Investigators (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. The Lancet, 394 (10212), 1915-1928. doi: 10.1016/S0140-6736(19)32591-7

Thompson-Harvey, Adam, Yetukuri, Mahi, Hansen, Alec R., Simpson, Matthew C., Adjei Boakye, Eric, Varvares, Mark A. and Osazuwa-Peters, Nosayaba (2019). Rising incidence of late-stage head and neck cancer in the United States. Cancer, 126 (5), 1090-1101. doi: 10.1002/cncr.32583

Graham, Jeffrey, Wells, J. Connor, Donskov, Frede, Lee, Jae Lyun, Fraccon, Anna, Pasini, Felice, Porta, Camillo, Bowman, I. Alex, Bjarnason, Georg A., Ernst, D. Scott, Rha, Sun Young, Beuselinck, Benoit, Hansen, Aaron, North, Scott A., Kollmannsberger, Christian K., Wood, Lori A., Vaishampayan, Ulka N., Pal, Sumanta K., Choueiri, Toni K. and Heng, Daniel Y. C. (2019). Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. European Urology Oncology, 2 (6), 643-648. doi: 10.1016/j.euo.2019.03.007

Nason, Gregory J., Wood, Lori, Huddart, Robert A., Albers, Peter, Rendon, Ricardo A., Einhorn, Lawrence H., Nichols, Craig R., Kollmannsberger, Christian, Anson-Cartwright, Lynn, Sweet, Joan, Warde, Padraig, Jewett, Michael A. S., Chung, Peter, Bedard, Philippe L., Hansen, Aaron R. and Hamilton, Robert J. (2019). A Canadian approach to the regionalization of testis cancer: a review. Canadian Urological Association Journal, 14 (10), 346-351. doi: 10.5489/CUAJ.6268

Iafolla, Marco A.J., Picardo, Sarah, Aung, Kyaw and Hansen, Aaron R. (2019). Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts. PLoS One, 14 (10) e0222359, 1-15. doi: 10.1371/journal.pone.0222359

Alfaraj, Fatimah, Craig, Tim, Huang, Shao Hui, O'Sullivan, Brian, Su, Jie, Bayley, Andrew, Bratman, Scott, Cho, John, Giuliani, Meredith, Kim, John, Ringash, Jolie, Waldron, John, Hansen, Aaron, de Almeida, John, Perez-Ordonez, Bayardo, Weinreb, Ilan, Tong, Li, Xu, Wei and Hope, Andrew (2019). Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy. Oral Oncology, 97, 124-130. doi: 10.1016/j.oraloncology.2019.05.012

Ren, Jianjun, Yang, Wen, Su, Jie, Ren, Xue, Fazelzad, Rouhi, Albert, Tiong, Habbous, Steven, Goldstein, David P, de Almeida, John R., Hansen, Aaron, Jang, Raymond, Bratman, Scott V., Hope, Andrew, Chen, Ruiqi, Wang, Jing, Xu, Yang, Cheng, Danni, Zhao, Yu, Xu, Wei and Liu, Geoffrey (2019). Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region. International Journal of Cancer, 145 (6), 1465-1474. doi: 10.1002/ijc.32164

Hamilton, Robert J., Jewett, Michael A.S., Warde, Padraig and Hansen, Aaron (2019). Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option. European Urology Focus, 5 (5), 702-703. doi: 10.1016/j.euf.2019.05.003

Hansen, Aaron R., Tannock, Ian F., Templeton, Arnoud, Chen, Eric, Evans, Andrew, Knox, Jennifer, Prawira, Amy, Sridhar, Srikala S., Tan, Susie, Vera-Badillo, Francisco, Wang, Lisa, Wouters, Bradly G. and Joshua, Anthony M. (2019). Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): phase II trial of high dose pantoprazole (autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer (mCRPC). The Oncologist, 24 (9), 1188-1194. doi: 10.1634/theoncologist.2018-0621

Oliva, Marc, Huang, Shao Hui, Xu, Wei, Su, Jie, Hansen, Aaron R., Bratman, Scott V., Ringash, J., Jang, Raymond, Cho, John, Bayley, Andrew, Hope, Andrew J., Chen, Eric, Giuliani, Meredith, Waldron, John, Weinreb, Ilan, Perez-Ordonez, Bayardo, Chepeha, Douglas, Kim, John, O´Sullivan, B., Siu, Lillian L. and Spreafico, Anna (2019). Impact of cisplatin dose and smoking pack-years in human papillomavirus–positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. European Journal of Cancer, 118, 112-120. doi: 10.1016/j.ejca.2019.06.019

Picardo, Sarah L., Coburn, Bryan and Hansen, Aaron R. (2019). The microbiome and cancer for clinicians. Critical Reviews in Oncology/Hematology, 141, 1-12. doi: 10.1016/j.critrevonc.2019.06.004

Green, Brenda J., Nguyen, Vivian, Atenafu, Eshetu, Weeber, Phillip, Duong, Bill T. V., Thiagalingam, Punithan, Labib, Mahmoud, Mohamadi, Reza M., Hansen, Aaron R., Joshua, Anthony M. and Kelley, Shana O. (2019). Phenotypic profiling of circulating tumor cells in metastatic prostate cancer patients using nanoparticle-mediated ranking. Analytical Chemistry, 91 (15), 9348-9355. doi: 10.1021/acs.analchem.9b01697

Billfalk-Kelly, Astrid, Yu, Eugene, Su, Jie, O'Sullivan, Brian, Waldron, John, Ringash, Jolie, Bartlett, Eric, Perez-Ordonez, Bayardo, Weinreb, Ilan, Bayley, Andrew, Bratman, Scott V., Cho, John, Giuliani, Meredith, Hope, Andrew, Hosni, Ali, Kim, John, Hansen, Aaron R., de Almeida, John, Tong, Li, Xu, Wei and Huang, Shao Hui (2019). Radiologic extranodal extension portends worse outcome in cN+ TNM-8 stage I human papillomavirus–mediated oropharyngeal cancer. International Journal of Radiation: Oncology - Biology - Physics, 104 (5), 1017-1027. doi: 10.1016/j.ijrobp.2019.03.047

Hamilton, Robert J., Nayan, Madhur, Anson-Cartwright, Lynn, Atenafu, Eshetu G., Bedard, Philippe L., Hansen, Aaron, Chung, Peter, Warde, Padraig, Sweet, Joan, O'Malley, Martin, Sturgeon, Jeremy and Jewett, Michael A.S. (2019). Treatment of relapse of clinical stage I nonseminomatous germ cell tumors on surveillance. Journal of Clinical Oncology, 37 (22), 1919-1926. doi: 10.1200/JCO.18.01250

Lee, Sangjune Laurence, Cabanero, Michael, Hyrcza, Martin, Butler, Marcus, Liu, Fei-Fei, Hansen, Aaron, Huang, Shao Hui, Tsao, Ming-Sound, Song, Yuyao, Lu, Lin, Xu, Wei, Chepeha, Douglas B., Goldstein, David P., Weinreb, Ilan and Bratman, Scott V. (2019). Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray. Clinical and Translational Radiation Oncology, 17, 32-39. doi: 10.1016/j.ctro.2019.05.001

Tan, Tira, Rheaume, Michael, Wang, Lisa, Chow, Helen, Spreafico, Anna, Hansen, Aaron R., Razak, Albiruni R.A., Siu, Lillian L. and Bedard, Philippe L. (2019). Referrals to a phase I clinic and trial enrollment in the molecular screening era. The Oncologist, 24 (7), e518-e525. doi: 10.1634/theoncologist.2018-0808

Chung, Peter, O'Malley, Martin E., Jewett, Michael A.S., Bedard, Philippe L., Panzarella, Tony, Sturgeon, Jeremy, Moore, Malcolm J., Hamilton, Robert, Hansen, Aaron R., Anson-Cartwright, Lynn, Gospodarowicz, Mary and Warde, Padraig (2019). Detection of relapse by low-dose computed tomography during surveillance in stage I testicular germ cell tumours. European Urology Oncology, 2 (4), 437-442. doi: 10.1016/j.euo.2018.08.031

Ren, J., Xu, W., Su, J., Ren, X., Bender, N., Habbous, S., de Almeida, J. R., Goldstein, D. P., Cheng, D., Chen, Z., Mirshams, M., Rahini, M., Huang, S. H., Spreafico, A., Hansen, A., Kim, J., Waldron, J., Perez-Ordonez, B., Zhao, Y., Hung, R., Waterboer, T. and Liu, G. (2019). HPV status improves classification of head and neck gray zone cancers. Journal of Dental Research, 98 (8), 879-887. doi: 10.1177/0022034519853771

Picardo, Sarah L. and Hansen, Aaron R. (2019). The PD-1/PD-L1 pathway in advanced prostate cancer-have we milked this cow?. Annals of Translational Medicine, 7 (14) 346. doi: 10.21037/atm.2019.05.86

O’Kane, Grainne M, Ezzat, Shereen, Joshua, Anthony M., Bourdeau, Isabelle, Leibowitz-Amit, Raya, Olney, Harold J., Krzyzanowska, Monika, Reuther, Dean, Chin, Soo, Wang, Lisa, Brooks, Kelly, Hansen, Aaron R., Asa, Sylvia L. and Knox, Jennifer J. (2019). A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial. British Journal of Cancer, 120 (12), 1113-1119. doi: 10.1038/s41416-019-0474-x

Nguyen, Linh T., Saibil, Samuel D., Sotov, Valentin, Le, Michael X., Khoja, Leila, Ghazarian, Danny, Bonilla, Luisa, Majeed, Habeeb, Hogg, David, Joshua, Anthony M., Crump, Michael, Franke, Norman, Spreafico, Anna, Hansen, Aaron, Al-Habeeb, Ayman, Leong, Wey, Easson, Alexandra, Reedijk, Michael, Goldstein, David P., McCready, David, Yasufuku, Kazuhiro, Waddell, Thomas, Cypel, Marcelo, Pierre, Andrew, Zhang, Bianzheng, Boross-Harmer, Sarah, Cipollone, Jane, Nelles, Megan, Scheid, Elizabeth ... Butler, Marcus O. (2019). Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2. Cancer Immunology, Immunotherapy, 68 (5), 773-785. doi: 10.1007/s00262-019-02307-x

Shepshelovich, Daniel, McDonald, Kate, Spreafico, Anna, Razak, Albiruni R.A., Bedard, Philippe L., Siu, Lillian L., Minasian, Lori and Hansen, Aaron R. (2019). Feasibility assessment of using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) item library. The Oncologist, 24 (4), e146-e148. doi: 10.1634/theoncologist.2018-0332

Stukalin, I., Wells, J. C., Graham, J., Yuasa, T., Beuselinck, B., Kollmansberger, C., Ernst, D. S., Agarwal, N., Le, T., Donskov, F., Hansen, A. R., Bjarnason, G. A., Srinivas, S., Wood, L. A., Alva, A. S., Kanesvaran, R., Fu, S. Y.F., Davis, I. D., Choueiri, T. K. and Heng, Daniel Y. C. (2019). Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium. Current Oncology, 26 (2), e175-e179. doi: 10.3747/co.26.4595

Clouthier, Derek L., Lien, Scott C., Yang, S. Y. Cindy, Nguyen, Linh T., Manem, Venkata S.K., Gray, DIana, Ryczko, Michael, Razak, Albiruni R.A., Lewin, Jeremy, Lheureux, Stephanie, Colombo, Ilaria, Bedard, Philippe L., Cescon, David, Spreafico, Anna, Butler, Marcus O., Hansen, Aaron R., Jang, Raymond W., Ghai, Sangeet, Weinreb, Ilan, Sotov, Valentin, Gadalla, Ramy, Noamani, Babak, Guo, Mengdi, Elston, Sawako, Giesler, Amanda, Hakgor, Sevan, Jiang, Haiyan, McGaha, Tracy, Brooks, David G. ... Siu, Lillian L. (2019). An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). Journal for ImmunoTherapy of Cancer, 7 (1) 72, 1-12. doi: 10.1186/s40425-019-0541-0

Maia, Manuel Caitano, Hansen, Aaron, Alves, Carolina and Salah, Samer (2019). Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: a review. Critical Reviews in Oncology/Hematology, 135, 76-84. doi: 10.1016/j.critrevonc.2019.01.008

Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Zalewski, Pawel, Canil, Christina M., Winquist, Eric, Hotte, Sebastien J., North, Scott A., Heng, Daniel Yick Chin, Macfarlane, Robyn Jane, Venner, Peter M., Kapoor, Anil, Hansen, Aaron R., Eigl, Bernhard J., Czaykowski, Piotr, Boyd, Ben, Wang, Lisa and Basappa, Naveen S. (2019). The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: a phase 2 clinical trial. European Journal of Cancer, 108, 69-77. doi: 10.1016/j.ejca.2018.12.006

Kanjanapan, Y., Day, D., Butler, M. O., Wang, L., Joshua, A. M., Hogg, D., Leighl, N. B., Razak, A. R. Abdul, Hansen, A. R., Boujos, S., Chappell, M., Chow, K., Sherwin, B., Stayner, L. A., Soultani, L., Zambrana, A., Siu, L. L., Bedard, P. L. and Spreafico, A. (2019). Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials. European Journal of Cancer, 107, 1-7. doi: 10.1016/j.ejca.2018.10.017

Kwan, Jennifer Yin Yee, Su, Jie, Huang, Shao Hui, Ghoraie, Laleh S., Xu, Wei, Chan, Biu, Yip, Kenneth W., Giuliani, Meredith, Bayley, Andrew, Kim, John, Hope, Andrew J., Ringash, Jolie, Cho, John, McNiven, Andrea, Hansen, Aaron, Goldstein, David, de Almeida, John R., Aerts, Hugo J., Waldron, John N., Haibe-Kains, Benjamin, O'Sullivan, Brian, Bratman, Scott V. and Liu, Fei-Fei (2018). Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma. International Journal of Radiation Oncology Biology Physics, 102 (4), 1107-1116. doi: 10.1016/j.ijrobp.2018.01.057

Lewin, Jeremy, Soltan Ghoraie, Laleh, Bedard, Philippe L., Hamilton, Robert J., Chung, Peter, Moore, Malcolm, Jewett, Michael A.S., Anson-Cartwright, Lynn, Virtanen, Carl, Winegarden, Neil, Tsao, Julie, Warde, Padraig, Sweet, Joan, Haibe-Kains, Benjamin and Hansen, Aaron R. (2018). Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours. BJU International, 122 (5), 814-822. doi: 10.1111/bju.14372

Krishnamurthy, Anuradha, Dasari, Arvind, Noonan, Anne M., Mehnert, Janice M., Lockhart, Albert C., Leong, Stephen, Capasso, Anna, Stein, Mark N., Sanoff, Hanna K., Lee, James J., Hansen, Aaron, Malhotra, Usha, Rippke, Sarah, Gustafson, Daniel L., Pitts, Todd M., Ellison, Kim, Davis, S. Lindsey, Messersmith, Wells A., Eckhardt, S. Gail and Lieu, Christopher H. (2018). Phase IB results of the rational combination of selumetinib and cyclosporin A in advanced solid tumors with an expansion cohort in metastatic colorectal cancer. Cancer Research, 78 (18), 5398-5407. doi: 10.1158/0008-5472.CAN-18-0316

Hansen, A. R., Massard, C., Ott, P. A., Haas, N. B., Lopez, J. S., Ejadi, S., Wallmark, J. M., Keam, B., Delord, J. P., Aggarwal, R., Gould, M., Yang, P., Keefe, S. M. and Piha-Paul, S. A. (2018). Pembrolizumab for advanced prostate adenocarcinoma: Findings of the KEYNOTE-028 study. Annals of Oncology, 29 (8), 1807-1813. doi: 10.1093/annonc/mdy232

Leão, Ricardo, van Agthoven, Ton, Figueiredo, Arnaldo, Jewett, Michael A.S., Fadaak, Kamel, Sweet, Joan, Ahmad, Ardalan E., Anson-Cartwright, Lynn, Chung, Peter, Hansen, Aaron, Warde, Padraig, Castelo-Branco, Pedro, O'Malley, Martin, Bedard, Philippe L., Looijenga, Leendert H.J. and Hamilton, Robert J. (2018). Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor. Journal of Urology, 200 (1), 126-135. doi: 10.1016/j.juro.2018.02.068

Girotra, Monica, Hansen, Aaron, Farooki, Azeez, Byun, David J., Min, Le, Creelan, Ben C., Callahan, Margaret K., Atkins, Michael B., Sharon, Elad, Antonia, Scott J., West, Pamela and Gravell, Amy E. (2018). The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management. Jnci Cancer Spectrum, 2 (3) pky021. doi: 10.1093/jncics/pky021

Lieng, Hester, Warde, Padraig, Bedard, Philippe, Hamilton, Robert J., Hansen, Aaron R., Jewett, Michael A.S., O'Malley, Martin, Sweet, Joan and Chung, Peter (2018). Recommendations for followup of stage i and II seminoma: The Princess Margaret Cancer Centre approach. Canadian Urological Association Journal, 12 (2), 59-2. doi: 10.5489/cuaj.4531

Barua, Reeta, Magony, Alexander, Khalili, Korosh, Bedard, Philippe L., Hansen, Aaron R. and Lewin, Jeremy (2018). Shrinking Hepatic Hemangiomas in a Patient Treated for Metastatic Germ Cell Tumor. Clinical Genitourinary Cancer, 16 (1), e69-e72. doi: 10.1016/j.clgc.2017.08.008

Lewin, Jeremy, Dufort, Paul, Halankar, Jaydeep, O'Malley, Martin, Jewett, Michael A.S., Hamilton, Robert J., Gupta, Abha, Lorenzo, Armando, Traubici, Jeffrey, Nayan, Madhur, Leão, Ricardo, Warde, Padraig, Chung, Peter, Cartwright, Lynn Anson, Sweet, Joan, Hansen, Aaron R., Metser, Ur and Bedard, Philippe L. (2018). Applying radiomics to predict pathology of postchemotherapy retroperitoneal nodal masses in germ cell tumors. JCO Clinical Cancer Informatics, 2018 (2), 1-12. doi: 10.1200/CCI.18.00004

Caparrotti, Francesca, Huang, Shao Hui, Lu, Lin, Bratman, Scott V., Ringash, Jolie, Bayley, Andrew, Cho, John, Giuliani, Meredith, Kim, John, Waldron, John, Hansen, Aaron, Tong, Li, Xu, Wei, O'Sullivan, Brian, Wood, Robert, Goldstein, David and Hope, Andrew (2017). Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer, 123 (19), 3691-3700. doi: 10.1002/cncr.30803

Khoja, L., Day, D., Wei-Wu Chen, T., Siu, L. L. and Hansen, Aaron R. (2017). Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: A systematic review. Annals of Oncology, 28 (10), 2377-2385. doi: 10.1093/annonc/mdx286

Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M. and Forde, Patrick M. (2017). Immuno-oncology trial endpoints: Capturing clinically meaningful activity. Clinical Cancer Research, 23 (17), 4959-4969. doi: 10.1158/1078-0432.CCR-16-3065

Hansen, Aaron, Staggs, Jason and Shenoi, Sujeet (2017). Security analysis of an advanced metering infrastructure. International Journal of Critical Infrastructure Protection, 18, 3-19. doi: 10.1016/j.ijcip.2017.03.004

Chan, Michael W., Yu, Eugene, Bartlett, Eric, O'Sullivan, Brian, Su, Jie, Waldron, John, Ringash, Jolie, Bratman, Scott V., Chen, Yingming Amy, Irish, Jonathan, Kim, John, Gullane, Patrick, Gilbert, Ralph, Chepeha, Douglas, Perez-Ordonez, Bayardo, Weinreb, Ilan, Hansen, Aaron, Tong, Li, Xu, Wei and Huang, Shao Hui (2017). Morphologic and topographic radiologic features of human papillomavirus-related and –unrelated oropharyngeal carcinoma. Head and Neck, 39 (8), 1524-1534. doi: 10.1002/hed.24764

Caparrotti, Francesca, O'Sullivan, Brian, Bratman, Scott V., Ringash, Jolie, Lu, Lin, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Kim, John, Waldron, John, Hansen, Aaron, Goldstein, David, Perez-Ordonez, Bayardo, Weinreb, Ilan, Tong, Li, Song, Yuyao, Xu, Wei and Huang, Shao Hui (2017). Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy. International Journal of Radiation Oncology Biology Physics, 98 (4), 858-867. doi: 10.1016/j.ijrobp.2016.11.044

Maia, Manuel Caitano and Hansen, Aaron R. (2017). A comprehensive review of immunotherapies in prostate cancer. Critical Reviews in Oncology/Hematology, 113, 292-303. doi: 10.1016/j.critrevonc.2017.02.026

McDowell, Lachlan J., Huang, Shao Hui, Xu, Wei, Che, Jiahua, Wong, Rebecca K.S., Brierley, James, Kim, John, Cummings, Bernard, Waldron, John, Bayley, Andrew, Hansen, Aaron, Witterick, Ian and Ringash, Jolie (2017). Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma. International Journal of Radiation Oncology Biology Physics, 98 (1), 186-195. doi: 10.1016/j.ijrobp.2017.01.003

Huang, Shao Hui, Waldron, John, Bratman, Scott V., Su, Jie, Kim, John, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Ringash, Jolie, Hansen, Aaron, de Almeida, John R., Goldstein, David, Perez-Ordonez, Bayardo, Weinreb, Ilan, Tong, Li, Xu, Wei and O'Sullivan, Brian (2017). Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. International Journal of Radiation Oncology Biology Physics, 98 (1), 159-169. doi: 10.1016/j.ijrobp.2017.01.018

Hansen, Aaron R., Cook, Natalie, Amir, Eitan, Siu, Lillian L. and Abdul Razak, Albiruni Ryan (2017). Determinants of the recommended phase 2 dose of molecular targeted agents. Cancer, 123 (8), 1409-1415. doi: 10.1002/cncr.30579

Rodin, Danielle, Caulley, Lisa, Burger, Emily, Kim, Jane, Johnson-Obaseki, Stephanie, Palma, David, Louie, Alexander V., Hansen, Aaron and O'Sullivan, Brian (2017). Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology Biology Physics, 97 (4), 709-717. doi: 10.1016/j.ijrobp.2016.11.029

Poudineh, Mahla, Aldridge, Peter M., Ahmed, Sharif, Green, Brenda J., Kermanshah, Leyla, Nguyen, Vivian, Tu, Carmen, Mohamadi, Reza M., Nam, Robert K., Hansen, Aaron, Sridhar, Srikala S., Finelli, Antonio, Fleshner, Neil E., Joshua, Anthony M., Sargent, Edward H. and Kelley, Shana O. (2017). Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking. Nature Nanotechnology, 12 (3), 274-281. doi: 10.1038/nnano.2016.239

Juergens, Rosalyn A., Bratman, Scott V., Tsao, Ming-Sound, Laurie, Scott A., Sara Kuruvilla, M., Razak, Albiruni R.A. and Hansen, Aaron R. (2017). Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck. Cancer Treatment Reviews, 54, 43-57. doi: 10.1016/j.ctrv.2017.01.003

Goncalves, Priscila H., Heilbrun, Lance K., Barrett, Michael T., Kummar, Shivaani, Hansen, Aaron R., Siu, Lillian L., Piekarz, Richard L., Sukari, Ammar W., Chao, Joseph, Pilat, Mary Jo, Smith, Daryn W., Casetta, Lindsay, Boerner, Scott A., Chen, Alice, Lenkiewicz, Elizabeth, Malasi, Smriti and LoRusso, Patricia M. (2017). A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma. Oncotarget, 8 (20), 32918-32929. doi: 10.18632/oncotarget.16464

Nayan, Madhur, Jewett, Michael A.S., Hosni, Ali, Anson-Cartwright, Lynn, Bedard, Philippe L., Moore, Malcolm, Hansen, Aaron R., Chung, Peter, Warde, Padraig, Sweet, Joan, O'Malley, Martin, Atenafu, Eshetu G. and Hamilton, Robert J. (2017). Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer. European Urology, 71 (1), 120-127. doi: 10.1016/j.eururo.2016.07.013

Prawira, A., Oosting, S. F., Chen, T. W., Delos Santos, K. A., Saluja, R., Wang, L., Siu, L. L., Chan, K. K.W. and Hansen, A. R. (2017). Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review. British Journal of Cancer, 117 (12), 1743-1752. doi: 10.1038/bjc.2017.357

Day, Daphne and Hansen, Aaron R. (2016). Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors. BioDrugs, 30 (6), 571-584. doi: 10.1007/s40259-016-0204-3

Spreafico, Anna, Huang, Shao Hui, Xu, Wei, Granata, Roberta, Liu, Chen-Shin, Waldron, John N., Chen, Eric, Ringash, Jolie, Bayley, Andrew, Chan, Kelvin K.W., Hope, Andrew J., Cho, John, Razak, Albiruni A.R., Hansen, Aaron, Jang, Raymond, Perez-Ordonez, Bayardo, Weinreb, Ilan, Bossi, Paolo, Orlandi, Ester, Licitra, Lisa F., Song, Yuyao, O'Sullivan, Brian, Siu, Lillian L. and Kim, John (2016). Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. European Journal of Cancer, 67, 174-182. doi: 10.1016/j.ejca.2016.08.013

Prawira, Amy, Brana-Garcia, Irene, Spreafico, Anna, Hope, Andrew, Waldron, John, Razak, Albiruni R. Abdul, Chen, Eric X, Jang, Raymond, O’Sullivan, Brian, Giuliani, Meredith, Bayley, Andrew, Cho, John, Wang, Lisa, Perez-Ordonez, Bayardo, Weinreb, Ilan, Siu, Lillian L. and Hansen, Aaron R (2016). Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001). Investigational New Drugs, 34 (5), 575-583. doi: 10.1007/s10637-016-0367-2

Oosting, Sjoukje F., Chen, Tom W.W., Huang, Shao H., Wang, Lisa, Waldron, John, Gilbert, Ralph, Goldstein, David, Halmos, Gyorgy B., Witjes, Max J.H., Gietema, Jourik A., O'Sullivan, Brian, Langendijk, Johannes A., Siu, Lillian L. and Hansen, Aaron R. (2016). A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. Oral Oncology, 59, 43-49. doi: 10.1016/j.oraloncology.2016.05.016

Hansen, Aaron R., Hughes, Brett G., Paul, Sanjoy, Steadman, Peter, Sommerville, Scott, Dickinson, Ian C., Walpole, Euan T., Thomson, Damien B., Mar Fan, Helen G. and Joubert, Warren L. (2016). Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma. Asia-Pacific Journal of Clinical Oncology, 12 (2), e222-e228. doi: 10.1111/ajco.12167

Hosni, Ali, Huang, Shao Hui, Goldstein, David, Xu, Wei, Chan, Biu, Hansen, Aaron, Weinreb, Ilan, Bratman, Scott V., Cho, John, Giuliani, Meredith, Hope, Andrew, Kim, John, O'Sullivan, Brian, Waldron, John and Ringash, Jolie (2016). Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy. Oral Oncology, 54, 75-80. doi: 10.1016/j.oraloncology.2015.11.023

Meulendijks, Didier, Lassen, Ulrik N., Siu, Lillian L., Huitema, Alwin D.R., Karanikas, Vaios, Mau-Sorensen, Morten, Jonker, Derek J., Hansen, Aaron R., Simcox, Mary E., Schostack, Kathleen J., Bottino, Dean, Zhong, Hua, Roessler, Markus, Vega-Harring, Suzana M., Jarutat, Tiantom, Geho, David, Wang, Karen, DeMario, Mark, Goss, Glenwood D. and Schellens, Jan H.M. (2016). Exposure and tumor Fn14 expression as determinants of pharmacodynamics of the anti- tweak monoclonal antibody RG7212 in patients with FN14-positive solid tumors. Clinical Cancer Research, 22 (4), 858-867. doi: 10.1158/1078-0432.CCR-15-1506

Sukhai, Mahadeo A., Craddock, Kenneth J., Thomas, Mariam, Hansen, Aaron R., Zhang, Tong, Siu, Lillian, Bedard, Philippe, Stockley, Tracy L. and Kamel-Reid, Suzanne (2016). A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. Genetics in Medicine, 18 (2), 128-136. doi: 10.1038/gim.2015.47

Day, D., Hansen, A. R. and Siu, L. L. (2016). Hypopharyngeal cancer: Looking back, moving forward. Current Oncology, 23 (4), 221-222. doi: 10.3747/co.23.3242

Hansen, Aaron R. and Siu, Lillian L. (2016). PD-L1 testing in cancer: Challenges in companion diagnostic development. JAMA Oncology, 2 (1), 15-16. doi: 10.1001/jamaoncol.2015.4685

Chen, T. W., Razak, A. R., Bedard, P. L., Siu, L. L. and Hansen, Aaron R. (2015). A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors. Annals of Oncology, 26 (9), 1824-1829. doi: 10.1093/annonc/mdv182

Cook, Natalie, Hansen, Aaron R., Siu, Lillian L. and Abdul Razak, Albiruni R. (2015). Early phase clinical trials to identify optimal dosing and safety. Molecular Oncology, 9 (5), 997-1007. doi: 10.1016/j.molonc.2014.07.025

Duhig, Edwina Elizabeth, Dettrick, Andrew, Godbolt, David Burleigh, Pauli, John, van Zwieten, Anthony, Hansen, Aaron Richard, Yang, Ian Anthony, Fong, Kwun Meng, Clarke, Belinda E. and Bowman, Rayleen V. (2015). Mitosis trumps T stage and proposed international association for the study of lung cancer/American thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma. Journal of Thoracic Oncology, 10 (4), 673-681. doi: 10.1097/JTO.0000000000000446

Huang, Shao Hui, Xu, Wei, Waldron, John, Siu, Lillian, Shen, Xiaowei, Tong, Li, Ringash, Jolie, Bayley, Andrew, Kim, John, Hope, Andrew, Cho, John, Giuliani, Meredith, Hansen, Aaron, Irish, Jonathan, Gilbert, Ralph, Gullane, Patrick, Perez-Ordonez, Bayardo, Weinreb, Ilan, Liu, Fei-Fei and O'Sullivan, Brian (2015). Refining American joint committee on cancer/union for international cancer control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. Journal of Clinical Oncology, 33 (8), 836-845. doi: 10.1200/JCO.2014.58.6412

Lassen, Ulrik N., Meulendijks, Didier, Siu, Lilian L., Karanikas, Vaios, Mau-Sorensen, Morten, Schellens, Jan H.M., Jonker, Derek J., Hansen, Aaron R., Simcox, Mary E., Schostack, Kathleen J., Bottino, Dean, Zhong, Hua, Roessler, Markus, Vega-Harring, Suzana M., Jarutat, Tiantom, Geho, David, Wang, Ka, Demario, Mark and Goss, Glenwood D. (2015). A phase I monotherapy study of RG7212, a first-in- class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers. Clinical Cancer Research, 21 (2), 258-266. doi: 10.1158/1078-0432.CCR-14-1334

Hansen, Aaron R., Cook, Natalie, Stacey Ricci, M., Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L. and Hinrichs, Mary Jane (2015). Choice of starting dose for biopharmaceuticals in first-in-human phase i cancer clinical trials. Oncologist, 20 (6), 653-659. doi: 10.1634/theoncologist.2015-0008

Huang, Shao Hui, Hansen, Aaron, Rathod, Shrinivas and O'Sullivan, Brian (2015). Primary surgery versus (chemo)radiotherapy in oropharyngeal cancer: The radiation oncologist's and medical oncologist's perspectives. Current Opinion in Otolaryngology and Head and Neck Surgery, 23 (2), 139-147. doi: 10.1097/MOO.0000000000000141

Hansen, Aaron R., Graham, Donna M., Pond, Gregory R. and Siu, Lillian L. (2014). Phase 1 trial design: Is 3 + 3 the best?. Cancer Control, 21 (3), 200-208. doi: 10.1177/107327481402100304

Hansen, Aaron R. and Bedard, Philippe L. (2013). Clinical application of high-throughput genomic technologies for treatment selection in breast cancer. Breast Cancer Research, 15 (5) R97. doi: 10.1186/bcr3558

Bedard, Philippe L., Hansen, Aaron R., Ratain, Mark J. and Siu, Lillian L. (2013). Tumour heterogeneity in the clinic. Nature, 501 (7467), 355-364. doi: 10.1038/nature12627

Hansen, Aaron R. and Siu, Lillian L. (2013). Epidermal growth factor receptor targeting in head and neck cancer: Have we been just skimming the surface?. Journal of Clinical Oncology, 31 (11), 1381-1383. doi: 10.1200/JCO.2012.47.9220

Hansen, Aaron R. and Bedard, Philippe L. (2012). Salvage chemotherapy for metastatic germ cell tumours: The known unknowns. Journal of the Canadian Urological Association, 6 (2), 117-118. doi: 10.5489/cuaj.12059

MEREDITH, W, RUTLEDGE, R, HANSEN, AR, OLLER, DW, THOMASON, M, CUNNINGHAM, P and BAKER, CC (1995). FIELD TRIAGE OF TRAUMA PATIENTS BASED UPON THE ABILITY TO FOLLOW COMMANDS - A STUDY IN 29,573 INJURED PATIENTS. Journal of Trauma-Injury Infection and Critical Care, 38 (1), 129-135. doi: 10.1097/00005373-199501000-00030

KOBS, JK, HANSEN, AR and KEEFE, B (1992). A RETAINED WOODEN FOREIGN-BODY IN THE FOOT DETECTED BY ULTRASONOGRAPHY - A CASE-REPORT. Journal of Bone and Joint Surgery-American Volume, 74A (2), 296-298. doi: 10.2106/00004623-199274020-00018

HANSEN, AR, MEYER, AA, PROCTOR, HJ and SHELDON, GF (1990). STAFFING A TRAUMA SYSTEM. Problems in General Surgery, 7 (2), 260-272.

KENNEDY, KA, HANSEN, AR and FISCHER, LJ (1977). DISTRIBUTION BETWEEN PLASMA AND BRAIN OF GLUTETHIMIDE AND 4-HYDROXYGLUTETHIMIDE FOLLOWING THEIR ADMINISTRATION TO MICE. Proceedings of the Society for Experimental Biology and Medicine, 156 (3), 491-495.

HANSEN, AR, AMBRE, JJ, KENNEDY, KA and FISCHER, LJ (1975). ACTIVITY OF GLUTETHIMIDE METABOLITE IN HUMAN BEINGS. New England Journal of Medicine, 292 (16), 871-871.

HANSEN, AR, KENNEDY, KA, AMBRE, JJ and FISCHER, LJ (1975). GLUTETHIMIDE POISONING - METABOLITE CONTRIBUTES TO MORBIDITY AND MORTALITY. New England Journal of Medicine, 292 (5), 250-252. doi: 10.1056/NEJM197501302920507

ABOULENEIN, HY, SCHAUBERGER, CW, HANSEN, AR and FISCHER, LJ (1975). SYNTHESIS OF AN ACTIVE HYDROXYLATED GLUTETHIMIDE METABOLITE AND SOME RELATED ANALOGS WITH SEDATIVE-HYPNOTIC AND ANTICONVULSANT PROPERTIES. Journal of Medicinal Chemistry, 18 (7), 736-741. doi: 10.1021/jm00241a019

HANSEN, AR and FISCHER, LJ (1974). GAS-CHROMATOGRAPHIC SIMULTANEOUS ANALYSIS FOR GLUTETHIMIDE AND AN ACTIVE HYDROXYLATED METABOLITE IN TISSUES, PLASMA, AND URINE. Clinical Chemistry, 20 (2), 236-242.

HANSEN, AR and FISCHER, LJ (1974). SPECIFICITY OF ANALYSIS FOR GLUTETHIMIDE AND ITS METABOLITES. Clinical Chemistry, 20 (7), 919-920.

OBER, RE, HANSEN, AR, MOURER, D, BAUKEMA, J and GWYNN, GW (1969). OXYGEN FLASK COMBUSTION ANALYSIS OF 14C AND 3H - DESCRIPTION OF METHOD AND APPARATUS AND SUMMARY OF EXPERIENCE, WITH EMPHASIS ON ANALYSIS OF LOW LEVELS OF ACTIVITY. International Journal of Applied Radiation and Isotopes, 20 (10), 703-&. doi: 10.1016/0020-708X(69)90067-2

Garcia, Enrique Sanz, Zhao, Eric Y., Melton, Collin A., Zhang, Junjun, Zhong, Yongqi, Bratman, Scott Victor, Williams, Alan, Allen, Brian, Zhang, Jing, De Carvalho, Daniel D., Hartman, Anne-Renee, Liu, Zhihui Amy, Abdul Razak, Albiruni Ryan, Spreafico, Anna, Bedard, Philippe, Hansen, Aaron Richard, Lheureux, Stephanie, Ohashi, Pamela S. and Siu, Lillian L. (2025). Validation of an optimized tissue-agnostic genome-wide methylome enrichment assay to predict clinical outcomes in patients treated with pembrolizumab. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2025.43.16_suppl.2545

Herrera, Mercedes, Marhon, Sajid A., Abbas-Aghababazadeh, Farnoosh, Chen, David, Liu, Amy, LooYau, Helen, Van de laar, Emily, Bruce, Jeffrey, Chow, Helen, Bedard, Philippe L., Razak, Albiruni, Spreafico, Anna, Hansen, Aaron R., Butler, Marcus O., Lheureux, Stephanie, Pugh, Trevor J., Haibe-Kains, Benjamin, De Carvalho, Daniel D., Siu, Lillian L. and Spiliopoulou, Pavlina (2025). Independent validation of endogenous retrotransposable elements as predictive biomarkers of immune checkpoint blockade response. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago Il, Apr 25-30, 2025. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2025-2060

Mak, Blossom, Tran, Ben, Thomas, Hayley, Pashankar, Farzana D., Hansen, Aaron Richard, Feldman, Darren R., Huddart, Robert A, Wheater, Matthew, Dunwoodie, Elaine, Mazhar, Danish, Lawrence, Nicola Jane, Stevanovic, Amanda Gwendolyn, Birtle, Alison Jane, Oladipo, Olabode, Wyld, David, Balagtas, Jay Michael S., Stockler, Martin R., Grimison, Peter S. and The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2025). An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs). 2025 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 13-15 February 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.5_suppl.tps653

Hansen, Aaron Richard, Pattison, David A., Ngai, Stanley, Karmann, Anna, Walker, Amanda J., Campbell, Louise, Brady, Jasmine, Katchel, Loren, Holmes, Ingrid, Rose, Stephen E., Baronet, Meghan C., Kryza, Thomas, Vito, Alyssa, Tieu, William, Kuan, Kevin, Griffiths, Matthew R., O’Mahoney, Eoin, Latter, Melissa, Gan, Chun Loo Loo and Wyld, David (2025). Phase Ib/IIa dose escalation and expansion study of [ 212 Pb]Pb-ADVC001 in metastatic castration-resistant prostate cancer: TheraPb–phase I/II study. 2025 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 13-15 February 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.5_suppl.tps275

Hansen, Aaron Richard, Zhang, Alison Yan, Boni, Valentina, Mantia, Charlene, Yu, Evan Y., Weickhardt, Andrew James, Robert, Marie, Gupta, Shilpa, Morales-Barrera, Rafael, Hoimes, Christopher J., Berlin, Jordan, Iyer, Gopa, Millward, Michael, Lihou, Christine Francis, Loriot, Yohan, Pouessel, Damien, Mittal, Kriti, Hill, Andrew Graham, Racca, Fabricio and Tran, Ben (2025). A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301). 2025 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 13-15 February 2025. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2025.43.5_suppl.TPS904

Bourdaniotis, Xanthia E., Ayre, Susannah K., Johnston, Elizabeth (Lizzy) A., Zajdlewicz, Leah, Beesley, Vanessa L., Pole, Jason D., Hansen, Aaron, Gasper, Harry, Cossio, Danica, Lock, Gemma and Goodwin, Belinda C. (2024). How should we design study invitation materials for cancer survivorship research? Findings from a consumer consultation study. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD Australia, 13–15 November 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Lumchee, Sarah and Hansen, Aaron (2024). Case report: Hereditary leiomyomatosis and renal cell cancer treated with bevacizumab and erlotinib. HOBOKEN: WILEY.

Tran, B., Boni, A., Hansen, A., Boni, V., Mantia, C., Yu, E., Weickhardt, A., Robert, M., Gupta, S., Necchi, A., Morales-Barrera, R., Hoimes, C., Berlin, J., Iyer, G., Millward, M., Burn, T., Lihou, C., Gammon, G., Rosenberg, J. and Loriot, Y. (2024). Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301). 36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR), Barcelona, Spain, 23-25 October 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.ejca.2024.114978

Sartor, O., Jiang, D. M., Smoragiewicz, M., Zibelman, M., Flechon, A., El-Haddad, G., Abikhzer, G., Saad, F., Tutrone, R., Tagawa, S. T., Metser, U., Calais, J., Hansen, A. R., Wu, W., Jensen, J., Trieu, C. R., Fleshner, N., Teslenko, I., Provost, J-C. G. and Chi, K. N. (2024). Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH). Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 13-17, 2024. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2024.08.2308

Spiliopoulou, P., Wong, M., Boukhaled, G. M., Gadalla, R., Strum, S., Liu, R., Heirali, A., Wang, B. X., Saibil, S., Hansen, A. R., Siu, L. L., Coburn, B. and Spreafico, A. (2024). Microbial ecosystem therapeutics 4 (MET4) treatment mediates a humoral response in patients treated with immune checkpoint inhibition (ICI). Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 13-17, 2024. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2024.08.1064

Rose, April A. N., Maxwell, Jennifer, Rousselle, Emmanuelle, Riaud, Melody, Tobin, Chantal, Mcguire, Meghan, King, Ian, Zhang, Tong, Kamil, Zaid Saeed, Pugh, Trevor J., Butler, Marcus O., Shepherd, Frances A., Bedard, Philippe L., Leighl, Natasha B., Razak, Albiruni Ryan Abdul, Hansen, Aaron Richard, Saibil, Samuel, Siu, Lillian L., Cescon, David W. and Spreafico, Anna (2024). Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2024.42.16_suppl.3104

Alshankati, Khadjah, Bruce, Jeffery P., Ohashi, Pamela S., Butler, Marcus O., Cescon, David W., Hansen, Aaron Richard, Linh Nguyen,, Tsao, Ming Sound, Haibe-Kains, Benjamin, Yu, Celeste, Sabatini, Peter, Razak, Albiruni Ryan Abdul, Spreafico, Anna, Wang, Ben X., Pugh, Trevor John, Siu, Lillian L. and Bedard, Philippe L. (2024). Comprehensive whole genome and transcriptome analysis of patients with advanced solid tumor treated with immune checkpoint inhibitor therapy in the pan-cancer cohorts from the Marathon of Hope Cancer Centres Network Study (MOHCCN). 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2024.42.16_suppl.2645

Herrera, Mercedes, Marhon, Sajid A., Liu, Zhihui Amy, Yau, Helen Loo, de laar, Emily Van, Bruce, Jeffrey, Chow, Helen, Bedard, Philippe L., Razak, Albiruni Ryan Abdul, Spreafico, Anna, Hansen, Aaron Richard, Butler, Marcus O., Lheureux, Stephanie, Pugh, Trevor John, de Carvalho, Daniel A., Siu, Lillian L. and Spiliopoulou, Pavlina (2024). Endogenous retrotransposable elements as a novel predictive biomarker of response to immunotherapy. Special Clinical Science Symposia, Electr Network, May 29-29, 2024. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Conduit, Ciara, Grimison, Peter S., Lewin, Jeremy Howard, Hansen, Aaron Richard, Lynam, James F., Weickhardt, Andrew James, Parente, Phillip, Campbell, David Colin, Hong, Wei, Marx, Gavin M., Heron, Orlaith Mary, Kuchel, Anna, McJannett, Margaret Mary, Cusick, Thomas, Fontela, Antoinette, Haire, Sophie O., Zlatic, Kristina, Davis, Ian D. and Ben Tran, (2023). CLIMATE: Assessing the clinical utility of miR-371a-3p as a marker of residual disease in stage 1 testicular germ cell tumour (TGCT) following orchiectomy: ANZUP 1906. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 2-6 June 2023. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2023.41.16_suppl.TPS5100

Feng, Gregory, Parthipan, Milothy, Breunis, Henriette, Timilshina, Narhari, Perez de Celis, Enrique Soto, Mina, Daniel Santa, Emmenegger, Urban, Hansen, Aaron Richard, Finelli, Antonio, Tomlinson, George, Krzyzanowska, Monika K., Matthew, Andrew, Clarke, Hance, Puts, Martine and Alibhai, Shabbir M. H. (2023). Feasibility of daily physical activity monitoring and associations with treatment toxicity in older adults with metastatic prostate cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.12055

Alshibany, Aisha, Al-Ezzi, Esmail Mutahar, Gupta, Abha A., Salawu, Abdulazeez, Watson, Geoffrey Alan, Wang, Lisa, Bedard, Philippe L., Spreafico, Anna, Hansen, Aaron Richard, Siu, Lillian L. and Razak, Albiruni Ryan Abdul (2023). Evaluation of hyperprogression in patients with sarcoma treated with targeted therapy and/ or immunotherapy in early-phase clinical trials. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.11560

Parthipan, Milothy, Feng, Gregory, Breunis, Henriette, Timilshina, Narhari, de Celis, Enrique Soto Perez, Hansen, Aaron Richard, Emmenegger, Urban, Finelli, Antonio, Warde, Padraig, Tomlinson, George, Krzyzanowska, Monika K., Matthew, Andrew, Clarke, Hance, Santa Mina, Daniel, Puts, Martine and Alibhai, Shabbir M. H. (2023). Understanding treatment toxicity patterns through remote symptom monitoring and examining the effect of frailty in older men with metastatic prostate cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.12054

Lemelin, Audreylie, Takemura, Kosuke, Ernst, Matthew Scott, Wells, J. Connor, Donskov, Frede, Porta, Camillo, de Velasco, Guillermo, Davis, Ian D., Wood, Lori, Pal, Sumanta Kumar, Hansen, Aaron Richard, Kollmannsberger, Christian K., Bjarnason, Georg A., Tran, Ben, Li, Haoran, Kanesvaran, Ravindran, Powles, Thomas, McKay, Rana R., Choueiri, Toni K. and Heng, Daniel Yick Chin (2023). Characterizing progression to subsequent lines of therapy in metastatic renal cell carcinoma (mRCC) after nivolumab plus ipilimumab (Nivo plus Ipi): Results from the International mRCC Database Consortium (IMDC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Genta, Sofia, Bruce, Jeff, Li, Xuan, Felicen, Sam, Razak, Albiruni Ryan Abdul, Saibil, Samuel, Butler, Marcus O., Bedard, Philippe L., Lam, Bernard, Tsao, Ming Sound, Leong, Wey Liang, Easson, Alexandra, Wang, Ben X., Lungu, Ilinca, Goldstein, David Paul, Hansen, Aaron Richard, Eng, Lawson, Pugh, Trevor John, Siu, Lillian L. and Spreafico, Anna (2023). Deciphering primary and acquired immunotherapy resistance with whole genome and transcriptome analysis (WGTA). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Spiliopoulou, Pavlina, Han, Ming, Wilson, Brooke, Sacher, Adrian G., Fallah-Rad, Nazanin, Sridhar, Srikala S., Shah, Elizabeth, Speers, Vanessa, Yu, Celeste, Thiagarajah, Madhuran, Lungu, Ilinca, Picardo, Sarah Louise, Iafolla, Marco, Lam, Bernard, Siu, Lillian L. and Hansen, Aaron Richard (2023). Global circulating free DNA methylation and fragmentome deconvolution in patients with metastatic renal cell carcinoma treated with immunotherapy (GOLDEN). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.4544

Salawu, Abdulazeez, Han, Ming, Gupta, Abha A., Berman, Hal, Wang, Ben X., Pfister, Thomas D., Hernando-Calvo, Alberto, Al-Ezzi, Esmail Mutahar, Ayodele, Olubukola, Stayner, Lee-Anne, Lam, Bernard, Hansen, Aaron Richard, Spreafico, Anna, Bedard, Philippe L., Butler, Marcus O., Haibe-Kains, Benjamin, Avery, Lisa, Siu, Lillian L. and Razak, Albiruni Ryan Abdul (2023). Immune correlates of outcome in patients with leiomyosarcoma (LMS) treated with durvalumab plus olaparib or cediranib: Transcriptome analysis from the DAPPER study. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.11567

Spiliopoulou, Pavlina, Rooney, Ashley, Genta, Sofia, Kulikova, Maria, Wang, Ben X., Tsao, Ming Sound, Felicen, Sam, Speers, Vanessa, Patrick, Theresa, Nguyen, Alisa, Butler, Marcus O., Eng, Lawson, Hansen, Aaron Richard, Saibil, Sam, Bedard, Philippe L., Pugh, Trevor John, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2023). Intestinal microbiome characterization in immune checkpoint inhibition (ICI) resistant disease. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.2515

Spiliopoulou, Pavlina, Rooney, Ashley, Genta, Sofia, Kulikova, Maria, Wang, Ben X., Felicen, Sam, Speers, Vanessa, Patrick, Theresa, Nguyen, Alisa, Butler, Marcus O., Eng, Lawson, Hansen, Aaron Richard, Saibil, Sam, Bedard, Philippe L., Pugh, Trevor John, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2023). Intestinal microbiome characterization in immune checkpoint inhibition (ICI) resistant disease. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Garcia, Enrique Sanz, Zou, Jinfeng, Avery, Lisa, Spreafico, Anna, Waldron, John, Goldstein, David Paul, Hansen, Aaron Richard, Cho, John, de Almeida, John R., Hope, Andrew, Hosni, Ali, Hahn, Ezra, Perez-Ordonez, Bayardo, Zhao, Zhen, Smith, Christopher Gareth, Zheng, Yangqiao, Rosenfeld, Nitzan, Singaravelan, Nittusha, Bratman, Scott Victor and Siu, Lillian L. (2023). Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2023.41.16_suppl.6065

Hilton, John, Renouf, Daniel, Cescon, David W., Hansen, Aaron, Razak, Alibiruni Abdul, Stayner, Lee-Anne, Denny, Trisha A., Roberts-Thomson, Emily, Chen, Dih-Yih, Bray, Mark and Bedard, Philippe (2023). An update to a Phase I trial of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors with HER2-negative breast cancer expansion cohorts. San Antonio Breast Cancer Symposium, San Antonio Tx, Dec 06-10, 2022. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.SABCS22-P6-10-13

Labidi, S., Meti, N., Barua, R., Riromar, J. J., Hansen, A. R., Jiang, D. M., Fallah-Rad, N., Sridhar, S., Ferrario, C., Pezo, R., Cheng, S., Sacher, A. and Rose, A. (2022). Association between body mass index (BMI) and anti-PD1/L1 immune checkpoint inhibitor (ICI) outcomes in patients with metastatic urothelial carcinoma (mUC). Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.1832

Mittal, A., Amer, L., Ayodele, O., Radi, S., Li, X., Mete, O., Pasternak, J., Jiang, D. M., Kumar, V. and Hansen, A. R. (2022). Beyond first-line therapy in metastatic adrenal cortical cancer (ACC): Is it time to move on from chemotherapy?. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.024

Takemura, K., Navani, V., Ernst, M. S., Wells, J. C., Choueiri, T. K., Meza, L., Pal, S. K., Lee, J-L., Li, H., Agarwal, N., Alva, A. S., Hansen, A. R., Basappa, N. S., Szabados, B. E., Powles, T. B., Tran, B., Hocking, C. M., Beuselinck, B., Yuasa, T. and Heng, D. Y. C. (2022). Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC). Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.1558

Dzienis, M. R., Cundom, J. E., Fuentes, C. S., Hansen, A. R., Nordlinger, M. J., Pastor, A. V., Oppelt, P., Neki, A., Gregg, R. W., Lima, I. P. F., Franke, F. A., Da Cunha Junior, G. F., Tseng, J. E., Loree, T., Joshi, A. J., Mccarthy, J. S., Naicker, N., Sidi, Y., Gumuscu, B. and De Castro, G. (2022). Pembrolizumab (pembro) plus carboplatin (carbo) plus paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 study. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.775

O'Malley, D., Bariani, G. M., Cassier, P. A., Marabelle, A., Hansen, A. R., De Jesus-Acosta, A., Miller, W. H., Safra, T., Italiano, A., Mileshkin, L., Yao, L., Gozman, A., Jin, F. J. and Maio, M. (2022). Pembrolizumab for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced endometrial cancer: Long-term follow-up results from KEYNOTE-158. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.674

Zhao, E. Y., Garcia, E. Sanz, Liu, Z., Marsh, K., Razak, A. Abdul, Spreafico, A., Bedard, P. L., Hansen, A. R., Lheureux, S., Torti, D., Lam, B., Pugh, T. J. and Siu, L. L. (2022). Tumor-naive methylomes and fragmentomes during pembrolizumab (P) in metastatic cancer patients. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2022.07.1744

Hansen, A. R., Probst, S., Tutrone, R. F., Osman, M. M., Delpassand, E. S., Nordquist, L. T., Viglianti, B. L., Michalski, J. M., Beauregard, J-M., Oz, O. K., Courtney, K., Jensen, J., Wu, W., Fleshner, N., Sartor, O., Chi, K. N. and Tagawa, S. T. (2022). Efficacy and safety of 177Lu-PNT2002 prostate-specific membrane antigen (PSMA) therapy in metastatic castration resistant prostate cancer (mCRPC): Initial results from SPLASH. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER.

Calvo, E., Doger de Speville, B., Carles Galceran, J., Peer, A., Sarid, D. L., Eigl, B. J., Avadhani, A., Yao, D., Lin, V., Wu, S., Jaiprasart, P., Loffredo, J., Tamegnon, M., Xie, H. and Hansen, A. R. (2022). JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 bispecific antibody, in prostate cancer: Initial results from a phase I dose escalation study. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 09-13, 2022. AMSTERDAM: ELSEVIER.

Naing, Aung, Callahan, Margaret, Costello, Brian A., Curti, Brendan, Hall, Evan, Hansen, Aaron, Long, Georgina V., Joshua, Anthony M., Wetmore, Cynthia and Weickhardt, Andrew (2022). A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer. Annual Meeting of the American-Association-for-Cancer-Research (AACR), New Orleans La, Apr 08-13, 2022. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Magalhaes, Marcos Aurelio Fonseca Filho, Voon, Pei Jye, Carlsson, Lindsay, Silver, Grace and Hansen, Aaron Richard (2022). A randomized study to measure and enhance the health-related quality of life in patients with cancer receiving immune checkpoint modulators (ME-Q). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Genta, Sofia, Keshavarzi, Sareh, Yee, Noelle, Heirali, Alya, Hansen, Aaron Richard, Siu, Lillian L., Saibil, Samuel, Stayner, Lee-Anne, Yanekina, Maryia, Sauder, Maxwell, Salawu, Abdulazeez, Spiliopoulou, Pavlina, Vornicova, Olga, Vilbert, Maysa Tamara Silveira, Butler, Marcus O., Bedard, Philippe L., Razak, Albiruni Ryan Abdul, Coburn, Bryan, Chruscinski, Andrzej and Spreafico, Anna (2022). Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Garcia, Enrique Sanz, Genta, Sofia, Chen, Xiaoxi, Ou, Qiuxiang, Araujo, Daniel Vilarim, Razak, Albiruni Ryan Abdul, Hansen, Aaron Richard, Spreafico, Anna, Bao, Hua, Wu, Xue, Siu, Lillian L. and Bedard, Philippe L. (2022). Early circulating tumor DNA (ctDNA) kinetics using a tumor-naive assay as a predictive biomarker in early-phase immunotherapy (IO) clinical trials. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Kolarski, Mirko Manojlovic, Su, Jie, Weinreb, Ilan, Perez-Ordonez, Bayardo, Patel, Snehal G., Valero, Cristina, Xu, Bin, Katabi, Nora, Clark, Jonathan, Low, Tsu-Hui Hubert, Gupta, Ruta, Graboyes, Evan Michael, Davies, Joel C., Richardson, Mary, Goldstein, David Paul, Huang, Shao Hui, O'Sullivan, Brian, Xu, Wei, Hansen, Aaron Richard and De Almeida, John R. (2022). Effectiveness of adjuvant chemoradiotherapy for oral cavity squamous cell carcinoma with minor and major extranodal extension: A multi-institutional consortium study. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Hernando-Calvo, Alberto, Yang, S. Y. Cindy, Vila-Casadesus, Maria, Berman, Hal K., Spreafico, Anna, Razak, Albiruni Ryan Abdul, Lheureux, Stephanie, Hansen, Aaron Richard, Lo Giacco, Deborah, Matito, Judit, Pugh, Trevor John, Bratman, Scott Victor, Berche, Roger, Gadea, Omar Saavedra Santa, Garralda, Elena, Elston, Sawako, Siu, Lillian L., Ohashi, Pamela S., Vivancos, Ana and Bedard, Philippe L. (2022). External validation of the VIGex gene-expression signature (GES) as a novel predictive biomarker for immune checkpoint treatment (ICT). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Al-Ezzi, Esmail Mutahar, Mittal, Abhenil, Ayodele, Olubukola, Amer, Lama, Li, Xuan, Araujo, Daniel Vilarim, Malone, Eoghan Ruadh, Ezzat, Shereen, Pasternak, Jesse, Mete, Ozgur, Kumar, Vikaash and Hansen, Aaron Richard (2022). Is there a role for surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC)?. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Garcia, Enrique Sanz, Zhao, Eric Y., Liu, Zhihui Amy, Marsh, Kayla, Razak, Albiruni Ryan Abdul, Spreafico, Anna, Bedard, Philippe L., Hansen, Aaron Richard, Lheureux, Stephanie, Torti, Dax, Lam, Bernard, Pugh, Trevor John and Siu, Lillian L. (2022). Methylated circulating tumor DNA (cfMeDIP) as a predictive biomarker of clinical outcome in pan-cancer patients (pts) treated with pembrolizumab (P). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Taylor, Kirsty, Zou, Jinfeng, Magalhaes Filho, Marcos Aurelio Fonseca, Howarth, Karen, Marsico, Giovanni, Terrell, Samantha, Jones, Gregory, Knape, Charlene, Forshew, Tim, Oliva, Marc, Spreafico, Anna, Hansen, Aaron Richard, McDade, Simon, Coyle, Victoria M., Lawler, Mark, Elimova, Elena, Bratman, Scott Victor and Siu, Lillian L. (2022). Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head and neck squamous cell cancer (R/M HNSCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Zimmermann, Camilla, Pope, Ashley, Hannon, Breffni, Krzyzanowska, Monika K., Rodin, Gary, Li, Madeline, Howell, Doris, Knox, Jennifer J., Leighl, Natasha B., Sridhar, Srikala S., Oza, Amit M., Prince, Rebecca M., Lheureux, Stephanie, Hansen, Aaron Richard, Dhani, Neesha C., Liu, Geoffrey, Bedard, Philippe L., Chen, Eric Xueyu, Swami, Nadia and Le, Lisa W. (2022). Randomized controlled trial (RCT) of symptom screening with targeted early palliative care (STEP) versus usual care in patients with advanced cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Alibhai, Shabbir M. H., Breunis, Henriette, Timilshina, Narhari, Feng, Gregory, Parthipan, Milothy, Sudharshan, Abirami, Hansen, Aaron Richard, Finelli, Antonio, Warde, Padraig, Tomlinson, George, Krzyzanowska, Monika K., Matthew, Andrew, Clarke, Hance, Mina, Daniel Santa, Soto Perez de Celis, Enrique, Puts, Martine and Emmenegger, Urban (2022). Remote symptom monitoring (RSM) during treatment for metastatic prostate cancer (mPC) in older men: Feasibility and efficacy. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Van Rensburg, Helena Jacoba Janse, Liu, Zhihui Amy, Razak, Albiruni Ryan Abdul, Spreafico, Anna, Bedard, Philippe L., Hansen, Aaron Richard, Lheureux, Stephanie, Butler, Marcus O. and Siu, Lillian L. (2022). The effect of circadian rhythm on clinical outcome in patients receiving pembrolizumab in the INSPIRE pan-cancer trial. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

De Almeida, John R., Goldstein, David Paul, Martino, Rosemary, Su, Jie, Hosni, Ali, Bratman, Scott Victor, Chepeha, Douglas Brian, Waldron, John, Weinreb, Ilan, Perez-Ordonez, Bayardo, Yu, Eugene, Metser, Ur, Hansen, Aaron Richard, Xu, Wei and Kim, John (2022). Transoral robotic surgery (TORS)-guided radiotherapy (RT) volume de-intensification in p16-positive unknown primary squamous cell carcinoma (SCC) of the neck: A phase 2 trial (FIND). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Graham, Jeffrey, Basappa, Naveen S., Ghosh, Sunita, Zhang, Hanbo, Hansen, Aaron Richard, Lalani, Aly-Khan A., Heng, Daniel Yick Chin, Soulieres, Denis, Castonguay, Vincent, Kollmannsberger, Christian K., Pavic, Michel, Wood, Lori, Kapoor, Anil and Bjarnason, Georg A. (2022). Association of cabozantinib dose reductions for toxicity with clinical effectiveness in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.316

Hoogenes, Jen, Breau, Rodney H., Bhindi, Bimal, Rendon, Ricardo A., Tanguay, Simon, Finelli, Antonio, So, Alan, Lavallee, Luke, Pouliot, Frederic, Lattouf, Jean-Baptiste, Dean, Lucas W., Drachenberg, Darrel E., Wood, Lori, Basappa, Naveen S., Yick, Daniel, Heng, Chin, Hansen, Aaron Richard, Soulieres, Denis, Bjarnason, Georg A., Mallick, Ranjeeta and Kapoor, Anil (2022). Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients. ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.361

Breunis, Henriette, Sudharshan, Abirami, Emmenegger, Urban, Hansen, Aaron Richard, De Celis, Enrique Soto Perez, Finelli, Antonio, Tomlinson, George, Warde, Padraig, Krzyzanowska, Monika K., Matthew, Andrew, Clarke, Hance, Mina, Daniel Santa, Puts, Martine and Alibhai, Shabbir M. H. (2022). Daily symptom monitoring commonly leads to treatment modification in older adults receiving treatment for metastatic prostate cancer (mPC). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.082

Laramee, Sophie, Ghosh, Sunita, Kollmannsberger, Christian K., Hansen, Aaron Richard, Wood, Lori, Soulieres, Denis, Canil, Christina M., Saleh, Ramy, Castonguay, Vincent, Bjarnason, Georg A., Basappa, Naveen S., Breau, Rodney H., Heng, Daniel Yick Chin, Pouliot, Frederic, Kapoor, Anil and Lalani, Aly-Khan A. (2022). Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.304

Kalirai, Austin, Joy, Isaiah, Ghosh, Sunita, Kollmannsberger, Christian K., Hansen, Aaron Richard, Thana, Myuran, Graham, Jeffrey, Heng, Daniel Yick Chin, Castonguay, Vincent, Bjarnason, Georg A., Breau, Rodney H., Kapoor, Anil, Pouliot, Frederic, Wood, Lori and Basappa, Naveen S. (2022). Efficacy of tyrosine kinase inhibitors (TKI) after combination ipilimumab plus nivolumab (I/N) in metastatic clear cell renal cell carcinoma (ccmRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.346

Stecca, Carlos, Selvarajah, Shamini, Jiang, Di Maria, Abdeljalil, Osama, Zhang, Tong, Bedard, Philippe L., Hansen, Aaron Richard, Fallah-Rad, Nazanin and Sridhar, Srikala S. (2022). Genomic characterization and identification of actionable variants in patients with locally advanced or metastatic urothelial carcinoma (mUC). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.562

Fleshner, Neil E., Hansen, Aaron Richard, Chin, Joseph, Winquist, Eric, Van der Kwast, Theodorus, Lajkosz, Katherine, Kenk, Miran, Berlin, Doron, Veloso, Rosette, Sridhar, Srikala S., Hamilton, Robert James, Kulkarni, Girish S., Finelli, Antonio, Zlotta, Alexandre R. and Joshua, Anthony M. (2022). Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP. ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.224

Lim, Emerson A., Schweizer, Michael Thomas, Chi, Kim N., Aggarwal, Rahul Raj, Agarwal, Neeraj, Gulley, James L., Attiyeh, Edward F., Greger, James, Wu, Shujian, Jaiprasart, Pharavee, Loffredo, John, Bandyopadhyay, Nibedita, Xie, Hong and Hansen, Aaron Richard (2022). Safety and preliminary clinical activity of JNJ-63898081 (JNJ-081), a PSMA and CD3 bispecific antibody, for the treatment of metastatic castrate-resistant prostate cancer (mCRPC). ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.279

Al-Ezzi, Esmail Mutahar, Mittal, Abhenil, Wilson, Brooke, Iafolla, Marco, Sridhar, Srikala S., Sacher, Adrian G., Fallah-Rad, Nazanin, Catton, Charles, Chung, Peter W. M., Perlis, Nathan and Hansen, Aaron Richard (2022). Survival outcomes of metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation (SD): A single-institutional experience and literature meta-analysis. ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.332

Mittal, Abhenil, Al-Ezzi, Esmail Mutahar, Li, Xuan, Wilson, Brooke, Spiliopoulou, Pavlina, Sridhar, Srikala S., Fallah-Rad, Nazanin, Chung, Peter W. M., Hamilton, Robert James and Hansen, Aaron Richard (2022). The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma. ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.345

Al-Ezzi, Esmail Mutahar, Mittal, Abhenil, Wilson, Brooke, Iafolla, Marco, Spiliopoulou, Pavlina, Sridhar, Srikala S., Fallah-Rad, Nazanin, Chung, Peter W. M., Perlis, Nathan and Hansen, Aaron Richard (2022). The survival outcomes of the metastatic renal cell carcinoma with rhabdoid differentiation in immunotherapy era: Princess Margaret Cancer Center experience. ASCO Genitourinary Cancers Symposium, Electr Network, Feb 17-19, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2022.40.6_suppl.333

Hilton, John, Renouf, Daniel J., Cescon, David W., Hansen, Aaron R., Razak, Albiruni R. A., Stayner, Lee-Anne, Denny, Trisha, Fletcher, Graham, Mak, Tak W., Bray, Mark and Bedard, Philippe L. (2022). Phase I study of cfi-402257, an oral ttk inhibitor, in patients with advanced solid tumors with breast cancer expansion cohorts. San Antonio Breast Cancer Symposium, San Antonio Tx, Dec 07-10, 2021. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.SABCS21-P1-18-17

Voon, Pei Jye, Chen, Eric X., Chen, Helen X., Lockhart, Albert C., Sahebjam, Solmaz, Kelly, Karen, Vaishampayan, Ulka N., Subbiah, Vivek, Razak, Albiruni R., Renouf, Daniel J., Hotte, Sebastien J., Singh, Arti, Bedard, Philippe L., Hansen, Aaron R., Percy, Ivy S., Wang, Lisa, Stayner, Lee-Anne, Siu, Lillian L. and Spreafico, Anna (2021). A phase 1 pharmacokinetic trial of single agent trametinib a MEK inhibitor in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI 9591). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-P035

Hernando-Calvo, Alberto, Malone, Eoghan, Dai, Daphne, Prawira, Amy, Weinreb, Ilan, Eliason, Anneli, Rodriguez, Angela, Lajkosz, Katherine, Jennings, Sarah, Spreafico, Anna, Siu, Lillian L. and Hansen, Aaron (2021). Genomic profiling and matched therapy for recurrent or metastatic salivary gland neoplasms. Results from the matched cohort of the GEMS-001 clinical trial. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-P154

Genta, Sofia, Aghababazadeh, Farnoosh Abbas, Tsao, Ming S., Hansen, Aaron R., Butler, Marcus O., Razak, Albiruni R., Bedard, Philippe L., Wang, Ben X., Trevor, Pugh J., Hakgor, Sevan, Woo, Jeffrey, Haibe-Kains, Benjamin, Siu, Lillian L. and Spreafico, Anna (2021). Immune resistance interrogation study (IRIS): Initial report of next generation sequencing (NGS) results in patients with primary versus acquired resistance to anti-PD1/L1 antibodies. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-LBA021

Carneiro, Benedito A., Jotte, Robert, Gabrail, Nashat, Hamid, Omid, Huang, Funan, Chaturvedi, Shalini, Herpers, Matthias, Soler, Lidia Mongay, Childs, Barrett H. and Hansen, Aaron (2021). Safety and efficacy of copanlisib in combination with nivolumab: A phase Ib study in patients with advanced solid tumors. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-P239

Naing, Aung, Callahan, Margaret, Costello, Brian, Curti, Brendan, Hall, Evan, Hansen, Aaron, Long, Georgina, Joshua, Anthony, Shankles, Brooke, Ulge, Umut, Ulge, Umut and Weickhardt, Andrew (2021). A FIRST-IN-HUMAN PHASE 1 STUDY OF NL-201 IN PATIENTS WITH RELAPSED OR REFRACTORY CANCER. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/jitc-2021-SITC2021.509

Genta, S., Yee, N., Keshavarzi, S., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L-A., Yanekina, M., Pimentel Muniz, T., Vilbert, M., Bedard, P., Abdul Razak, A. R., Coburn, B., Chruscinski, A. and Spreafico, A. (2021). Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT). Congress of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1373

Rose, A., Ayodele, O., Genta, S., Pimentel Muniz, T., Kelly, D. C., Hodgson, K., King, I., Stockley, T., Pugh, T., Saeed Kamil, Z., Butler, M. O., Shepherd, F. A., Bedard, P., Leighl, N., Abdul Razak, A. R., Hansen, A. R., Saibil, S., Cescon, D. W., Siu, L. L. and Spreafico, A. (2021). Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial. Congress of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1053

Garcia, E. Sanz, Genta, S., Liu, Z., Razak, A. R. Abdul, Hansen, A. R., Spreafico, A., Zhang, W., Chen, E., Siu, L. L. and Bedard, P. (2021). Changes in serum choline (Ch) levels to predict treatment outcomes in advanced cancer patients (pts) treated with immunotherapy (IO). Congress of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.394

Taylor, K., Zou, J., Burgener, J., Zhao, E., Torti, D., Oliva, M., Spreafico, A., Hansen, A. R., Jang, R., McDade, S. S., Coyle, V. M., Lawler, M., Elimova, E., Bratman, S. V. and Siu, L. L. (2021). Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients. Congress of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1296

Hussein, M., Percent, I., Arrowsmith, E., Arkenau, H-T., Chu, Q., Hansen, A. R., Erzen, D., Qiu, S., Lucarelli, A. and Ulahannan, S. (2021). Ezabenlimab (BI 754091), an anti-PD-1 antibody, in combination with BI 836880, a VEGF/Ang2-blocking nanobody, in patients (pts) with previously treated advanced solid tumours. Congress of the European-Society-for-Medical-Oncology (ESMO), Paris France, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1063

O'Malley, D., Bariani, G. M., Cassier, P. A., Marabelle, A., Hansen, A. R., Acosta, A. De Jesus, Miller, W. H., Safra, T., Italiano, A., Mileshkin, L., Amonkar, M., Xu, L., Jin, F., Norwood, K. and Maio, M. (2021). Health-related quality of life (HRQoL) with pembrolizumab (pembro) monotherapy in patients (pts) with previously treated advanced microsatellite instability high (MSI-H) endometrial cancer: Results from KEYNOTE-158. Congress of the European-Society-for-Medical-Oncology (ESMO), Paris France, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1239

O'Malley, D., Bariani, G. M., Cassier, P. A., Marabelle, A., Hansen, A. R., Acosta, A. De Jesus, Miller, W. H., Safra, T., Italiano, A., Mileshkin, L., Xu, L., Jin, F., Norwood, K. and Maio, M. (2021). Pembrolizumab (pembro) in patients (pts) with microsatellite instability-high (MSI-H) advanced endometrial cancer (EC): Updated results from KEYNOTE-158. Congress of the European-Society-for-Medical-Oncology (ESMO), Electr Network, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1237

Hansen, A. R., Gomez-Roca, C. A., Lolkema, M. P., Verlingue, L., Italiano, A., Spicer, J., Steeghs, N., Bauman, J. E., Fayette, J., Niu, J., Prenen, H., Dejardin, D., Boetsch, C., Kraxner, A., Evers, S., Vardar, T., Keshelava, N., Teichgraber, V. and Bonomi, M. (2021). Simlukafusp a and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck. Congress of the European-Society-for-Medical-Oncology (ESMO), Paris France, Sep 16-21, 2021. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2021.08.1316

Even, Caroline, Delord, Jean-Pierre, Price, Katharine A., Nakagawa, Kazuhiko, Oh, Do-Youn, Burge, Matthew, Chung, Hyun Cheol, Doi, Toshihiko, Fakih, Marwan, Takahashi, Shunji, Xu, Lei, Jin, Fan, Norwood, Kevin and Hansen, Aaron (2021). Evaluation of pembrolizumab monotherapy in patients with salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Joint European Congress on Head and Neck Oncology (ECHNO) / International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Electr Network, Jun 30-Jul 03, 2021. AMSTERDAM: ELSEVIER.

Ayodele, Olubukola, Wang, Ben X., Pfister, Thomas D., Al-Ezzi, Esmail Mutahar, Berman, Hal, Hansen, Aaron Richard, Gupta, Abha A., Spreafico, Anna, Arones, Limore, Bedard, Philippe L., Carlsson, Lindsay, Butler, Marcus O., Haibe-Kains, Benjamin, Xu, Wei, Siu, Lillian L. and Razak, Albiruni Ryan Abdul (2021). A phase II, open-label, randomized trial of durvalumab (D) with olaparib (O) or cediranib (C) in patients (pts) with leiomyosarcoma (LMS). Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.11522

Genta, Sofia, Tsao, Ming Sound, Wang, Ben X., Hansen, Aaron Richard, Pugh, Trevor John, Lupien, Mathieu, Coburn, Bryan, Diaz-Mejia, Javier, Butler, Marcus O., Bedard, Philippe L., Razak, Albiruni Ryan Abdul, Hakgor, Sevan, Speers, Vanessa, Wagner, Heidi, Tamblyn, Laura, Ketela, Troy, Torti, Dax, Radulovich, Nikolina, Siu, Lillian L. and Spreafico, Anna (2021). Immune Resistance Interrogation Study (IRIS): A prospective comprehensive multi-omic analysis in patients with intrinsic and acquired resistance to immunotherapy. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.TPS2679

Hernando-Calvo, Alberto, Rezqallah, Alejandra, Malone, Eoghan Ruadh, Gadea, Omar Saavedra Santa, Spreafico, Anna, Vieito, Maria, Weinreb, Ilan, Aguilar, Susana, Eliason, Anneli, Assaf, Juan David, Rodriguez, Angela, Bescos, Coro, Lajkosz, Katherine, Lorente, Juan, Jennings, Sarah, Felip, Enriqueta, Garralda, Elena, Siu, Lillian L., Hansen, Aaron Richard and Brana, Irene (2021). Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.6081

Watson, Geoffrey Alan, Veitch, Zachary William Neil, Shepshelovich, Daniel, Liu, Zhihui (Amy), Spreafico, Anna, Razak, Albiruni Ryan Abdul, Bedard, Philippe L., Siu, Lillian L., Minasian, Lori M. and Hansen, Aaron Richard (2021). Patient experience of early high grade symptomatic adverse events on early phase clinical trials using the PRO-CTCAE. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.12051

Hussein, Maen A., Percent, Ivor John, Bendell, Johanna C., Arrowsmith, Edward, Arkenau, Hendrik-Tobias, Chu, Quincy S., Hansen, Aaron Richard, Erzen, Damijan, Qiu, Sheng, Lucarelli, Anthony and Ulahannan, Susanna Varkey (2021). Platform trial of ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients (pts) with previously treated advanced solid tumors: Combination with BI 836880, a VEGF/Ang2-blocking nanobody. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.2582

Rose, April A. N., Ayodele, Olubukola, Genta, Sofia, Muniz, Thiago Pimentel, Kelly, Deirdre, Hodgson, Kelsey, King, Ian, Stockley, Tracy, Pugh, Trevor J., Kamil, Zaid Saeed, Butler, Marcus O., Shepherd, Frances A., Bedard, Philippe L., Leighl, Natasha B., Razak, Albiruni Ryan Abdul, Hansen, Aaron Richard, Saibil, Samuel, Cescon, David W., Siu, Lillian L. and Spreafico, Anna (2021). Preliminary results of BEAVER: An investigator-initiated phase II study of binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts). Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.e15038

Watson, Geoffrey Alan, Heirali, Alya, Bernal, Marc Oliva, Cochrane, Kyla, Allen-Vercoe, Emma, Eliason, Anneli, Jennings, Sarah, Taylor, Rachel, Hosni, Ali, Hope, Andrew, Bratman, Scott Victor, Chepeha, Douglas Brian, Weinreb, Ilan, Perez-Ordonez, Bayardo, Waldron, John, Xu, Wei, Hansen, Aaron Richard, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2021). Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation (ROMA2). Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.6059

Perez-Gracia, Jose Luis, Hansen, Aaron Richard, Eefsen, Rikke Helene Loevendahl, Gomez-Roca, Carlos A., Negrier, Sylvie, Pedrazzoli, Paolo, Lee, Jae-Lyun, Gordoa, Teresa Alonso, Rodriguez, Cristina Suarez, Mellado, Begona, Moreno, Victor, Rodriguez-Vida, Alejo, Hussain, Arif, Getzmann, Nicole, Dejardin, David, Boetsch, Christophe, Kraxner, Anton, Vardar, Taner, Teichgraber, Volker and Powles, Thomas (2021). Randomized phase Ib study to evaluate safety, pharmacokinetics and therapeutic activity of simlukafusp α in combination with atezolizumab ± bevacizumab in patients with unresectable advanced/ metastatic renal cell carcinoma (RCC) (NCT03063762). Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.4556

Donahoe, Laura L., Nason, Gregory J., Bedard, Philippe L., Hansen, Aaron R., Jewett, Michael A. S., Hamilton, Robert J. and de Perrot, Marc (2021). Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest. 100th Annual Meeting of the American-Association-for-Thoracic-Surgery (AATS) - A Virtual Learning Experience, Online, 25 April-23 May 2020. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.jtcvs.2020.10.158

Graham, Jeffrey, Wells, Connor, Dudani, Shaan, Gan, Chun Loo, Donskov, Frede, Lee, Jae-Lyun, Kollmannsberger, Christian K., Pal, Sumanta K., Beuselinck, Benoit, Hansen, Aaron Richard, North, Scott A., Bjarnason, Georg A., Agarwal, Neeraj, Kanesvaran, Ravindran, Wood, Lori, Hotte, Sebastien J., McKay, Rana R., Choueiri, Toni K. and Heng, Daniel Yick Chin (2021). Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC). ASCO Genitourinary Cancers Symposium (GU ASCO), Electr Network, Feb 11-13, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.6_suppl.316

Schmidt, Andrew Lachlan, Xie Wanling, , Gan, Chun Loo, Wells, Connor, Dudani, Shaan, Donskov, Frede, Porta, Camillo, Suarez, Cristina, Szabados, Bernadett, Wood, Lori, Ruiz Morales, Jose Manuel, Tran, Ben, Bjarnason, Georg A., Yuasa, Takeshi, Beuselinck, Benoit, Hansen, Aaron Richard, Agarwal, Neeraj, Bakouny, Ziad, Heng, Daniel Yick Chin and Choueiri, Toni K. (2021). The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC). ASCO Genitourinary Cancers Symposium (GU ASCO), Electr Network, Feb 11-13, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.6_suppl.339

Mahler, Mary, Al-Ezzi, Esmail Mutahar, Shrem, Noa Shani, Winquist, Eric, Canil, Christina M., Ong, Michael, Hansen, Aaron Richard and Emmenegger, Urban (2021). UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castrate-sensitive prostate cancer. ASCO Genitourinary Cancers Symposium (GU ASCO), Electr Network, Feb 11-13, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.6_suppl.117

Hussein, Maen A., Bendell, Johanna C., Arkenau, Hendrik-Tobias, Chu, Quincy S., Hansen, Aaron Richard, Erzen, Damijan, Sun Zhichao, , Lucarelli, Anthony and Percent, Ivor John (2021). Platform trial of BI 754091, an anti-PD-1 antibody, in patients with previously treated advanced solid tumors: Combination with BI 836880, a VEGF/Ang2-blocking nanobody. Gastrointestinal Cancers Symposium, Electr Network, Jan 15-17, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.3_suppl.TPS152

Soberano, Spencer, Khan, Khaleeq, Hueniken, Katrina, Famoriyo, Elyon Diekoloreoluwa, Soriano, Joelle, Gill, Sarfraz, Zhan, Luna Jia, Shepherd, Frances A., Sacher, Adrian G., Bradbury, Penelope Ann, Leighl, Natasha B., Bedard, Philippe L., Hansen, Aaron Richard, Spreafico, Anna, Xu, Wei, Brown, Catherine and Liu, Geoffrey (2020). Barriers and facilitators to implementation of serial point-of-care hearing tests using a novel iPad-based audiometry in platinum chemotherapy-treated cancer patients (pts). Quality Care Symposium of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Oct 09-10, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Haddad, Ghazal, Hueniken, Katrina, Bratman, Scott Victor, de Almeida, John R., Goldstein, David Paul, Huang, Shao Hui, Hansen, Aaron Richard, Hope, Andrew J., Spreafico, Anna, Xu, Wei and Liu, Geoffrey (2020). Machine learning to classify clinically meaningful patient groups by ESAS symptom clusters in oropharyngeal cancer patients undergoing initial treatment. Quality Care Symposium of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Oct 09-10, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Zazuli, Zulfan, Xu, Wei, Vijverberg, Susanne, Masereeuw, Rosalinde, Mirshams, Maryam, Khan, Khaleeq, Ordonez-Perez, Bayardo, Huang, Shao Hui, Spreafico, Anna, Hansen, Aaron, Goldstein, David, Bratman, Scott, Hope, Andrew, Carleton, Bruce, Maitland-van der Zee, Anke Hilse and Liu, Geoffrey (2020). Association between genetic variants and cisplatin nephrotoxicity: A genome-wide approach. HOBOKEN: WILEY.

Zazuli, Z., Xu, W., Vijverberg, S., Masereeuw, R., Mirshams, M., Khan, K., Ordonez-Perez, B., Huang, S. H., Spreafico, A., Hansen, A. R., Goldstein, D., de Almeida, J., Bratman, S., Hope, A., Carleton, B., Maitland-van der Zee, A-H. and Liu, G. (2020). Association between genetic variants and cisplatin nephrotoxicity: A genome-wide approach. ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1062

Nguyen, Eric K., Lalani, Aly-Khan, Ghosh, Sunita, Kapoor, Anil, Hansen, Aaron, Kollmannsberger, Christian, Heng, Daniel, Wood, Lori, Catonguay, Vincent, Soulieres, Denise, Winquist, Eric, Canil, Christina, Graham, Jeffrey, Bjarnason, Georg, Breau, Rodney, Pouliot, Frederic, Basappa, Naveen and Swaminath, Anand (2020). OUTCOMES OF RADIOTHERAPY PLUS IMMUNOTHERAPY IN METASTATIC RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM (CKCis). Scientific Meeting of the Canadian-Association-of-Radiation-Oncology (CARO) - Equity in Radiation Oncology - Patients, Providers and Practice, Electr Network, Sep 23-25, 2020. CLARE: ELSEVIER IRELAND LTD.

Watson, G. A., Oliva, M., Chen, B., Eliason, A., Jennings, S., Taylor, R., Abdalaty, A. H., Bayley, A., Hope, A., Bratman, S., Chepeha, D., Weinreb, I., Waldron, J., Xu, W., Hansen, A. R., Siu, L. L., Coburn, B. and Spreafico, A. (2020). Role of microbiome as a biomarker in locoregionally-advanced oropharyngeal squamous cell carcinoma 2 (ROMA LA-OPSCC2). ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1092

Saleh, Ramy R., Chan, Olivia, Kuld, Silvi, Marban, Patrick, Spreafico, Anna, Hansen, Aaron, Razak, Albiruni, Siu, Lillian L. and Bedard, Philippe L. (2020). A novel electronic platform to improve clinical trial workflow and screening. AACR Special Conference on Advancing Precision Medicine Drug Development - Incorporation of Real-World Data and Other Novel Strategies, San Diego Ca, Jan 09-12, 2020. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Saleh, Ramy, Bedard, Philippe L., Nguyen, Paul, Malone, Eoghan Ruadh, Yu, Celeste, Amir, Eitan, Earle, Craig, Gyawali, Bishal, Hansen, Aaron Richard, Mittmann, Nicole, Peng, Yingwei, Pugh, Trevor J., Razak, Albiruni Ryan Abdul, Sabatini, Peter, Spreafico, Anna, Stockley, Tracy, Torchia, Jonathon, Williams, Christine, Siu, Lillian L. and Hanna, Timothy P. (2020). An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Watson, Geoffrey Alan, Zhang, Wenjiang, Liu, Zhihui (Amy), Spreafico, Anna, Hansen, Aaron Richard, Bedard, Philippe L., Lheureux, Stephanie, Razak, Albiruni Ryan Abdul, Cescon, David W., Butler, Marcus O., Xu, Wei, Mak, Tak, Siu, Lillian L. and Chen, Eric Xueyu (2020). An increase in serum choline levels to predict progression-free survival (PFS) in patients (pts) with advanced cancers receiving pembrolizumab. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Dudani, Shaan, Gan, Chun Loo, Wells, Connor, Bakouny, Ziad, Dizman, Nazli, Pal, Sumanta K., Wood, Lori, Kollmannsberger, Christian K., Szabados, Bernadett, Powles, Thomas, Beuselinck, Benoit, Donskov, Frede, Hansen, Aaron Richard, Bjarnason, Georg A., Canil, Christina M., Srinivas, Sandy, Agarwal, Neeraj, Liow, Elizabeth Chien Hern, Choueiri, Toni K. and Heng, Daniel Yick Chin (2020). Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Dudani, Shaan, de Velasco, Guillermo, Wells, Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae-Lyun, Hansen, Aaron Richard, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina M., Choueiri, Toni K. and Heng, Daniel Yick Chin (2020). Characterizing sites of metastatic involvement in metastatic clear-cell, papillary, and chromophobe renal cell carcinoma. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Bernal, Marc Oliva, (Amy) Liu, Zhihui, Iafolla, Marco Adelmo James, Spreafico, Anna, Jennings, Sarah, Razak, Albiruni Ryan Abdul, Yang, Cindy, Bratman, Scott Victor, Torti, Dax, Pugh, Trevor John, Siu, Lillian L. and Hansen, Aaron Richard (2020). Circulating tumor DNA dynamics as prognostic and predictive biomarkers of response to pembrolizumab in patients with virally-related tumors (VRT) treated within the INSPIRE study. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Araujo, Daniel Vilarim, Wells, Connor, Hansen, Aaron Richard, Dizman, Nazli, Pal, Sumanta K., Beuselinck, Benoit, Donskov, Frede, Gan, Chun Loo, Yan, Flora, Tran, Ben, Kollmannsberger, Christian K., de Velasco, Guillermo, Yuasa, Takeshi, Reaume, M. Neil, Ernst, D. Scott, Powles, Thomas, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Yick Chin and Dudani, Shaan (2020). Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Araujo, Daniel Vilarim, Bernal, Marc Oliva, Tan, Tira Jing Ying, Heirali, Alya Abbas, Schneeberger, Pierre H. H., Muniz, Thiago Pimentel, Chen, Bo, Stayner, Lee-Anne, Xia, Kathy, Hansen, Aaron Richard, Wang, Ben X., Hogg, David, Cochrane, Kyla, Langer, Shawn, Mashiach, Nissim, Xu, Wei, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2020). First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Hansen, Aaron Richard, Stanton, Thomas S., Hong, Min Hee, Cohen, Ezra E. W., Mehanna, Hisham Mohamed, Chisamore, Michael Jon, Turner, David, Yadavilli, Sapna, Bell, Kelly, Baccan, Carlos, Leone, Rosalida, Chen, Helen, Zhou, Helen, Ellis, Catherine Elizabeth, Ballas, Marc S., Hoos, Axel and Rischin, Danny (2020). INDUCE-3: A randomized, double-blind study of GSK3359609 (GSK609), an inducible T-cell co-stimulatory (ICOS) agonist antibody, plus pembrolizumab (PE) versus placebo (PL) plus PE for first-line treatment of PD-L1-positive recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Watson, Geoffrey Alan, Veitch, Zachary William Neil, Shepshelovich, Daniel, Liu, Zhihui (Amy), Spreafico, Anna, Razak, Albiruni Ryan Abdul, Bedard, Philippe L., Siu, Lillian L., Minasian, Lori M. and Hansen, Aaron Richard (2020). Mapping PRO-CTCAE responses to clinician-graded adverse events, dose reductions, interruptions, and discontinuations in phase I cancer trials. Annual Scientific Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-Jun 02, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Malone, Eoghan Ruadh, Lewin, Jeremy Howard, Wang, Lisa, Lau, Susan, Hamilton, Robert James, Hansen, Aaron Richard, Jarvi, Keith, Zhang, Wenjiang, Chen, Eric Xueyu and Bedard, Philippe L. (2020). Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Malone, Eoghan Ruadh, Spreafico, Anna, Weinreb, Ilan, Jennings, Sarah, Carlsson, Lindsay, Noori, Ahmad, Wang, Lisa, Siu, Lillian L. and Hansen, Aaron Richard (2020). Recurrent or metastatic salivary gland tumor (MSGT) patients treated with selinexor, a first in class selective exportin-1 (XPO1) inhibitor. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Bernal, Marc Oliva, Araujo, Daniel Vilarim, Chepeha, Douglas Brian, Prawira, Amy, Spreafico, Anna, Bratman, Scott Victor, Shek, Tina, de Almeida, John R., Hansen, Aaron Richard, Hope, Andrew J., Goldstein, David Paul, Weinreb, Ilan, Perez-Ordonez, Bayardo, Pugh, Trevor John, Ohashi, Pamela S., Wang, Ben X., Irish, Jonathan Crawford, Der-Torossian, Hirak, Chen, Isan and Siu, Lillian L. (2020). SNOW: Sitravatinib and nivolumab in oral cavity cancer (OCC) window of opportunity study. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Angevin, Eric, Groenland, Stefanie L., Lim, Annette May Ling, Martin-Liberal, Juan, Moreno, Victor, Manuel Trigo, Jose, Le Tourneau, Christophe, Mathew, Matthen, Cho, Daniel C., Hansen, Aaron Richard, Vicente, David, Maio, Michele, Italiano, Antoine, Bauman, Jessica Ruth, Chisamore, Michael Jon, Zhou, Helen, Ellis, Catherine Elizabeth, Ballas, Marc S., Hoos, Axel and Rischin, Danny (2020). Updated analysis of the inducible T-cell co-stimulatory receptor (ICOS) agonist, GSK3359609 (GSK609), combination with pembrolizumab (PE) in patients (pts) with anti-PD-1/L1 treatment-naive head and neck squamous cell carcinoma (HNSCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, May 29-31, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Herrera-Caceres, Jaime, Joshua, Anthony, Sweet, Joan, Chin, Joseph, Hansen, Aaron, Hamilton, Robert, Sridhar, Srikala, Finelli, Antonio, Zlotta, Alexandre, Fleshner, Neil and Winquist, Eric (2020). ANTI-ANDROGENS AND CABAZITAXEL IN DEFINING COMPLETE RESPONSE IN PROSTATECTOMY (ACDC TRIAL) (ACDC-RP). Annual Meeting of the American-Urological-Association (AUA), Washington Dc, May 15-18, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Bobrowski, Adam, Landoni, Lauren, Anson-Cartwright, Lynn, Hansen, Aaron, Chung, Peter, Bedard, Philippe L., Warde, Padraig, Jewett, Michael A. S., O'Malley, Martin, Sweet, Joan and Hamilton, Robert J. (2020). ROLE OF LACTATE DEHYDROGENASE (LDH) IN IDENTIFYING RELAPSE FOR PATIENTS WITH STAGE I TESTIS CANCER ON ACTIVE SURVEILLANCE. Annual Meeting of the American-Urological-Association (AUA), Washington Dc, May 15-18, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Nason, Gregory, Landoni, Lauren, Kuhathaas, Kopika, Chung, Peter, Bedard, Philippe, Warde, Padraig, Hansen, Aaron, Tran Truong, , Hahn, Ezra, Jewett, Michael and Hamilton, Robert (2020). WATCHMAN: A RANDOMIZED TRIAL OF VIRTUAL SURVEILLANCE VERSUS STANDARD IN-PERSON CARE FOR CLINICAL STAGE I TESTICULAR CANCER. Annual Meeting of the American-Urological-Association (AUA), Washington Dc, May 15-18, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Gan, Chun Loo, Dudani, Shaan, Wells, Connor, Donskov, Frede, Pal, Sumanta K., Dizman, Nazli, Rathi, Nityam, Beuselinck, Benoit, Yan, Flora, Lalani, Aly-Khan A., Hansen, Aaron Richard, Szabados, Bernadett, de Velasco, Guillermo, Tran, Ben, Lee, Jae-Lyun, Vaishampayan, Ulka N., Bjarnason, Georg A., Subasri, Mathushan, Choueiri, Toni K. and Heng, Daniel Yick Chin (2020). Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Jiang, Di Maria, Wong, Bryan, Hansen, Aaron Richard, Fallah-Rad, Nazanin, Sacher, Adrian G., Zhang, Tong, Selvarajah, Shamini, Stockley, Tracy, Bedard, Philippe L. and Sridhar, Srikala S. (2020). Comprehensive genomic profiling (CGP) of metastatic castrate-sensitive prostate cancer (mCSPC) to reveal potential biomarkers and therapeutic targets. Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Araujo, Daniel Vilarim, Malone, Eoghan Ruadh, Sacher, Adrian G., Fallah-Rad, Nazanin, Sridhar, Srikala S. and Hansen, Aaron Richard (2020). Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Parmar, Ambika, Ghosh, Sunita, Lalani, Aly-Khan A., Hansen, Aaron Richard, Reaume, M. Neil, Wood, Lori, Basappa, Naveen S., Heng, Daniel Yick Chin, Graham, Jeffrey, Kollmannsberger, Christian K., Soulieres, Denis, Breau, Rodney H., Tanguay, Simon, Kapoor, Anil, Pouliot, Frederic and Bjarnason, Georg A. (2020). Impact of early identification of brain metastases in metastatic renal cell carcinoma (mRCC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Beyer, Joerg, Collette, Laurence, Daugaard, Gedske, De Wit, Ronald, Tryakin, Alexey, Albany, Costantine, Stahl, Olof, Fizazi, Karim, Gietema, Jourik A., De Giorgi, Ugo, Hansen, Aaron Richard, Feldman, Darren R., Cafferty, Fay, Tandstad, Torgrim, del Muro, Xavier Garcia, Huddart, Robert A., Sweeney, Christopher, Necchi, Andrea, Assele, Samson and Gillessen, Silke (2020). Prognostic factors in advanced seminoma: An analysis from the IGCCCG Update Consortium. Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Al-Ezzi, Esmail Mutahar, Alqaisi, Husam, Picardo, Sarah, Iafolla, Marco, Sridhar, Srikala S., Sacher, Adrian G., Fallah-Rad, Nazanin, Catton, Charles, Warde, Padraig, Hamilton, Robert James, Fleshner, Neil Eric, Zlotta, Alexandre and Hansen, Aaron Richard (2020). Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223. Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Zhang, Hanbo, Basappa, Naveen S., Joy, Isaiah, Ghosh, Sunita, Lalani, Aly-Khan A., Hansen, Aaron Richard, Heng, Daniel Yick Chin, Castonguay, Vincent, Kollmannsberger, Christian K., Winquist, Eric, Wood, Lori, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frederic, Kapoor, Anil and Graham, Jeffrey (2020). Real-world evidence of cabozantinib in metastatic renal-cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Thana, Myuran, Basappa, Naveen S., Ghosh, Sunita, Kollmannsberger, Christian K., Heng, Daniel Yick Chin, Graham, Jeffrey, Soulieres, Denis, Hansen, Aaron Richard, Lalani, Aly-Khan A., Castonguay, Vincent, Reaume, M. Neil, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frederic, Kapoor, Anil and Wood, Lori (2020). Real-world utilization and safety of ipilimumab plus nivolumab (I plus N) in metastatic renal cell carcinoma (mRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Stukalin, Igor, Dudani, Shaan, Wells, Connor, Gan, Chun Loo, Pal, Sumanta K., Dizman, Nazli, Powles, Thomas, Donskov, Frede, Wood, Lori, Bakouny, Ziad, Kollmannsberger, Christian K., Basappa, Naveen S., Hansen, Aaron Richard, de Velasco, Guillermo, Beuselinck, Benoit, Canil, Christina M., Vaishampayan, Ulka N., Agarwal, Neeraj, Choueiri, Toni K. and Heng, Daniel Yick Chin (2020). Second-line VEGF TKI after IO combination therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Dudani, Shaan, de Velasco, Guillermo, Wells, Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Hansen, Aaron Richard, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Hotte, Sebastien J., Lalani, Aly-Khan A., Yuasa, Takeshi, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina M., Choueiri, Toni K. and Heng, Daniel Yick Chin (2020). Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Alibhai, Shabbir M. H., Breunis, Henriette, Timilshina, Narhari, Hansen, Aaron Richard, Joshua, Anthony M., Warde, Padraig Richard, Gregg, Richard William, Fleshner, Neil Eric, Tomlinson, George, Hotte, Sebastien J. and Emmenegger, Urban (2020). The effect of docetaxel, enzalutamide, abiraterone, and radium-223 on cognitive function in older men with metastatic castrate-resistant prostate cancer (mCRPC). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Hamilton, Robert James, Landoni, Lauren, Kuhathaas, Kopika, Chung, Peter W. M., Bedard, Philippe L., Warde, Padraig Richard, Hansen, Aaron Richard, Truong, Tran, Hahn, Ezra and Jewett, Michael A. S. (2020). WATChmAN: A randomized trial of virtual surveillance versus standard in-person care for clinical stage I testicular cancer. Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco Ca, Feb 13-15, 2020. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Hilton, John, Gelmon, Karen, Cescon, David, Tinker, Anna, Jonker, Derek, Goodwin, Rachel, Laurie, Scott, Hansen, Aaron, Aparicio, Samuel, Soong, John, Hagerman, Linda, Lui, Hongbo, Bedard, Philippe, Pritchard, Kathleen, Tu, Dongsheng and Seymour, Lesley (2020). Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies. 42nd Annual San Antonio Breast Cancer Symposium, San Antonio Tx, Dec 09-14, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.SABCS19-PD4-02

Groves, Morris, Hansen, Aaron, Harb, Wael, Curtis, Kelly, Koga-Yamakawa, Erina, Origuchi, Makoto, Li, Zhonggai, Iglesias, Jose, Shaib, Walid and Spira, Alexander (2019). Multicenter, open-label, phase 1 study of DSP-7888 Dosing Emulsion (DSP-7888) in patients with advanced malignancies. LONDON: BMJ PUBLISHING GROUP.

Hansen, A. R., Strauss, J., Chaves, J., Piha-Paul, S. A., Park, H., Garralda, E., Matheny, C. J., Carver, J., Moore, A. and Hug, B. A. (2019). A phase I, open-label study of GSK1795091 administered in combination with immunotherapies in participants with advanced solid tumours (NCT03447314). 44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. AMSTERDAM: ELSEVIER.

Yang, C., Iafolla, M. A., Dashner, S., Xu, W., Hansen, A. R., Bedard, P., Lheureux, S., Spreafico, A., Razak, A. A., Wu, H. -T., Shchegrova, S., Liu, Z. A., Ohashi, P. S., Torti, D., Louie, M., Sethi, H., Aleshin, A., Siu, L. L., Bratman, S. and Pugh, T. J. (2019). Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single agent pembrolizumab (P). 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Araujo, D. V., Wang, A., Torti, D., Huang, J., Leon, A., Marsh, K., McCarthy, A., Berman, H., Spreafico, A., Hansen, A. R., Razak, A. A., Bedard, P., Wang, L., Plackmann, E., Chow, H., Bao, H., Wu, X., Pugh, T. J. and Siu, L. L. (2019). Blood-based TMB (bTMB) correlates with tissue-based TMB (tTMB) in a multi-cancer phase I IO cohort. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Hotte, S. J., Winquist, E., Chi, N., Ellard, S. L., Sridhar, S., Emmenegger, U., Salim, M., Iqbal, N. N., Canil, C., Kollmannsberger, C. K., Hansen, A. R., Lalani, A-K. A., Gingerich, J., Finch, D., Cabanero, M., Wyatt, A. W., Tu, D., Vera-Badillo, F., Seymour, L. K. and Smoragiewicz, M. (2019). CCTG IND 232: A phase II study of durvalumab with or without tremelimumab in patients with metastatic castration resistant prostate cancer (mCRPC). 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Hansen, A. R., Ala-Leppilampi, K., McKillop, C., Siu, L. L., Bedard, P., Razak, A. R. Abdul, Spreafico, A., Sridhar, S., Leighl, N. B., Butler, M. O., Hogg, D., Sacher, A., Oza, A. M., Nisenbaum, R., Webster, K. A., Cella, D. and Parsons, J. (2019). Development of the functional assessment of cancer therapy-immune checkpoint modulator (FACT-ICM): A scale to measure quality of life in cancer patients treated with ICMs. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Lalani, A-K. A., Bakouny, Z., Farah, S., Xie, W., Flippot, R., Steinharter, J. A., Nuzzo, P. V., Fleischer, J., Pal, S. K., Rathi, N., Hansen, A. R., Donskov, F., Dudani, S., Yuasa, T., Vaishampayan, U., Subasri, M., Wells, J. C., Basappa, N. S., Heng, D. Y. C. and Choueiri, T. K. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC). 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Al-Ezzi, E. M., Veitch, Z. W., Salah, S., Van der Kwast, T., Stockley, T., Malone, E., Sridhar, S., Sacher, A. G., Fallah-rad, N., Kulkarni, G., Zlotta, A., Finelli, A. and Hansen, A. R. (2019). Genomic characterization of non-schistosomiasis-related squamous cell carcinoma (NSR-SCC) of the urinary bladder: A retrospective study of potential prognostic and predictive biomarkers. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Veitch, Z. W., Shepshelovich, D., Gallagher, C., Wang, L., Razak, A. A., Spreafico, A., Bedard, P., Siu, L. L., Minasian, L. and Hansen, A. R. (2019). Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events. 44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. AMSTERDAM: ELSEVIER.

Rischin, D., Groenland, S. L., Lim, A. M. L., Martin-Liberal, J., Moreno, V., Trigo Perez, J. M., Le Tourneau, C., Mathew, M., Cho, D. C., Hansen, A. R., Vincente-Baz, D., Maio, M., Italiano, A., Bauman, J. R., Chisamore, M., Zhou, H., Ellis, C., Ballas, M., Hoos, A. and Angevin, E. (2019). Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC). 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Billfalk-Kelly, Astrid, Huang, Shao Hui, Xu, Wei, Lin, Lu, Wu, Raymond, Bayley, Andrew, Brattman, Scott, Cho, John, Giuliani, Meredith, Kim, John, O'Sullivan, Brian, Ringash, Jolie, Hansen, Aaron, Irish, Jonathan, Monteiro, Eric, de Almeida, John, Goldstein, David, Waldron, John, Hope, Andrew and Hosni, Ali (2019). OUTCOMES OF ORAL CAVITY SQUAMOUS CELL CARCINOMA PATIENTS UNDER THE AGE OF 40 YEARS: A PROPENSITY MATCHED ANALYSIS. Annual Scientific Meeting of the Canadian-Association-for-Radiation-Oncology (CARO), Halifax Canada, Oct 02-05, 2019. CLARE: ELSEVIER IRELAND LTD.

O'Malley, D., Marabelle, A., De Jesus-Acosta, A., Piha-Paul, S. A., Arkhipov, A., Longo, F., Motola-Kuba, D., Shapira-Frommer, R., Geva, R., Rimel, B. J., Lopez-Martin, J. A., Hansen, A. R., Mehnert, J. M., Chen, X., Jin, F., Norwood, K. and Ott, P. A. (2019). Pembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study. 44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. AMSTERDAM: ELSEVIER.

Alshammari, K., Aung, K. L., Zhang, T., Albiruni, A. R. R., Serra, S., Stockley, T., Wang, L., Nguyen, J., Spreafico, A., Hansen, A. R., Zwir, D., Siu, L. L. and Bedard, P. (2019). Phase II trial of trametinib (T) and panitumumab (Pmab) in RAS/RAF wild type (wt) metastatic colorectal cancer (mCRC). 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Gillessen, S., Collette, L., Daugaard, G., de Wit, R., Tryakin, A., Albany, C., Stahl, O., Fizazi, K., Gietema, J. A., De Giorgi, U. F. F., Hansen, A. R., Feldman, D., Cafferty, F., Tandstad, T., Garcia del Muro, X., Huddart, R. A., Sweeney, C. J., Heng, D. Y. C., Sauve, N. and Beyer, J. (2019). Redefining the IGCCCG classification in advanced non-seminoma. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Voss, M. H., Azad, A. A., Hansen, A. R., Gray, J. E., Welsh, S. J., Achour, I., Hu, H., Lewis, L., Walcott, F. L. and Oosting, S. F. (2019). Results from a randomised phase I/II trial evaluating the safety and antitumour activity of anti-PD-1 (MEDI0680)/anti-PD-L1 (durvalumab) vs anti-PD-1 (nivolumab) alone in metastatic clear cell renal cell carcinoma (ccRCC). 44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. AMSTERDAM: ELSEVIER.

Eng, L., Su, J., Hueniken, K., Brown, M. C., Saunders, D. P., de Almeida, J. R., Hope, A., Selby, P., Spreafico, A., Hansen, A. R., Goldstein, D. P., Xu, W., Giuliani, M. E., Evans, W. K., Liu, G. and Chaiton, M. (2019). Tobacco retail access and tobacco cessation among head and neck cancer (HNC) survivors. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona Spain, Sep 27-Oct 01, 2019. OXFORD: OXFORD UNIV PRESS.

Glicksman, Rachel, Heaton, Jaqueline and Hansen, Aaron R. (2019). USE OF COMBINED HORMONE THERAPY WITH POST-OPERATIVE RADIATION TREATMENT FOR PROSTATE CANCER: IMPACT OF RANDOMIZED TRIALS ON CLINICAL PRACTICE. Annual Scientific Meeting of the Canadian-Association-for-Radiation-Oncology (CARO), Halifax Canada, Oct 02-05, 2019. CLARE: ELSEVIER IRELAND LTD.

Bapat, Priya, Chow, Pansy, Hueniken, Katrina, Mahler, Mary, Brown, M. Catherine, Falls, Carolyn, Hope, Andrew J., Hansen, Aaron Richard, Goldstein, David Paul, Rutka, John, Howell, Doris, Xu, Wei and Liu, Geoffrey (2019). Barriers and facilitators to the implementation of routine ototoxicity screening for head and neck cancer patients. Quality Care Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Diego Ca, Sep 06-07, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.27_suppl.127

Lynn Huynh, , Savard, Marie-France, Wells, J. Connor, Graham, Jeffrey, Steinharter, John, McGregor, Bradley, Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka, Hansen, Aaron, Iafolla, Marco, Zanotti, Giovanni, Nguyen, Catherine, Chang, Rose, Duh, Mei S. and Heng, Daniel Y. C. (2019). Real-world assessment of clinical outcomes among first-line (1 L) Sunitinib patients with metastatic renal cell carcinoma (MRCC) by the international Mrcc database consortium (IMDC) risk group. HOBOKEN: WILEY.

Hansen, Aaron, Abdul-Karim, Raghad, Rizvi, Naiyer, Rischen, Danny, Hilton, John, Li, Zujun, Ott, Patrick, Karpinich-Fedoriw, Natalie, Yadavilli, Sapna, Wang, Xiaowei, Adams, Laurel, Wyres, Melody, Ferte, Charles, Ballas, Marc, Hoos, Axel and Zandberg, Daniel (2019). A Phase I/II, open-label, two part study of GSK3359609 in combination with tremelimumab in participants with selected, advanced solid tumors. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta Ga, Mar 29-Apr 03, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2019-CT166

Taylor, Kirsty, Yau, Helen Loo, Wang, Ben X., Bedard, Philippe L., Razak, Albiruni R., Hansen, Aaron R., Spreafico, Anna, Cescon, Dave, Butler, Marcus O., Oza, Amit M., Lheureux, Stephanie, Stjepanovic, Neda, Wang, Lisa, Van As, Brendan, Boross-Harmer, Sarah, Pugh, Trevor, Siu, Lillian L. and De Carvalho, Daniel D. (2019). A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR). Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta Ga, Mar 29-Apr 03, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2019-CT190

Bernal, Marc Oliva, Chepeha, Douglas, Prawira, Amy, Vines, Douglass, Spreafico, Anna, Bratman, Scott, De Almeida, John, Hansen, Aaron, Goldstein, David, Gilbert, Ralph, Gullane, Patrick, Brown, Dale H., Weinreb, Ilan, Perez-Ordonez, Bayardo, Ohashi, Pamela S., McGaha, Tracy, Wang, Ben X., Irish, Jonathan, Chen, Isan and Siu, Lillian L. (2019). Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW). Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta Ga, Mar 29-Apr 03, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2019-CT124

Kushnir, Igal, Basappa, Naveen S., Ghosh, Sunita, Lalani, Aly-Khan A., Soulieres, Denis, Bjarnason, Georg A., Wood, Lori, Dawe, David, Kollmannsberger, Christian K., Heng, Daniel Yick Chin, Kapoor, Anil, Hansen, Aaron Richard, Pouliot, Frederic and Reaume, M. Neil (2019). Active surveillance in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). 55th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.15_suppl.4516

Iafolla, Marco Adelmo James, Yang, Cindy, Dashner, Scott, Xu, Wei, Hansen, Aaron Richard, Bedard, Philippe L., Lheureux, Stephanie, Spreafico, Anna, Razak, Albiruni Ryan Abdul, Wu, Hsin-Ta, Shchegrova, Svetlana, Liu, Zhihui (Amy), Ohashi, Pamela S., Torti, Dax, Louie, Maggie C., Sethi, Himanshu, Aleshin, Alexey, Siu, Lillian L., Bratman, Scott Victor and Pugh, Trevor John (2019). Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single-agent pembrolizumab (P). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.15_suppl.2542

Bhindi, Bimal, Graham, Jeffrey, Wells, Connor, Donskov, Frede, Pasini, Felice, Lee, Jae-Lyun, Basappa, Naveen S., Hansen, Aaron Richard, Wood, Lori, Kollmannsberger, Christian K., Kanesvaran, Ravindran, Yuasa, Takeshi, Ernst, D. Scott, Srinivas, Sandy, Rini, Brian I., Bowman, I. Alex, Pal, Sumanta K., Choueiri, Toni K. and Heng, Daniel Yick Chin (2019). Deferred cytoreductive nephrectomy among patients with newly diagnosed metastatic renal cell carcinoma treated initially with sunitinib. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.15_suppl.4578

Tan, Tira Jing Ying, Butler, Marcus O., Hansen, Aaron Richard, Hogg, David, Sacher, Adrian G., Bedard, Philippe L., Ross, Kendra, Chow, Helen, Al-Kindy, Aida, Boross-Harmer, Sarah, Xu, Wei, Coburn, Bryan, Siu, Lillian L. and Spreafico, Anna (2019). Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.15_suppl.TPS2664

Tan, Tira Jing Ying, Cescon, David W., Wang, Lisa, Amir, Eitan, Vieira, Daniella, Zammit, Kaitlyn, Warr, David, Elser, Christine, Butler, Marcus O., Razak, Albiruni Ryan Abdul, Hansen, Aaron Richard, Spreafico, Anna, Siu, Lillian L. and Bedard, Philippe L. (2019). Hyperprogressive disease in advanced triple-negative breast cancer (aTNBC) treated with immunotherapy (10). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.15_suppl.1086

Bernal, Marc Oliva, Huang, Shao Hui, Taylor, Rachel, Su, Jie, Xu, Wei, Hansen, Aaron Richard, Jang, Raymond Woo-Jun, Bayley, Andrew, Hosni, Ali, Giuliani, Meredith Elana, Ringash, Jolie, Bratman, Scott Victor, Cho, John, Irish, Jonathan Crawford, Waldron, John, Weinreb, Ilan, Kim, John, O'Sullivan, Brian, Siu, Lillian L. and Spreafico, Anna (2019). Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Jiang, Di Maria, Fallah-Rad, Nazanin, Lee, Roy, Ng, Pamela, Smith, Alan D., Hansen, Aaron Richard, Joshua, Anthony M. and Sridhar, Srikala S. (2019). Minimizing drug wastage (DW) and cost of cabazitaxel used to treat metastatic castrate-resistant prostate cancer (mCRPC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.15_suppl.6550

Bang, Yung-Jue, Ueno, Makoto, Malka, David, Chung, Hyun Cheol, Nagrial, Adnan, Kelley, Robin Kate, Piha-Paul, Sarina Anne, Ros, Willeke, Italiano, Antoine, Nakagawa, Kazuhiko, Rugo, Hope S., De Braud, Filippo G., Varga, Andrea I., Hansen, Aaron Richard, Gao, Chao, Krishnan, Suba, Norwood, Kevin and Doi, Toshihiko (2019). Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies. 55th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.15_suppl.4079

de Almeida, John R., Hueniken, Katrina, Eng, Lawson, Giuliani, Meredith, Ringash, Jolie, Hansen, Aaron Richard, Liu, Geoffrey, Xu, Wei, Li, Madeline and Goldstein, David Paul (2019). Predictors of financial toxicity among head and neck cancer patients: A prospective cohort study. 55th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.15_suppl.e18361

Bernal, Marc Oliva, Schneeberger, Pierre H. H., Taylor, Rachel, Rey, Victor, Hansen, Aaron Richard, Taylor, Kirsty, Bayley, Andrew, Hope, Andrew, Hosni, Ali, Bratman, Scott Victor, Ringash, Jolie, Gilbert, Ralph William, Weinreb, Ilan, Perez-Ordonez, Bayardo, Waldron, John, Xu, Wei, Guttman, David, Siu, Lillian L., Coburn, Bryan and Spreafico, Anna (2019). Role of the oral and gut microbiota as a biomarker in locoregionally advanced oropharyngeal squamous cell carcinoma (ROMA LA-OPSCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Alibhai, Shabbir M. H., Breunis, Henriette, Gregg, Richard William, Hansen, Aaron Richard, Warde, Padraig Richard, Timilshina, Narhari, Tomlinson, George, Joshua, Anthony M., Fleshner, Neil Eric and Emmenegger, Urban (2019). Validating the Cancer and Aging Research Group (CARG) toxicity prediction tool in older men receiving chemotherapy for metastatic castration-resistant prostate cancer (mCRPC) and extending it to androgen receptor targeted agents. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Nason, Gregory, Donahoe, Laura, Aditya, Ishan, De Perrot, Marc, Anson-Cartwright, Lynn, Jewett, Michael, Hansen, Aaron, Bedard, Philippe, Warde, Padraig, Chung, Peter, Sweet, Joan, O'Malley, Martin and Hamilton, Robert (2019). SIMULTANEOUS VERSUS SEQUENTIAL RETROPERITONEAL AND THORACIC RESECTION OF POST CHEMOTHERAPY RESIDUAL MASSES IN PATIENTS WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS OF THE TESTIS. 114th Annual Meeting of the American-Urological-Association (AUA), Chicago Il, May 03-06, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Nason, Gregory, Hansen, Aaron, Bedard, Philippe, Warde, Padraig, Chung, Peter, Jewett, Michael, Anson-Cartwright, Lynn, Sweet, Joan, O'Malley, Martin and Hamilton, Robert (2019). SURVEILLANCE OF POST CHEMOTHERAPY NON SEMINOMATOUS GERM CELL TUMOR (NSGCT) RESIDUAL (≤1CM) MASSES. 114th Annual Meeting of the American-Urological-Association (AUA), Chicago Il, May 03-06, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Al-Ezzi, Esmail Mutahar, Riromar, Jamila Jama Almi, Amir, Eitan, Fazelzad, Rouhi and Hansen, Aaron Richard (2019). Cross-trial comparison of taxane versus non-taxane combination chemotherapy regimens for advanced penile cancer (APC): A systematic review. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.7_suppl.511

Lu, Ning-Ning, Hansen, Aaron Richard, Bedard, Philippe L., Warde, Padraig Richard, Sweet, Joan, Hamilton, Robert James, O'Malley, Martin and Chung, Peter W. M. (2019). Excellent outcomes in bilateral testicular germ cell tumors over four decades. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.7_suppl.523

Dudani, Shaan, Graham, Jeffrey, Wells, Connor, Pal, Sumanta K., Dizman, Nazli, Donskov, Frede, Bjarnason, Georg A., Hansen, Aaron Richard, Iafolla, Marco Adelmo James, Vaishampayan, Ulka N., Porta, Camillo, Beuselinck, Benoit, Yan, Flora, Wood, Lori, Liow, Elizabeth Chien Hern, Kollmannsberger, Christian K., Yuasa, Takeshi, Zhang, Chiyuan A., Choueiri, Toni K. and Heng, Daniel Yick Chin (2019). First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.7_suppl.584

Riromar, Jamila Jama Almi, Veitch, Zachary William Neil, Sacher, Adrian G., Maganti, Manjula, Fallah-Rad, Nazanin, Hansen, Aaron Richard and Sridhar, Srikala S. (2019). Impact of bone metastasis on clinical outcomes in metastatic urothelial bladder cancer (mUC) for patients treated with first-line platinum-based chemotherapy. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.7_suppl.431

Picardo, Sarah Louise, Iafolla, Marco Adelmo James, Sridhar, Srikala S., Sacher, Adrian G. and Hansen, Aaron Richard (2019). Patterns of response of organ specific metastasis in patients with metastatic renal cell cancer (mRCC) treated with an immune checkpoint inhibitor (CPI) post tyrosine kinase inhibitor (TKI). ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.7_suppl.605

Malone, Eoghan Ruadh, Lewin, Jeremy Howard, Lau, Susan, Hamilton, Robert James, Hansen, Aaron Richard, Jarvi, Keith, Zhang, Wenjiang, Chen, Eric Xueyu and Bedard, Philippe L. (2019). Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.7_suppl.519

Herrera-Caceres, Jaime Omar, Goldberg, Hanan, Hansen, Aaron Richard, Sridhar, Srikala S., Hamilton, Robert James, Finelli, Antonio, Zlotta, Alexandre, Joshua, Anthony M. and Fleshner, Neil Eric (2019). Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.7_suppl.98

Savard, Marie-France, Wells, J. Connor, Graham, Jeffrey, Steinharter, John A., McGregor, Bradley Alexander, Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka N., Hansen, Aaron Richard, Iafolla, Marco Adelmo James, Zanotti, Giovanni, Huynh, Lynn, Duh, Mei Sheng and Heng, Daniel Yick Chin (2019). Real-world assessment of clinical outcomes among first-line (1L) sunitinib (SUN) patients (pts) with metastatic renal cell carcinoma (mRCC) by the international mRCC database consortium (IMDC) risk group. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2019.37.7_suppl.610

Iafolla, Marco Adelmo James, Picardo, Sarah Louise, Aung, Kyaw Lwin and Hansen, Aaron Richard (2019). Systematic review and REMARK scoring of renal cell carcinoma (RCC) prognostic circulating biomarker manuscripts. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco Ca, Feb 28-Mar 02, 2019. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2019.37.7_suppl.569

Kanjanapan, Yada, Day, Daphne, Wang, Lisa, Hansen, Aaron Richard, Razak, Albiruni Ryan Abdul, Spreafico, Anna, Leighl, Natasha B., Joshua, Anthony M., Butler, Marcus O., Hogg, David, Siu, Lillian L. and Bedard, Philippe L. (2018). Hyperprogressive disease (HPD) in early-phase immunotherapy (IO) trials. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.15_suppl.3063

Shokar, Simranjot, Buldo, Elena, Siu, Lillian L., Hansen, Aaron Richard, Spreafico, Anna, Doi, Jeffrey, Carlsson, Lindsay and Bedard, Philippe L. (2018). Patient knowledge, attitudes, and expectations of cancer immunotherapies. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.15_suppl.e18551

Omar, Jamila Jama Almi Rir, Ghosh, Sunita, Fallah-Rad, Nazanin, Elimova, Elena, Hansen, Aaron Richard and Sridhar, Srikala S. (2018). Real life outcomes of metastatic urothelial carcinoma (mUC) patients treated post first line platinum based systemic therapy: A single centre experience. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Leao, Ricardo, van Agthoven, Ton, Fadaak, Kamel, Castelo-Branco, Pedro, Jewett, Michael, Sweet, Joan, Ahmad, Ardalan E., Anson-Cartwright, Lynn, Chung, Peter, Hansen, Aaron, Warde, Padraig, O'Malley, Martin, Bedard, Philippe L., Looijenga, Leendert H. J. and Hamilton, Robert J. (2018). SERUM MIRNA PREDICTS VIABLE DISEASE POST-CHEMOTHERAPY IN TESTICULAR NON-SEMINOMA GERM CELL TUMOR PATIENTS. American-Urological-Association(AUA) Annual Meeting, San Francisco Ca, May 18-21, 2018. NEW YORK: ELSEVIER SCIENCE INC.

Graham, Jeffrey, Wells, Connor, Donskov, Frede, Lee, Jae-Lyun, Fraccon, Anna Paola, Pasini, Felice, Porta, Camillo, Bowman, I. Alex, Bjarnason, Georg A., Ernst, D. Scott, Rha, Sun Young, Beuselinck, Benoit, Hansen, Aaron Richard, North, Scott A., Kollmannsberger, Christian K., Wood, Lori, Vaishampayan, Ulka N., Pal, Sumanta K., Choueiri, Toni K. and Heng, Daniel Yick Chin (2018). Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Genitourinary Cancers Symposium, San Francisco Ca, Feb 08-10, 2018. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.6_suppl.581

Xie, Wanling, DiNatale, Renzo, Hakimi, A. Ari, Donskov, Frede, Porta, Camillo, Reaume, M. Neil, Basappa, Naveen S., Hansen, Aaron Richard, Rini, Brian I., Beuselinck, Benoit, Bjarnason, Georg A., Srinivas, Sandy, Brugarolas, James, Rha, Sun Young, Wood, Lori, Lalani, Aly-Khan A., Bosse, Dominick, Duquette, Audrey, Heng, Daniel Yick Chin and Choueiri, Toni K. (2018). Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy. Genitourinary Cancers Symposium, San Francisco Ca, Feb 08-10, 2018. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.6_suppl.667

Stukalin, Igor, Wells, J. Connor, Graham, Jeffrey, Yuasa, Takeshi, Beuselinck, Benoit, Kollmannsberger, Christian K., Ernst, D. Scott, Agarwal, Neeraj, Le, Tri, Donskov, Frede, Hansen, Aaron Richard, Bjarnason, Georg A., Srinivas, Sandy, Wood, Lori, Alva, Ajjai Shivaram, Kanesvaran, Ravindran, Fu, Simon Yuen Fai, Davis, Ian D., Choueiri, Toni K. and Heng, Daniel Yick Chin (2018). Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Genitourinary Cancers Symposium, San Francisco Ca, Feb 08-10, 2018. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.6_suppl.615

Sridhar, Srikala S., Smith, Alan D., Fallah-Rad, Nazanin and Hansen, Aaron Richard (2018). Retrospective analysis of fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide. Genitourinary Cancers Symposium, San Francisco Ca, Feb 08-10, 2018. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.6_suppl.374

Leao, Ricardo Romao Nazario, Van Agthoven, Ton, Figueiredo, Arnaldo, Fadaak, Kamel, Castelo-Branco, Pedro, Jewett, Michael A. S., Sweet, Joan, Ahmad, Ardalan, Anson-Cartwright, Lynn, Bedard, Philippe L., Chung, Peter W. M., Hansen, Aaron Richard, Warde, Padraig Richard, O'Malley, Martin, Looijenga, Leendert and Hamilton, Robert James (2018). Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients. Genitourinary Cancers Symposium, San Francisco Ca, Feb 08-10, 2018. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2018.36.6_suppl.546

Hsu, Chiun, Lee, Se-Hoon, Ejadi, Samuel, Even, Caroline, Cohen, Roger B., Le Tourneau, Christophe, Mehnert, Janice M., Algazi, Alain, Van Brummelen, Emilie M. J., Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D. and Hansen, Aaron R. (2017). Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 study. American Society of Clinical Oncology. doi: 10.1200/JCO.2017.73.3675

Wong, H-L., Luechtefeld, T., Prawira, A., Patterson, Z., Workman, J., Day, D., Chooback, N., Nappi, L., Samawi, H. H., Lavoie, J-M., Spreafico, A., Hansen, A. R., Sahebjam, S., Siu, L. L., Ivy, S. P., Paller, C. and Renouf, D. (2017). Development of a web-based application using machine learning algorithms to facilitate systematic literature reviews. 42nd Annual Meeting of the European-Society-of-Medical-Oncology (ESMO), Madrid Spain, Sep 08-12, 2017. AMSTERDAM: ELSEVIER.

Prawira, A., Stundzia, A. B., Dufort, P., Halankar, J., Paravasthu, D. M., Spreafico, A., Hansen, A. R., Razak, A. R. Abdul, Bedard, P. L., Butler, M., Lheureux, S., Oza, A. M., Jang, R. W., Suta, K. M., Boross-Harmer, S., Cipollone, J., Chow, H., Metser, U. and Siu, L. L. (2017). Evaluation of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs). 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid Spain, Sep 08-12, 2017. OXFORD: OXFORD UNIV PRESS.

Day, D., Locke, G., Chan, K., Cheng, S., Wang, L., O'Sullivan, B. and Hansen, A. R. (2017). Hyperfractionated twice daily re-irradiation (bid re-RT) and chemotherapy (CT) for locoregionally recurrent head and neck squamous cell carcinoma (LR HNSCC): A systematic review (SR). 42nd Annual Meeting of the European-Society-of-Medical-Oncology (ESMO), Madrid Spain, Sep 08-12, 2017. AMSTERDAM: ELSEVIER.

Kanjanapan, Y., Day, D., Butler, M., Wang, L., Joshua, A. M., Hogg, D., Leighl, N. B., Razak, A. R. A., Hansen, A. R., Boujos, S., Chappell, M. A., Chow, K., Paolo, M., Sherwin, B., Stayner, L-A., Soultani, L., Zambrana, A., Siu, L. L., Bedard, P. L. and Spreafico, A. (2017). Immune related adverse events (irAEs) in early phase immunotherapy (IO) trials: Implications for recommended phase 2 dose (RP2D) determination. 42nd Annual Meeting of the European-Society-of-Medical-Oncology (ESMO), Madrid Spain, Sep 08-12, 2017. AMSTERDAM: ELSEVIER.

Bjarnason, G. A., Knox, J., Kollmannsberger, C. K., Soulieres, D., Ernst, D. S., Zalewski, P., Canil, C. M., Winquist, E., Hotte, S. J., North, S. A., Heng, D. Y. C., Macfarlane, R. J., Venner, P. M., Kapoor, A., Hansen, A. R., Czaykowski, P., Boyd, B., Wang, L. and Basappa, N. S. (2017). Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid Spain, Sep 08-12, 2017. OXFORD: OXFORD UNIV PRESS.

Ribnikar, D., Bedard, P. L., Hamilton, R. J., Jewett, M., Warde, P., Chung, P., Cartwright, L. Anson, Templeton, A., Amir, E., Hansen, A. R. and Lewin, J. (2017). The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic germ cell tumors. 42nd Annual Meeting of the European-Society-of-Medical-Oncology (ESMO), Madrid Spain, Sep 08-12, 2017. AMSTERDAM: ELSEVIER.

Angevin, Eric, Bauer, Todd M., Ellis, Catherine E., Gan, Hui, Hall, Rigel, Hansen, Aaron, Hoos, Axel, Jewell, Roxanne C., Katz, Jessica, Martin-Liberal, Juan, Maio, Michele, Mayes, Patrick A., Mazumdar, Jolly, Millward, Michael, Rischin, Danny, Schellens, Jan H., Yadavilli, Sapna and Zhou, Helen (2017). INDUCE-1: a phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with selected, advanced solid tumors. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington Dc, Apr 01-05, 2017. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2017-CT039

Hansen, Aaron Richard, Shapiro, Geoffrey, Do, Khanh T., Kumar, Rajiv, Martin-Liberal, Juan, Higano, Celestia S., Wisinski, Kari Braun, Dean, Emma Jane, Heath, Elisabeth I., Dana, E. Rathkopf, Linch, Mark David, Barry, Simon T., Brugger, Wolfram, De Bruin, Elza, Colebrook, Steve, Klinowska, Teresa, Mitchell, Patrick D., Moorthy, Ganesh, De Bono, Johann S. and Siu, Lillian L. (2017). A first in human phase I study of AZD81 86, a potent and selective inhibitor of PI3K in patients with advanced solid tumours as monotherapy and in combination with the dual mTORC1/2 inhibitor vistusertib (AZD2014) or abiraterone acetate. 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.2570

Krishnamurthy, Anuradha, Dasari, A., Noonan, Anne M., Mehnert, Janice M., Lockhart, Albert C., Stein, Mark N., Sanoff, Hanna Kelly, Lee, James J., Hansen, Aaron Richard, Malhotra, Usha, Rippke, Sarah, Davis, Sarah Lindsey, Messersmith, Wells A., Eckhardt, S. Gail and Christopher, (2017). A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC). 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.2587

Clouthier, Derek L., Yang, Cindy, Lien, Scott, Gray, Diana, Colombo, Ilaria, Lheureux, Stephanie, Lewin, Jeremy Howard, Razak, Albiruni Ryan Abdul, Spreafico, Anna, Bedard, Philippe L., Butler, Marcus O., Day, Daphne, Hansen, Aaron Richard, Pugh, Trevor John, Chow, Helen, Kobori, Sawako, Giesler, Amanda, Ohashi, Pamela S. and Siu, Lillian L. (2017). A technical feasibility report on correlative studies from the investigator-initiated phase II study of pembrolizumab (Pembro) immunological response evaluation (INSPIRE). 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.11607

Lewin, Jeremy Howard, Dufort, Paul, Halankar, Jaydeep, O'Malley, Martin, Jewett, Michael A. S., Hamilton, Robert James, Gupta, Abha A., Lorenzo, Armando J., Traubici, Jeffrey, Nayan, Madhur, Leao, Ricardo Romao Nazario, Warde, Padraig Richard, Chung, Peter W. M., Anson-Cartwright, Lynn, Sweet, Joan, Hansen, Aaron Richard, Metser, Ur and Bedard, Philippe L. (2017). Applying radiomics to predict pathology of post chemotherapy retroperitoneal nodal masses in germ cell tumors (GCT). 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.4559

Angevin, Eric, Barnette, Mary S., Bauer, Todd Michael, Cho, Daniel C., Ellis, Catherine Elizabeth, Gan, Hui Kong, Hansen, Aaron Richard, Hoos, Axel, Jewell, Roxanne C., Katz, Jessica, -Liberal, Juan Martin, Maio, Michele, Mayes, Patrick A., Millward, Michael, Moreno, Victor, Olszanski, Anthony J., Rischin, Danny and Schellens, Jan H. M. (2017). INDUCE-1: A phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with advanced solid tumors. 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.TPS3113

Cescon, David W., Hansen, Aaron Richard, Razak, Albiruni Ryan Abdul, Stayner, Lee-Anne, Hilton, John Frederick, Renouf, Daniel John, Denny, Trisha, Fletcher, Graham, Mak, Tak W., Bray, Mark R. and Bedard, Philippe L. (2017). Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors. 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.TPS2619

Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Zalewski, Pawel, Canil, Christina M., Winquist, Eric, Hotte, Sebastien J., North, Scott A., Heng, Daniel Yick Chin, Macfarlane, Robyn Jane, Venner, Peter M., Kapoor, Anil, Hansen, Aaron Richard, Eigl, Bernhard J., Czaykowski, Piotr, Boyd, Ben, Wang, Lisa and Basappa, Naveen S. (2017). Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.4514

Fallah-Rad, Nazanin, Lee, Roy, Ng, Pamela, Smith, Alan D., Hansen, Aaron Richard, Joshua, Anthony M. and Sridhar, Srikala S. (2017). Strategies to minimize wastage of expensive drugs in expensive times: Cabazitaxel, a single center experience. 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago Il, Jun 02-07, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.e18297

Day, Daphne, Spreafico, Anna, Lheureux, Stephanie, Razak, Albiruni Ryan Abdul, Hansen, Aaron Richard, Wang, Lisa, Butler, Marcus O., Siu, Lillian L. and Bedard, Philippe L. (2017). Validation of the Princess Margaret immune oncology prognostic index (PM-IPI) for patients (pts) treated in immune oncology (IO) early phase trials. 53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2017.35.15_suppl.3070

Nayan, Madhur, Daugaard, Gedske, Jewett, Michael, Lauritsen, Jakob, Bandak, Mikkel, Mortensen, Mette Saksoe, Kier, Maria Gry Gundgaard, Bedard, Philippe, Hansen, Aaron, Warde, Padraig, Chung, Peter, Atenafu, Eshetu and Hamilton, Robert (2017). LECONDITIONAL RISK OF RELAPSE IN 3,601 PATIENTS MANAGED WITH SURVEILLANCE FOR STAGE I TESTICULAR CANCER. Annual Meeting of the American-Urological-Association (AUA), Boston Ma, May 12-16, 2017. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.juro.2017.02.2404

Krishnamurthy, Anuradha, Dasari, A., Lockhart, Albert C., Stein, Mark N., Sanoff, Hanna Kelly, Lee, James J., Hansen, Aaron Richard, Bekaii-Saab, Tanios S., Malhotra, Usha, Rippke, Sarah, Davis, Sarah Lindsey, Messersmith, Wells A., Yao, James C., Meric-Bernstam, Funda, Eckhardt, S. Gail and Lieu, Christopher Hanyoung (2017). A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC). 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago Il, Jun 02-07, 2017. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2017.35.4_suppl.609

Hansen, A. -M. and Bartels, P. (2016). MEASURING PATIENT SAFETY USING CLINICAL REGISTRIES - OPPORTUNITIES AND AREAS FOR IMPROVEMENT. OXFORD: OXFORD UNIV PRESS.

Lee, Sangjune, Cabanero, Michael, Hyrcza, Martin, Butler, Marcus, Liu, Fei-Fei, Hansen, Aaron, Huang, Shao Hui, Tsao, Ming, Song, Yuyao, Xu, Wei, Goldstein, David, Weinreb, Ilan and Bratman, Scott (2016). COMPUTER- ASSISTED IMAGE ANALYSIS OF AN ORAL CAVITY SQUAMOUS CELL CARCINOMA TISSUE MICROARRAY. CLARE: ELSEVIER IRELAND LTD.

Rathod, Shrinivas, Huang, Shao Hui, Su, Jie, Kim, John, Waldron, John, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Ringash, Jolie, Hansen, Aaron, Goldstein, David, Tong, Li, Xu, Wei and O'Sullivan, Brian (2016). IMPACT OF TUMOUR VOLUME AND THE SURROGATE EFFECT OF LYMPH NODE LOCATION ON THE RISK OF DISTANT METASTASIS IN NASOPHARYNGEAL CANCER. CLARE: ELSEVIER IRELAND LTD.

Huang, Shao Hui Sophie, Bratman, Scott V., Su, Jie, Tong, Li, Kim, John, Waldron, John, Hansen, Aaron, Goldstein, David, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Ringash, Jolie, Xu, Wei and O'Sullivan, Brian (2016). PROGNOSTIC VALUE OF PRE-TREATMENT SERUM LACTATE DEHYDROGENASE IN HPV-RELATED AND HPV-UNRELATED OROPHARYNGEAL CANCER. CLARE: ELSEVIER IRELAND LTD.

Hansen, Aaron R., Infante, Jeffrey R., McArthur, Grant, Gordon, Michael S., Lesokhin, Alexander M., Stayner, Ann-Lee, Bauer, Todd M., Sandhu, Shahneen, Tsai, Frank, Snyder, Alexandra, Subramaniam, Deepa S., Kim, Jeong, Stefanich, Eric, Li, Chi-Chung, Ruppel, Jane, Anderson, Maria, Gilbert, Houston, McCall, Bruce, Huseni, Mahrukh A., Rhee, Ina and Pishvaian, Michael (2016). A first -in -human phase I dose escalation study of the 0X40 agonist MOXR0916 in patients with refractory solid tumors. 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), New Orleans La, Apr 16-20, 2016. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Capasso, Anna, Dasari, Arvind, Lockhart, A. Craig, Stein, Mark, Sanoff, Hanna, Lee, James, Hansen, Aaron, Bekaii-Saab, Tanios, Rippke, Sarah, Yao, James, Meric-Bernstam, Funda, Eckhardt, S. Gail and Lieu, Christopher H. (2016). A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC). 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), New Orleans La, Apr 16-20, 2016. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2016-CT146

Infante, Jeffrey R., Hansen, Aaron Richard, Pishvaian, Michael J., Chow, Laura Quan Man, McArthur, Grant A., Bauer, Todd Michael, Liu, Stephen V., Sandhu, Shahneen Kaur, Tsai, Frank Yung -Chin, Kim, Jeong, Stefanich, Eric, Li, Chi -Chung, Gilber, Houston, Mccall, Bruce, Anderson, Maria S., Huseni, Mahrukh, Rhee, Ina Park, Siu, Lillian L. and Gordon, Michael S. (2016). A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor atezolizumab in patients with advanced solid tumors. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.101

Day, Daphne, Joshua, Anthony M., Wang, Lisa, Razak, Albiruni R., Hansen, Aaron Richard, Leighl, Natasha B., Butler, Marcus O., Spreafico, Anna, Siu, Lillian L. and Bedard, Philippe L. (2016). Development of the Princess Margaret Immune Oncology Prognostic Index (PM-IPI): A novel prognostic score for patients (pts) treated in immune oncology (IO) phase I (P1) trials. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2016.34.15_suppl.3058

Mesia, Ricard, Bossi, Paolo, Hansen, Aaron Richard, Hsieh, Ching-Yun, Licitra, Lisa F., Tan, Eng-Huat, Begic, Damir, Li, Li, Fandi, Abderrahim, Siu, Lillian L. and Haddad, Robert I. (2016). Interim results from a phase II study of CC-486 in previously treated patients (pts) with locally advanced/metastatic nasopharyngeal cancer (NPC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2016.34.15_suppl.6029

Hansen, Aaron Richard, Tannock, Ian, Prawira, Amy, Knox, Jennifer J., Templeton, Arnoud J., Vera-Badillo, Francisco, Chen, Eric Xueyu, Zavitz, Mary-Beth, Wang, Lisa, Evans, Andrew, Tan, Susie, Wouters, Brad, Sridhar, Srikala S. and Joshua, Anthony M. (2016). Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): a phase II trial in men with castration resistant prostate cancer (mCRPC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.e16502

Prawira, Amy, Oosting, Sjoukje, Chen, Tom Wei-Wu, Saluja, Ronak, Delos Santos, Keemo, Wang, Lisa, Siu, Lillian L., Chan, Kelvin K. and Hansen, Aaron Richard (2016). Systemic therapies for recurrent/metastatic nasopharyngeal carcinoma (RM NPC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.6031

Day, Daphne, Khoja, Leila, Chen, Tom Wei-Wu, Siu, Lillian L. and Hansen, Aaron Richard (2016). Tumor- and class-specific patterns of immune-related adverse events (irAEs) of immune checkpoint inhibitors (ICIs): A systematic review (SR). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.3065

Lewin, Jeremy Howard, Bedard, Philippe L., Hamilton, Robert James, Chung, Peter W. M., Moore, Malcolm J., Jewett, Michael A. S., Anson-Cartwright, Lynn, Virtanen, Carl, Winegarden, Neil, Haibe-Kains, Benjamin, Warde, Padraig Richard, Sweet, Joan and Hansen, Aaron Richard (2016). Gene-expression signatures as prognostic for relapse in stage I testicular germ cell tumors (TGCT). Genitourinary Cancers Symposium, San Francisco Ca, Jan 07-09, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2016.34.2_suppl.493

McPartlin, Andrew, Hosni, Ali, Bedard, Philippe L., Hansen, Aaron Richard, Jewett, Michael A. S., Hamilton, Robert James, O'Malley, Martin, Sweet, Joan, Warde, Padraig Richard and Chung, Peter W. M. (2016). Optimization of an imaging protocol for stage I seminoma surveillance based on variations in relapse location over time. American-Society-of-Clinical-Oncology Genitourinary Cancers Symposium (ASCO-GU), San Francisco Ca, Jan 07-09, 2016. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/jco.2016.34.2_suppl.475

Bedard, Philippe L., Oza, Amit, Clarke, Blaise, Tsao, Ming-Sound, Leighl, Natasha B., Chen, Eric X., Razak, Albiruni, Berman, Hal K., Serra, Stefano, Roehrl, Michael, Califaretti, Nadia, Trinkaus, Mateya, Zhang, Tong, Sukhai, Mahadeo A., Milea, Anca, Hansen, Aaron R., Pugh, Trevor J., Stockley, Tracy, Kamel-Reid, Suzanne and Siu, Lillian L. (2016). Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials. Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy, Salt Lake Ut, Jun 13-16, 2015. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1557-3265.PMSCLINGEN15-PR03

Rathod, S., Huang, S. H., Kim, J. H., Su, S., Xu, W., Waldron, J., Bayley, A., Bratman, S., Cho, J., Giuliani, M. E., Hope, A. J., Ringash, J. G., Hansen, A., Goldstein, D., Tong, L., Perez-Ordonez, B., Weinreb, I. and O'Sullivan, B. (2015). Natural Course Following Failure After Definitive Chemoradiation Therapy in HPV-Related and HPV-Unrelated Oropharyngeal Cancer. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio Tx, Oct 18-21, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2015.07.1322

Hosni, A., Huang, S. H., Goldstein, D., Xu, W., Chan, B., Hansen, A., Bayley, A., Bratman, S., Cho, J., Giuliani, M. E., Hope, A. J., Kim, J. J., O'Sullivan, B., Waldron, J. and Ringash, J. G. (2015). Outcome Predictors for Major Salivary Gland Carcinoma Following Postoperative Radiation Therapy. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio Tx, Oct 18-21, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2015.07.1336

O'Sullivan, B., Huang, S. H., Waldron, J., Su, S., Bayley, A., Bratman, S., Cho, J., Giuliani, M. E., Hope, A. J., Kim, J. H., Ringash, J. G., Hansen, A., Goldstein, D., Tong, L., Perez-Ordonez, B., Weinreb, I., Liu, F. F. and Xu, W. (2015). Reaffirming Metastatic Risk Profiles in Human Papillomavirus-related Oropharyngeal Cancer Following Definitive Radiation Therapy With or Without Chemotherapy. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio Tx, Oct 18-21, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2015.07.415

Huang, S. H., Waldron, J., Su, S., Tong, L., Bayley, A., Bratman, S., Cho, J., Giuliani, M. E., Hope, A. J., Kim, J. H., Ringash, J. G., Hansen, A., Goldstein, D., Perez-Ordonez, B., Weinreb, I., Xu, W., Liu, F. F. and O'Sullivan, B. (2015). Risk Stratification for Relapse in Human Papillomavirus-Unrelated Oropharyngeal Carcinoma Treated With Definitive Radiation Therapy With or Without Chemotherapy. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio Tx, Oct 18-21, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2015.07.310

Oosting, S. F., Chen, T. W. W., Huang, S. H. H., Wang, L., Waldron, J., Gilbert, R., Goldstein, D. P., Halmos, G. B., Witjes, M. J. H., Gietema, J. A., O'Sullivan, B., Langendijk, J. A., Siu, L. L. and Hansen, A. R. (2015). A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(16)31601-X

Siu, Lillian L., Papadopoulos, Kyriakos P., Tsai, Frank Yung-Chin, Hansen, Aaron Richard, Robbins, Paul B., Li, Xia, Lai, Dominic W., Blake-Haskins, John A. and Fury, Matthew G. (2015). Phase I study to evaluate the safety and efficacy of MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago Il, May 29-Jun 02, 2015. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2015.33.15_suppl.tps3090

Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Canil, Christina M., Winquist, Eric, Zalewski, Pawel, Hotte, Sebastien J., North, Scott A., Heng, Daniel Yick Chin, Macfarlane, Robyn Jane, Venner, Peter M., Tannock, Ian, Kapoor, Anil, Eigl, Bernhard J., Hansen, Aaron Richard, Czaykowski, Piotr, Boyd, Ben and Basappa, Naveen S. (2015). Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago Il, May 29-Jun 02, 2015. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2015.33.15_suppl.4555

Chen, Wei-Wu, Razak, Albiruni R. A., Bedard, Philippe L., Siu, Lillian L. and Hansen, Aaron Richard (2014). A systematic review of immune-related adverse event (irAE) reporting in clinical trials of immune checkpoint inhibitors (ICIs). 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 30-Jun 03, 2014. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/jco.2014.32.15_suppl.3057

Hansen, Aaron Richard, Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni R. A., Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L. and Hinrichs, Mary Jane (2014). Choice of starting dose for biopharmaceuticals in first-in-human phase I cancer clinical trials. 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 30-Jun 03, 2014. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/jco.2014.32.15_suppl.2596

Goncalves, Priscila Hermont, Kummar, Shivaani, Siu, Lillian L., Hansen, Aaron Richard, Savvides, Panayiotis, Sukari, Ammar, Chao, Joseph, Heilbrun, Lance K., Pilat, Mary Jo, Smith, Daryn W., Casetta, Lindsay, Boerner, Scott Anthony and LoRusso, Patricia (2013). A phase II study of suberoylanilide hydroxamic acid (SAHA) in subjects with locally advanced, recurrent, or metastatic adenoid cystic carcinoma (ACC). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Bedard, Philippe L., Oza, Amit M., Tsao, Ming-Sound, Leigh, Natasha B., Shepherd, Frances A., Chen, Eric Xueyu, Tannock, Ian, Krzyzanowska, Monika K., Dhani, Neesha C., Clarke, Blaise, Berman, Hal K., Serra, Stefano, Craddock, Kenneth J., Chadwick, Dianne, Zhang, Tong, Sukhai, Mahadeo A., Yu, Celeste, Hansen, Aaron Richard, Kamel-Reid, Suzanne and Siu, Lillian L. (2013). Princess Margaret Cancer Centre (PMCC) Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT) using genotyping and targeted next-generation sequencing (NGS). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Hansen, Aaron Richard, Brown, Andrew M. K., Bedard, Philippe L., Hotte, Sebastien J., Winquist, Eric, Goss, Glenwood D., Vergidis, Dimitrios, Hirte, Hal W., Welch, Stephen, Zhang, Tong, Stein, Lincoln D., Ferretti, Vincent, Watt, Stuart, Jiao, Wei, Ng, Karen, Petrocelli, Teresa, Siu, Lillian L., McPherson, John D., Kamel-Reid, Suzanne and Dancey, Janet (2013). Real-time clinical application of next-generation sequencing (NGS): Results from a multicenter program. 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Browne, Daniel, Kempf, Robert, Hansen, Aaron, O'Neal, Michael and Yates, William (2013). Enabling Systems Modeling Language Authoring in a Collaborative Web-based Decision Support Tool. 11th Annual Conference on Systems Engineering Research (CSER), Atlanta Ga, Mar 19-22, 2013. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/j.procs.2013.01.039

Hansen, A., Colosimo, M., Fong, K., Yang, I. A., Bowman, R. V., Clarke, B. E., Duhig, E. E., Maar, K. and Windsor, M. (2011). The prognostic significance of high risk features in Resected Nsclc: a single institution retrospective review. 3rd Australian Lung Cancer Conference (ALCC), Melbourne, VIC Australia, 7-9 October 2010. New York, NY United States: Elsevier.

Toscano, LS, Hansen, AM, Nielsen, M, Arpi, M and Grunnet, N (2004). Evaluation of an enhanced bacterial detection system in leucocyte depleted platelets stored in platelet additive solution. 57th Annual Meeting of the American-Association-of-Blood-Banks, Baltimore Md, Oct 23-26, 2004. MALDEN: BLACKWELL PUBLISHING INC.

Hougaard, KS, Andersen, MB, Hansen, ÅM, Hass, U, Werge, T and Lund, SP (2003). Differential effects of stress and toluene in fetal life. 2nd World Congress on Dietal Origins of Adult Disease, Brighton England, Jun 07-10, 2003. BALTIMORE: INT PEDIATRIC RESEARCH FOUNDATION, INC.

Associate Professor Aaron Hansen

Publications

Book Chapter

Journal Articles

Conference Papers